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Abstract
Vita  Medical  Lt  approached  the  principal  researcher  at  Bankstown 
Hospital Nuclear Medicine department, to examine the possibility of using 
positive  ventilation  for  patients  unable  to  undergo  the  conventional 
method  of  lung  scintigraphy.  In  consequence,  a  report  and  a 
manufacturing study were produced for Vita Medical to substantiate the 
use of positive ventilation – TEBA - for the above patient groups. As a 
result of these findings and initial research work, this was the first time in 
Australia’s field of nuclear medicine such equipment was used for the 
diagnosis of Pulmonary Embolism. Learning how TEBA apparatus works 
and conducting several research studies enabled this knowledge to be 
passed onto other medical radiation scientists.
The Technegas system is in common use for lung ventilation scintigraphy but 
cannot easily be used in Chronic Airways Limitation or CAL patients due to 
their moderate to severe dyspnoea, hence the need for the Technegas Easy 
Breather Accessory or TEBA apparatus.
The findings of this thesis represent a novel aspect in lung ventilation imaging 
involving a series of experiments with this new apparatus known as TEBA. The 
investigations  were undertaken  with  both  normal  and  Chronic  Airways 
Limitation (CAL) volunteers and with Intubated Intensive Care patients. 
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This study centred around four experiments:
Experiment 1 TEBA with CAL patients and normal volunteers
Experiment 2 TEBA with Pulmonary Embolism (PE) patients and 
normal volunteers.
Experiment 3 TEBA with Intensive Care patients
Experiment 4 Using Technegas with an electron microscope to study 
patients with known lung disease who had lung 
ventilation scan prior to a bronchoscopy.
The  findings  provide  important  new  information  about  the  effectiveness  of 
TEBA and the action of Technegas at the cellular level. Significantly, the results 
have  the  potential  to  change  the  current  thought  on  Technegas  ventilation 
imaging and its distribution throughout the nuclear medical community.
The data presented in this research were collected from 144 patients in total. In 
experiment 1 there were 25 normal volunteers who underwent  conventional 
ventilation imaging and 25 normal volunteers who underwent TEBA assisted 
ventilation imaging, while in experiment 2, there were 25 volunteers with CAL 
for conventional  ventilation and 25 for TEBA; in experiment  3,  25 Intensive 
Care Patients only had TEBA as they were intubated and therefore required 
the assistance of positive pressure for their lung ventilation;  moreover these 
patients were too ill  to  undergo two parts.  For experiment four,  20 patients 
volunteered  to  have  a  Technegas  ventilation  completed  prior  to  their 
bronchoscopy procedure.
The  major  findings  are  presented  in  experiments  one  and  two.  These 
demonstrated that TEBA was effective in distinguishing normal lung ventilation 
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from  ventilation  defects  found  in  Chronic  Airways  Limitation  (CAL)  and 
Pulmonary Embolism (PE). 
Experiment three demonstrated both normal and PE ventilation patterns of 
uptake  in  a  group  of  Intensive  Care  Patients  (ICU)  who  were  not  able  to 
undergo the TEBA procedure. This experiment with ICU showed that TEBA 
ventilation imaging could be used on ventilated and unconscious patients. This 
has significant implications for the diagnosis and treatment for patients in ICU 
who formerly could not undergo this procedure. The results of this experiment 
will have implications for improving the diagnosis and treatment of patients in 
critical care. 
The final experiment four studied the action of Technegas at the cellular level 
and was mainly focussed on the chemical composition of Technegas and its 
physical structure.
The findings of this thesis provide further evidence for the first line role of lung 
scintigraphy  in  the  diagnosis  of  Pulmonary  Embolism (PE).  This  is  of  vital 
importance  to  the  large  number  of  patients  who  are  at  risk  from  the  life-
threatening  diseases  of  PE  and  Deep  Venous  Thrombosis  (DVT).  This  is 
because timely lung ventilation imaging in the diagnosis and follow-up phase of 
these diseases will  reduce the clinical uncertainty in directing treatment and 
consequently lower health care costs. 
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Abbreviations and Glossary of Terms
Important terms to know in the Intensive Care Unit
Tidal Volume (Vt) Volume of air inspired or expired during normal breathing (Hess 
1996 Essentials of Ventilation)
Respiratory Rate Mandatory or fixed breath rate is the total frequency of breaths 
per  minute.  Spontaneous  or  unprompted  breath  rate  is 
dependent  on patient’s  own  effort  (Fahey 1995  ICU Liverpool 
Health Service)
Minute Volume Inspiratory rate x Vt in one minute. Minute volume is utilized to 
set the lower  and upper minute volume alarm limits.  Adjusting 
either tidal volume or respiratory rate will affect  Partial Pressure 
of Carbon Dioxide PaCO2. This is an important measure, as an 
increase may cause Acute Respiratory Acidosis while a decrease 
may cause Acute Respiratory Alkalosis (Fahey 1995)
Fraction of inspired 
oxygen (FIO2)
Sets oxygen  concentration  in  the gas delivered to the patient. 
The normal setting range is from 21% (room air) to 100% (SW 
Area Health Service ICU Guideline May 2000)
Sensitivity Patient  effort  or  triggering  device.  Also  known  as  amount  of 
negative  pressure  or  flow change  patient  must  generate  from 
circuit  to  initiate  assisted  breath  within  SIMV  or  intermittent 
mandatory  ventilation  (Hess  1996  Essentials  of  Mech. 
Ventilation)
Inspiratory Time Total inspiratory time measured per breath in secs (Fahey 1995)
Inspiratory pause Apneustic episode of 15 seconds or more. Apneusis or apneustic 
breathing is an abnormal  breathing pattern characterized by a 
prolonged pause at full  inspiration.  Also called inspiratory hold, 
end inspiratory pause and plateau, maintains air in lungs at the 
end of inspiration (Fahey 1995)
Expiratory time Total expiratory time measured per breath in secs (Fahey 1995)
Inspiratory: 
Expiratory (I: E) ratio
Comparing inspiration  to  expiration  as  fraction  or  ratio  (Fahey 
1995)
Inverse I: E ratio Reciprocal of I: E ratio (Fahey 1995)
Peak Flow / Flow Rate Peak  flow  rate  is  the  speed  with  which  the  tidal  volume  is 
delivered.  It  is  measured  in  litres  per  minute  (Hess  1996 
Essentials of Mechanical Ventilation)
Pressure Support Defines  inspiratory  pressure  during  pressure-supported  breath 
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Level (Hillman Liverpool Health Service-Sydney in Critical Care)
Inspiratory pressure Defines inspiratory pressure during a pressure-controlled breath 
(Hillman Liverpool Health Service)
Peak Inspiratory 
Pressure
Maximum airway pressure reached during the delivery of gas into 
the patient circuit and is dependent on lung compliance, airway 
resistance,  tidal  volume  and  flow  pattern  (Hillman  Liverpool 
Health Service)
PEEP – Positive End 
Expiratory Pressure
The  aim  of  mechanical/artificial  ventilation  is  to  improve  gas 
exchange, and thus reduce the work of breathing. Used to set 
the desired level of PEEP in cm H2O (SW Area Health Service 
ICU Guideline May 2000)
Pressure Limit The ventilator delivers a breath until set pressure is reached then 
vents remaining gas (SW Area Health Service ICU Guideline)
Accelerating 
Waveforms
Section of waveform where flow rate is increasing with time. Flow 
gradually accelerates in a linear fashion to already set peak flow 
rate (SW Area Health Service ICU Guideline).
Square Waveform Reaches  its  peak  flows  rapidly  and  maintains  this  rate  until 
breath is delivered.  Peak flow rate is  delivered immediately at 
onset  of  inspiration,  maintained  throughout  inspiratory  phase, 
and abruptly terminated at onset of expiration. This is the most 
commonly  used  wave  pattern  (SW  Area  Health  Service  ICU 
Guideline).
Sine Waveform The  sine  waveform  was  designed  to  match  the  normal  flow 
waveform of a spontaneously breathing patient. Inspiratory flow 
rate gradually accelerates to peak flow and then tapers off. (SW 
Area Health Service ICU Guideline)
Weaning a patient 
from ventilation
Weaning means that a patient will go through a gradual transition 
from mechanical  ventilatory support  to  spontaneous breathing. 
(Laghi 1995 Weaning: Current opinion in Critical Care 1: p.71-76)
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CHAPTER 1 LITERATURE REVIEW
1. 1 Introduction
According  to  Van Beek,  1996,  Pulmonary  Embolism (PE)  is  responsible  for 
more deaths than any other single disease yet it is often under diagnosed. Beek 
suggests PE will only be diagnosed in thirty percent (30%) of cases, while Faiad 
and associates (1997) report that “Pulmonary Embolism” is the leading cause of 
death in all age groups. A good clinician who suspects their patient may have 
PE, actively  pursues a definitive  and prompt diagnosis,  because the correct 
diagnosis and treatment can dramatically reduce the mortality of the disease 
(Faiad 1997).
PE is  seen  as  such  a  serious life-threatening  illness  because  it  can cause 
permanent damage to part of the lung due to the lack of blood supply to lung 
tissue, resulting in cyanosis from low blood oxygen levels or leading to damage 
of other vital organs from lack of oxygen (Howarth, 1999).  Acute respiratory 
consequences of pulmonary embolism include increased alveolar dead space, 
pneumoconstriction, hypoxia and hyperventilation.  Prolonged exposure to lack 
of  perfusion  includes regional  loss  of  surfactant  and subsequent  pulmonary 
infarction (Kamanger, 2010).
If  a  large  enough  clot  is  left  untreated,  PE  will  cause  death.  Of  the  many 
patients who die every year from PE, most die within thirty (30) to sixty (60) 
minutes after symptoms commence (Howarth, 1999).
PE is one of the most common causes of death in hospitalised patients who 
must  remain  immobilised.  The  greatest  risk  of  PE  occurs  in  patients  with 
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previous  deep  vein  thrombosis  (DVT)  or  a  history  of  previous  PE  (Clinical 
Imaging, 1994). In addition, the risk of PE doubles every ten (10) years after the 
age of sixty-five (65) (Faiad, 1997).  Therefore, in order to effect, timely and 
appropriate  treatment  of  this  disease,  it  is  important  to  gain  an  accurate 
diagnosis of PE as quickly as possible. There are various types of diagnostic 
tools used in the clinical diagnosis of PE.  These tools are:
 Physical examination of the patient
 Chest Radiograph (CXR)
 Computerised Tomography (CT)
 Pulmonary Angiography
 Computed Tomographic Angiography (CTA)
 Lung Scintigraphy
1.2 Examining patients
1.2.1 Physical examination
According to Faiad (1999), PE can be so lethal that the diagnosis should be 
sought  actively  in  any  patients  presenting  with  chest  symptoms.  These 
symptoms may be chest wall and shoulder pain, wheezing, palpitations, and in 
the  relatively  small  number  of  patients  who  present  with  haemoptysis, 
suggesting an embolus. 
Thus the physical examination is of vital importance to the diagnosis of PE. The 
majority of PE patients demonstrate an increased respiratory rate and present 
with rates audible on auscultation. An increased second heart sound is also 
common (Ramzi, 1994). Other physical signs of PE may include tachycardia, 
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increased  temperature,  physical  evidence  of  phlebitis,  cardiac  tamponade, 
diaphoresis, oedema, cardiac murmur and cyanosis (Ramzi, 1994). In addition, 
patients with PE often present with primary or isolated complaints of seizure, 
syncope,  productive  cough,  fever,  new  onset  of  a  reactive  airway  disease 
known as “Adult Asthma” and/or atrial fibrillation as well as an array of other 
symptoms (Faiad 1997). It is therefore not surprising that the clinical diagnosis 
of  PE  is  fraught  with  error.  Signs  and  symptoms  serve  only  to  raise  the 
suspicion of PE.
1.2.2 Chest Radiograph
The chest radiograph (CXR) is often the first imaging procedure obtained as the 
patient  presents with  dyspnoea.   Many studies have reported that  a  normal 
CXR occurs only in the minority of cases of PE.  However in most patients with 
a positive diagnosis of PE the CXR is often abnormal. For example, a study by 
Galvin and associates in 1994 of patients with PE and no pre-existing cardiac or 
pulmonary  disease  reported  only  fourteen  percent  (14%)  of  the  chest 
radiographs were normal. 
Thus the standard CXR on its own may display densities that could indicate the 
presence  of  a  number  of  pulmonary  disorders.  For  example,  areas  of 
Atelectasis  have  been  found  in  the  lower  lobe  and  reported  as  areas  of 
parenchymal density (Rays, 1996). In addition, after twenty-four (24) to forty - 
eight  (48)  hours,  one  third  of  the  patients  with  proven  PE  develop  focal 
infiltrates and signs of pneumonia on their CXR. To further complicate the use 
of CXR results, most of the densities that appear in the CXR are caused by 
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pulmonary haemorrhaging and oedema and can be confused with  infectious 
infiltrates or malignant masses (Rays, 1996).
Pleural effusions are commonly reported on the CXR and are mostly unilateral 
despite the fact that most clots are bilateral (Faiad, 1997). In many cases the 
diaphragm may be elevated, reflecting volume loss in the affected lung and the 
central  pulmonary  arteries  may  be  prominent  either  from  pulmonary 
hypertension or the presence of a clot in those arteries (Faiad, 1997). 
As a result of the variable findings on the CXR, in isolation from other imaging 
procedures, the CXR is not able to provide a positive diagnosis for PE (Rays, 
1996). Therefore, although a useful first line of attack in the diagnosis of PE the 
CXR  can  only  assist  in  evaluating  an  alternative  diagnostic  consideration 
(Clinical Imaging, 1994). 
1.2.3 Computerised Tomography (CT)
In contrast to the CXR, the faster scan times in current generation CT scanners 
enable  CT to  provide  a  more  detailed  assessment  of  the  lung parenchyma 
(Madan, 2000). For example, CT is able to readily identify a bulging appearance 
at the boarders of the lungs due to the affected lobule being filled with blood 
and oedematous fluid (Van Beek, 1996).  CT is also able to resolve a linear 
strand at the apex that usually represents a distal pulmonary artery filled with a 
clot,  while  low attenuation areas on CT usually represent  viable lung tissue 
(Faiad, 1997).
Since the clinical  presentation of PE is non-specific,  the findings on CT are 
often  the  first  clinical  indication  that  the  patient  may  be  suffering  from  PE 
(Murray, 1988). In addition to visualising the area of infarction, CT can see the 
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exact  location of the clot.  CT has also been shown to be useful  in patients 
suffering  from  CAL,  dyspnoea,  and  known  pulmonary  artery  hypertension 
(Clinical Imaging, 1994). These diseases are all difficult to diagnose. 
Recent  improvements in  the resolution of  CT have enabled this  modality  to 
image very small PE. Therefore one may ask what is the risk-to-benefit ratio of  
anticoagulating these patients with small sub-segmental PE who have no other 
clot  and  no ongoing  risk  factors  for  venous thromboembolism (Rays  1996). 
Despite these improvements in technology,  a major consideration particularly 
for patients receiving multiple CT scans, is the significant radiation burden that 
CT delivers to the patient (Clinical Imaging, 1994).
1.2.4 Pulmonary Angiography
Until  the  advent  of  high  resolution  helical  (spiral)  computed  tomographic 
angiography (CTA), pulmonary angiography was known as the “gold standard” 
imaging  procedure  for  identifying  emboli  that  lodge  in  segmental  or  larger 
arteries. Pulmonary angiography has the major disadvantage of being highly 
invasive and not without risks to the patient as it requires the placement of a  
catheter from either the femoral or a peripheral vein through the right - sided 
cardiac structures including the right atrium, tricuspid valve and right ventricle 
into the main pulmonary artery. The catheter is then directed into either the right 
or left pulmonary artery using the ventilation perfusion scan as a “road map”. 
The  intravenous  administration  of  contrast  media  in  pulmonary  angiography 
provides a more detailed view of the pulmonary vasculature (Madan, 2000). 
The most reliable signs of PE in a pulmonary angiogram include an intraluminal 
filling  defect  and  an  abrupt  termination  of  a  branch  vessel.  In  addition, 
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pulmonary angiography is most accurate for perfusion defects in segmental and 
larger sized arteries. However, the reproducibility of readings in sub-segmental 
and smaller vessels is poor (Madan, 2000). 
The majority  of  patients  with  a  negative  angiogram have  a  good prognosis 
(Ramzi, 1994), hence the former “gold standard” status of this imaging modality.  
However, pulmonary angiography is an invasive procedure with minimal though 
measurable levels of patient morbidity and mortality (Madan, 2000). 
1.2.5 Computed Tomographic Angiography (CTA)
CTA  is  less  invasive  than  pulmonary  angiography  as  it  does  not  require 
pulmonary artery catheters and is more sensitive than pulmonary angiography 
(Clinical Imaging, 1994). Recent reports indicate that CTA’s absolute sensitivity 
and specificity is evolving over time so that much smaller emboli are able to be 
identified even in distal lung vessels (Faiad, 1997). However CTA, due to its 
high cost, is found only in major hospital centres. In addition, CTA gives a high 
radiation dose to the patient plus it cannot easily distinguish between PE, CAL 
and other overlying respiratory conditions. 
1.2.6 Lung Scintigraphy
Lung scintigraphy, also known as the V/Q scan is performed in two parts, the 
ventilation  and  the  perfusion  study  (Taylor,  2000).  The  ventilation  scan  (V) 
assesses the airflow to the lungs. In this procedure, patients are asked to inhale 
a  radioactive  aerosol  or  gas.  Images  can  then  be  taken  at  multiple  angles 
around the chest. The perfusion lung scan (Q) assesses the blood flow to the 
lungs (Taylor, 2000). Following the intravenous injection of a radioactive tracer 
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such as Macro Aggregated Albumin or MAA, patients are imaged around the 
chest using the same angles as the ventilation images (Taylor, 2000).
 Perfusion Lung scans
The  perfusion  scan  evaluates  blood  flow  within  the  lungs.  In  the  case  of 
suspected pulmonary embolus (PE), both ventilation and perfusion scintigraphy 
can be performed either simultaneously or one immediately after the other. If 
ventilation is normal but perfusion is abnormal, a “mismatch” is said to exist. 
This mismatch is often indicative of a PE (Taylor, 2000).
 Lung Perfusion Radiopharmaceuticals
The principle of the perfusion scintigraphy is simple.  It relies on the virtually 
complete removal  of  intravenously injected radioactive  particles by arteriolar 
capillary blockade. Provided these particles are mixed homogeneously in blood 
in  the  right  side  of  the  heart,  and  are  almost  entirely  extracted  from  the 
pulmonary circulation during the first passage, their appearance in the lung will 
provide images of regional pulmonary perfusion (Taylor, 2000, Murray, 1998).
 Particles used for Lung Scintigraphy
Red blood cells are 7 ± 1.5 μm in diameter and are able to pass through the 
smallest capillaries which are 8.2  + 1.5 μms in diameter (Cheng, 2000). The 
pre-capillary arterioles are 25  + 10 μm in diameter, compared with the much 
larger distribution arteries 80 + 20 μm (Cheng, 2000).  Injected particles in the 
perfusion  lung  scan  are  larger  than  particular  vessels  and  are  therefore 
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selectively  filtered out  almost  entirely on the first  pass of  blood through the 
lungs (Murray, 1988).
The most commonly used particulate material used in perfusion lung scans is 
known  as  Macro  Aggregated  Albumin  or  MAA.  The  particles  used  in  MAA 
contain the following size distribution:
10 - 20 μm 66%
20 - 40 μm 26%
40 - 60 μm   6%
60 - 80 μm   2%
Therefore most of the particles found in MAA lodge in the pre-capillary arterioles 
and not in the capillaries (Taylor, 2000). The human lung contains about 200 to 
300 x 106 pre-capillary arterioles so that a lung scanning MAA dose of 1 x 106 
particles would block only 0.3 to 0.5% of these vessels (Zöphel et al., 2009). 
Perfusion lung scanning has a reputation of great safety and can be used in 
severely ill patients without apparent ill effect (Murray, 1988).
When  macroaggregates  of  albumin  are  used,  less  than  1mg  of  protein  is 
administered.  A  considerably  larger  quantity  of  protein  must  be  given 
experimentally  before  any  effects  are  noted  (Habibian,  1999).  It  is  usually 
accepted that the adult human dose should contain 200,000 - 400,000 particles.  
Doses much below 100,000 particles may produce poor scans.  It is therefore 
important that the amount of activity added to the kits should not greatly exceed 
the manufacturer’s specifications (Murray, 1988). The TC-99m MAA vial should 
be agitated prior to withdrawing the dose. Immediately prior to injection, the 
syringe should be gently inverted a few times to ensure re-suspension of the 
particles  (Habibian,  1999).  The  radiopharmaceutical  should  be  injected  with 
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patient  supine.   The patient  should  breathe deeply  during  the  injection  and 
blood must not be drawn back into the syringe as this could cause “clumping” if 
re-injected into the patient (Taylor, 2000).
 Ventilation Scans
The ventilation scan is used to evaluate the ability of air to reach all portions of  
the lungs, whereas the perfusion scan measures the supply of blood through 
the lungs (Danjan, 1994). A ventilation and perfusion lung scintigraphy (V/Q) 
scan is most often performed to detect a PE but it is also used to evaluate lung 
function  in  people with  advanced pulmonary disease such as CAL,  Chronic 
Bronchitis and to detect the presence of shunts (abnormal circulation) in the 
pulmonary blood vessels (James, 1995). In a ventilation scan a mask is placed 
over the nose and mouth, and the patient is asked to breathe the gas while lying 
supine  on  the  gantry  table  outside  the  scanner.  Six  standard  images  are 
acquired post ventilation (Isawa, 1991); these include anterior, posterior, right 
and left anterior and posterior oblique images.
1.2.7 Ventilatory Systems
There are four types of ventilatory systems used for intubation.  Every patient 
will  be different regarding which classification and mode of ventilation will  be 
required, and this will change at different stages of their disease. In addition,  
Intermittent Positive Pressure (IPPV) has two distinct pathways, either volume 
controlled ventilation or pressure controlled ventilation; from both these groups, 
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depending on both the pathological and physical condition of the patient, there 
will be varying modes. 
1) Pressure cycled ventilation
Here the ventilator is manually set to reach an upper pressure limit; once the 
patient reaches this level, inspiration ceases and expiration commences. The 
inspiratory time, inspiratory flow rate, and tidal volume vary with every breath, 
depending on a patient’s resistance and compliance, according to Hess (1996).
2) Volume cycled ventilation
In the volume cycled system, the ventilator is set to reach a set tidal volume, 
once this tidal volume is reached, inspiration ends and expiration commences. 
The airway pressure attained, inspiratory flow rate, and inspiratory time vary 
with each breath, depending on the patient’s resistance and compliance.
3) Time cycled ventilation
If using time cycled ventilation, inspiration ends and expiration begins after a 
predetermined time interval has been reached.  Generally an inspiratory time, a 
respiratory  pause  or  plateau,  or  an  I-E  ratio  (inspiration/expiration)  are  set, 
depending  on  the  specifications  of  the  ventilator  used,  to  determine  time 
cycling. The airway pressure attained, the inspiratory flow, and the tidal volume 
vary with every breath, depending on the patient’s resistance and compliance.
4) Flow cycled ventilation
Flow cycled ventilation uses the principle that inspiration ends and expiration 
begins when the flow rate drops to a predetermined percentage of  its peak 
value. The tidal volume and inspiratory time vary with every breath, depending 
on the patient’s resistance and compliance (Fahey, 1995).
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1.3 Aerosols in Nuclear Medicine
Aerosols were discovered by Burch in 1965 and are described as very small 
particles suspended in air (Burch, 1965). Since that time research has shown 
(Atkins, 2004) that images do not really measure regional ventilation but rather 
airway patency and the relationship between ventilation and aerosol  particle 
deposition (Kuni, 2000).
With the introduction of smaller and more uniform aerosol particles it is seen 
that >70% of the deposited activity is located in the lung parenchyma (James, 
2002).
In  Chronic  Airways  Limitation  or  CAL  patients,  aerosol  droplets  of  particles 
<2.0µm are  deposited in  the  central  airways  in  greater  amounts,  roughly in 
proportion to the airways obstruction. In moderate CAL the aerosol will  show 
some central deposition, with reasonable penetration of activity to the periphery 
of the lungs. Severe CAL has marked central deposition with much impaired or 
absent peripheral penetration of the labelled aerosol (James, 2002).
Aerosols that have been used in Nuclear Medicine lung scintigraphy include:
133Xe Xenon, 
127Xe Xenon
 Krypton-81m
Tc-99m Diethylene triamine-pentacetic acid (DTPA)
Tc 99m Technegas.
1.3.1 133Xe Xenon
Since its introduction in 1965, 133Xe had been the most widely used radionuclide 
for assessing pulmonary ventilation (Cherng, 2000).  More recently,  127Xe also 
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has  been  used  (Cherng,  2000).   Since  Xenon  is  physiologically  inert,  the 
relatively long physical half-lives of 133Xe (5.3 days) and 127Xe (36.4 days) do not 
contribute to patient radiation exposure.  This is because most of the gas is 
removed  from the  body by expiration.  The usual  activity  administered for  a 
single 133Xe wash-out procedure ranges between 370 and 740 MBq. Ventilation 
scanning  is  undertaken  by  using  radioactive  Xenon,  for  which  the  patient 
breathes through a closed gas delivery system (Cherng, 2000).
Upon injection of Xenon gas into the delivery system, it starts to be taken into 
the lungs. This process of “wash in” is recorded. Further imaging is done during 
equilibrium and finally the system is opened to room air during inhalation which 
leads to  the “wash-out”  of  the radioactive Xenon (Cherng,  2000).  When Tc-
labelled aerosols are used, the agent sticks to the bronchiolar and alveolar walls 
once  inhaled,  thus  allowing  the  measurement  of  uptake  and  equilibrium 
distribution, but not the wash-out (Cherng, 2000).
Xenon-133 (gamma energy lower than Tc-99m, dosage 40 MBq) and aerosol 
ventilation scans (dosage 800 - 1,200 MBq = 22 -32 mCi, of which only about  
10% will actually be used) have to be acquired prior to perfusion scanning, as 
the perfusion agent remains in the lung after perfusion scanning and therefore 
also appears in the ventilation image (Cherng, 2000).
While Xe-133 scans are usually done using a dorsal projection, aerosols are 
imaged with the projections given above. Aerosols are given in a dose which is  
so small that the remaining radioactivity of the ventilation study will not interfere 
with the radioactivity from the perfusion study (Cherng, 2000).
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1.3.2 127Xe Xenon
Xe-127 (dosage 40 MBq), has a gamma energy higher than that of Tc-99m, and 
can  be  used  in  post-perfusion  ventilation  scanning  (Hannah,  1992).  The 
advantage  of  this  technique  is  that  the  projection  most  clearly  showing  a 
perfusion  defect  can  also  be  imaged  during  ventilation,  but  has  the 
disadvantages of high cost and limited availability (Cherng, 2000).
1.3.3 Krypton-81m
Krypton-81m is a poorly soluble inert gas with a 13 second half-life.  It decays to 
Krypton-81m by isomeric transition, emitting 190 KeV gamma rays and internal 
conversion  electrons  (Cherng,  2000).   The  gas  is  obtained  by  eluting  a 
generator  containing  its  4.7  hour  half-life  parent  Rubidium-81m;  this  is  a 
cyclotron  produced  positron  emitter,  hence  has  limited  availability  (Cherng, 
2000). During a ventilation scintigraphy scan, patients breathe at their own pace 
from  a  reservoir  that  stores  the  continuously  eluted  Krypton  81m  between 
inspirations.  The short time required for imaging Krypton 81m, its simplicity,  
and the low absorbed radiation dose enable images of ventilatory flow to be 
obtained in multiple views (Cherng, 2000).
1.3.4 Tc-99m DTPA Aerosol
Tc-99m  Diethylene  triamine-pentacetic  acid  (DTPA)  is  administered  via  a 
nebulizer  of  which  the  patient  should  receive  an  administered  activity  not 
exceeding  80MBq  in  the  lungs  (Clinical  Imaging,  1994).  The  amount  of 
administered activity should be reduced if the perfusion study is to be performed 
immediately after  ventilation study.  As both agents are labelled Tc-99m, the 
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count rate of the second study must be at least four times the count rate of the  
first study (Clinical Imaging, 1994). The aerosol should be administered supine. 
DTPA aerosol  from a  nebuliser  has  been  found  to  be  a  useful  marker  for 
interstitial lung disease as well as for PE (Rays, 1996). However, delivering the 
aerosol to a patient whose breathing was already compromised, is not easy nor 
always successful.
Lung ventilation imaging is frequently performed with Tc-99m DTPA, derived 
from a commercial nebuliser. Airborne contamination is a significant problem 
with this procedure; it results in exposure of staff to radiation and can reduce 
gamma camera performance when the ventilation is performed in the camera 
room. It is essential for the patient to have his/her mouth securely around the 
mouthpiece as this is where leakage of DTPA occurs when the lips are not 
tightly secured.
1.3.5 Tc-99m Technegas
A serendipitous  experience  by  Dr  Bill  Burch  in  1986,  when  he  accidentally 
inhaled an ultra-fine mist of technetium “vapour”, led to the development of a 
ventilation  agent  that  became  known  as  Technegas  (Burch  et  al,  1986). 
Technegas can be produced readily from standard sodium pertechnetate.  On 
inhalation,  it  diffuses  and  adheres  to  the  alveolar  walls,  enabling  multiple 
conventional views. The production method involves the use of a Technegas 
Generator in which 800 - 1000 MBq of Tc-99mO4- is evaporated to dryness in a 
graphite  crucible  (Lemb,  1993).   The  crucible  is  heated  to  2500oC  in  an 
atmosphere of pure Argon for 15 seconds.  The resulting vapour and Argon 
mixture are inhaled by the patient via a Patient Administration Set (PAS). The 
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Technegas  produced  is  a  dispersion  of  carbon  particles  containing  Tc-99m 
atoms, either trapped within  the core or between overlapping sheets.  These 
clusters have a maximum size of 0.017 μm and the carbon mass inhaled by a 
patient in a Technegas study was measured as 5 micrograms (+20%) (Lemb, 
1993).
Technegas,  the  radioaerosol  used  for  ventilation,  should  not  show  any 
significant  clearance  from  lungs  or  redistribution  for  the  duration  of  image 
acquisition, allowing multiple images to be taken (Senden, 1997). Technegas 
with effective half-time of 335 minutes has an advantage over Xenon 133 as it  
remains within the lung to allow multiple planar and/or Single Photon Emission 
Computed Tomography (SPECT) imaging to be done.
This 335 minute half-time is nearly equivalent to the half – life due to physical 
decay alone (361 minutes),  therefore  only  a  minimal  dose of  Technegas is 
required  for  lung scintigraphy,  resulting  in  a  relatively  low incidence of  side 
effects (Burch, 1986).
Thus  aerosol  deposition  patterns  in  the  lungs  are  helpful  in  the  differential  
diagnosis of chronic obstructive lung diseases such as CAL and diagnosing PE, 
(Burch, 1984). Technegas being an ultrafine aerosol, is probably more useful for 
ventilation studies than conventional aerosols produced by a nebulizer. Besides 
respiratory lung function, pulmonary nuclear medicine techniques have made it 
possible to study non-respiratory lung function such as mucociliary clearance 
mechanisms.
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1.4 Interpretation of Images
The interpretation of lung images will give information on the regional perfusion 
and  ventilation  of  the  lung.   The  physiological  change  caused  by  PE  is 
decreased perfusion with normal ventilation or V/Q mismatch. Most cases of PE 
are  multiple  and  reported  as  high  probability  scan  in  which  two  or  more 
segments of V/Q mismatches have occurred. Other scanning reports will have 
varying  diagnostic  yields.  High probability  of  PE shows perfusion defects  of 
greater than ninety percent (90%), intermediate 30 to 40 percent (30% - 40%), 
low probability is less than ten percent (10%) and normal lung scan is zero (0) 
(Danjun, 1994).
Repeat scintigraphy is requested in seven days for a positive result of PE to 
assess response to anticoagulant therapy. The objectives of treatment for PE 
are to  prevent  death and recurrent  DVT and PE and to  prevent  the post  – 
phlebotic syndrome (damage to valves within the deep veins).  Anticoagulant 
drugs  constitute  the  mainstay  of  treatment,  and  graduated  compression 
stockings (for up to 24 months) significantly decrease the incidence of the post-
thrombotic syndrome (Taylor, 2000).
The problems in clinical diagnosis of PE relate to the non-specificity of clinical  
signs  and  symptoms.  Other  problems  relate  to  the  invasive  nature  and 
increased  costs  associated  with  diagnostic  procedures  (Prospective 
Investigation of Pulmonary Embolism Diagnosis, PIOPED, 1990). These include 
CXR, Pulmonary Angiography,  Spiral  CT, MRI and V/Q Scans. The decision 
about  the  right  combination  of  tests  to  investigate  PE is  subject  to  various 
debates. Smith et al. 2000 believed Spiral CT was the only way to fully observe 
intraluminal filling defects, as the pulmonary arterial phase and venous phase 
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can  be  clearly  separated  after  injection  with  intravenous  contrast  medium. 
However, in a completely occluded vessel, estimation of the degree of location 
of perfusion defects is far better seen with lung scintigraphy (Early, 1995).
Economic  evaluations  of  performing  lung  scintigraphy  in  nuclear  medicine 
require a report of the analysis as well as the way in which the study has been 
performed.  A direct specification of at least two alternative programs involves 
economic evaluation, an outcome measure, method of costing, benefits, and an 
allowance  for  uncertainties  e.g.  by  implementing  a  sensitivity  analysis 
(PIOPED,1990). Decision analysis can be based on clinical trials, retrospective 
(PIOPED,1990). Decision analysis can be based on clinical trials retrospective 
studies or databases.  The outcome measure is therefore the key to an overall  
economic evaluation (PIOPED, 1990). In nuclear medicine, cost effectiveness 
analysis benefits are frequently used. Effectiveness is applied to the number of  
studies performed, survival probability, morbidity, and quality of life etc. (EJNM, 
2004). To diagnose deep venous thrombosis (DVT) is the first step in patient 
selection as it has a high incidence and significant mortality rate (Taylor, 2000). 
Patients with symptoms of chest pain, dyspnoea and tachypnoea with absent 
cardiorespiratory  disease  should  be  investigated  for  underlying  PE  (James, 
1995).  The concern for time, patient selection and various procedures can be 
overcome  by  integrating  results  in  ‘synergism’  thus  together  or  in  unison, 
therefore an added value for the patient and diagnostic evaluation.  Teamwork 
of  specialists  from  different  disciplines  is  necessary  to  integrate  their 
competencies and attain established objectives (Taylor 2000).  Advantages of 
risk stratification for diagnosis of patients suspected of having PE have been 
shaped primarily by diagnostic accuracy studies.  Much more meaningful to the 
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practice of clinical medicine are outcome studies.  There are risks and expense 
associated  with  anticoagulation  treatment,  therefore  a  certain  degree  of 
offsetting benefit of treatment.  In high probability patients treatment has been 
well established what is still uncertain is whether there are patients who have 
insignificant PR (Taylor, 2000).
Figure 1.1 Perfusion lung scan demonstrating inhomogeneous flow pattern 
in a patient with primary pulmonary hypertension. Nuclear Medicine, 
Bankstown, Lidcombe, Sydney
This image (figure 1.1) is a ventilation/perfusion scan demonstrating multiple 
defects  consistent  with  thromboemboli  in  a  patient  with  chronic  pulmonary 
hypertension. 
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PE may include subtle abnormalities, which are diagnosed as PE and are false 
positives. However as diagnostic equipment improves, smaller emboli  will  be 
detected, and then we should ask when emboli would be regarded as clinically  
significant  (James,  1995).  Emphasis  must  therefore  be  placed  on  patient 
outcome research looking at thromboembolic disease.
Patients who had a low probability scan / diagnosis for PE were not treated and 
a prospective study outcome by Wells in 1998 concluded that: “management of 
patients with suspected PE on the basis of pre-test probability and the results of 
ventilation-perfusion scanning are safe” (PIOPED).
Pre-test  probability  has  been  assessed  using  a  defined  algorithm  that 
considered  signs  and  symptoms,  and  that  an  alternative  diagnosis  was 
responsible for patients’ symptoms and presence of risk factors (Rays, 1996). A 
more realistic approach that would result in better diagnosis and management 
for patients would be to use risk stratification. This would involve categorizing 
patients into high risk, intermediate and low probability of pulmonary embolism. 
Risk  stratification  requires  pre-test  probability  and taking  a  thorough patient 
history for evidence of underlying cardio-respiratory disease, the presence of 
PE and whether there is potential for future emboli occurring (Rays, 1996).
Both lung scintigraphy and spiral CT play a potential role in the risk stratification 
and assessment of PE.  However, it is still uncertain whether it is better to use 
spiral CT to observe intraluminal filling defects or lung scintigraphy for regional 
perfusion  abnormalities.  In  patients  with  an  increased  pulmonary  vascular 
resistance, which can be fatal, there has been considerable argument (Clinical 
Imaging,  1994)  as  to  whether  the  assessment  of  ventilation  and  perfusion 
defects  with  lung  scintigraphy  has  a  more  prognostic  significance  in  risk 
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stratification than the presence of intraluminal  filling defects using spiral  CT. 
The Wells (1998) report provided satisfactory evidence that non-invasive tests, 
such as lung scintigraphy, can safely be used to identify low risk patients.
There is little evidence to suggest spiral CT can be used to risk-stratify patients.  
A study carried out by Rathbun and associates in 2004, concluded that use of  
helical CT in the diagnosis of PE has not been adequately evaluated as the 
safety of not administering anticoagulants to patients with negative results on 
spiral CT is uncertain (Clinical Imaging, 1994).
Lung scintigraphy still plays an important first line role in the diagnosis of PE. 
The efficacy of lung scintigraphy in diagnosis and treatment monitoring played a 
significant role in reducing the clinical uncertainty, in directing treatment and in 
lowering health care costs in PE (Kobzik, 2000).
Henry Royal (1999) suggested lung scintigraphy is a useful tool in stratifying 
patients suspected of PE. “Sometime in the future, lung scans may be in need 
of life support, but today, lung scans are alive and well.” (European Economic 
Evaluation 1999).
However,  a  major  limitation  in  lung  scintigraphy  is  the  high  amount  of 
intermediate  or  indeterminate  probability  lung  scans  still  being  reported. 
Nonetheless, the number of lung scintigraphy results in these categories has 
declined due to patient clinical pre-selection and improved scanning procedures 
(Rays,  1996). Lung scintigraphy itself  remains pivotal  in the diagnosis of PE 
even though there is divided opinion on the choice of interpretive criteria for 
lung scintigraphy reporting. Further study is therefore needed to help identify 
patients  with  suspected  PE  who  may  benefit  from  additional  diagnostic 
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procedures  after  low  or  intermediate  probability  lung  scintigraphy 
(Howarth,1999).
1.4.1 Technegas study at the Cellular level
Studying  Technegas  at  the  cellular  level  will  allow  both  the  physical 
characteristics of  the Technegas aerosol particles and their  behaviour to be 
studied. Investigating this area links both the properties of chemistry and the 
physical nature of Technegas together as they are related since the behaviour 
of  the  particles  in  the  lung  and  appearance  depends  on  their  physical 
properties (Burch, 1993).
Technegas particles have a uniform deposition in the lungs, as particles are 
much smaller than conventional radioaerosols thus making these Technegas 
particles  penetrate  deeper  into  the  lungs  (Strong,  1989).  Small  particles  of 
Technegas  give  better  penetration  into  the  lung  but  are  more  difficult  to 
produce  and  do  carry  less  mass  of  the  prepared  aerosol.  Particle  size 
distribution and inhalation methods may allow us to have a better knowledge of 
the  method  of  Technegas  delivery  to  different  sections  of  the  lung  (Burch, 
1993).
Trans Electron Microscopy, known as TEM, is used for research of Technegas 
as both the resolving power and resolution are specified using the minimum 
resolvable distance. To-date research done in this area of cellular structure of 
Technegas post ventilation on humans has been minimal. There has, however,  
been a great deal of information on Technegas at the chemical level and its 
physical  structure, looking mainly at the biochemical side of Technegas and 
pertechnetate.
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Examining bronchial washings and sputum under TEM may provide information 
on the Technegas particle  and its  characteristics (Strong, 1989).  Studies of 
particle size have also suggested that lung scintigraphy in CAL patients is often 
non-uniform, of poor quality, and the lung deposition is degrading the end result  
of the diagnostic test (James, Brown, 2002).
1.5 Diseases of the Lung and Respiratory System
1.5.1 Perception of Chronic Airways Limitation (CAL)
When asked to imagine a patient who presents with a 'disabling disease of the 
airways', most people think of an asthmatic, possibly a child, in the throes of an 
acute  exacerbation,  desperately  searching for  their  metered-dose inhaler  for 
relief (American Lung Association, March 2002).  Compare this with  the CAL 
patient, usually over 60 years old with breathlessness, wheeze and productive 
cough, whose disease is probably self-inflicted by smoking and who responds 
relatively poorly to treatment. No wonder there is such a chasm between these 
two images in the public perception and that of healthcare workers (FDA, 1999).
The good news is that research has raised the profile of CAL to the extent that  
international  bodies  responsible  for  respiratory  care  are  now  producing 
guidelines and they, too, are attempting to raise the profile and awareness of 
CAL.
CAL is not a single entity but a collection of conditions that share the features of 
chronic obstruction of expiratory flow.  As a diagnostic label,  it  encompasses 
many  previously  used  clinical  descriptions  including  chronic  bronchitis, 
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emphysema,  chronic  obstructive  airways  disease,  chronic  airflow obstruction 
and some cases of  chronic  asthma which have resulted in  irreversible  lung 
destruction (FDA, 1999).  CAL is one of the five most lethal  diseases in the 
world. Both its mortality and its frequency are increasing. The disease is closely 
associated with smoking. Studies have shown that smoking is associated with 
up to a 20–fold increase in the risk of death from CAL. Smoking can lead to the 
two most common forms of this disease, emphysema and chronic bronchitis. 
CAL is largely a disease of the elderly. Although symptoms may begin to occur 
in the 40s, the disease is generally not diagnosed until the patient has reached 
his or her 60s. There is no known cure for CAL, so it is very important to learn 
how to effectively manage the disease. Strategies for managing CAL include 
making lifestyle changes (e.g. quitting smoking) and taking medications such as 
bronchodilators (Lippincott, 1991).
In more severe cases, oxygen replacement therapy in which patients breathe 
oxygen  from  either  oxygen  cylinders  or  electric  concentrators  that  extract 
oxygen directly from air. In extreme cases surgery to reduce the lung volume or 
even  lung  transplantation  is  recommended.  Researchers  are  studying 
experimental medications and surgeries in the hope of finding a more effective 
treatment for CAL and, ideally, a cure (American Lung Association, 2002).
1.5.2 What is Chronic Airway Limitation
Chronic Airway Limitation (CAL) is a chronic, progressive disease of the lungs 
that  gradually  reduces  airflow.  It  is  characterized  by  phlegmy  coughing, 
wheezing and dyspnoea.  As the  disease progresses,  quality  of  life  may be 
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severely compromised.  The key features of CAL are of a slowly progressive 
condition characterised by marked airways obstruction, which does not change 
markedly over time. Under the microscope, pathological changes can be seen 
in the large airways, small bronchi and bronchioles, and in the lung tissue itself  
as well as lung blood flow (Hannah, 1992).
Hypersecretion of mucus and airway inflammation occurs primarily in the large 
airways. The small airways are the sites of increased airways resistance. The 
alveoli are also destroyed and this is described as emphysema. In CAL patients 
radioaerosol  images  with  airways  limitation  are  often  of  poor  quality,  with 
considerable particle deposition in the major airways and minimal penetration to 
the lung parenchyma.  Attempts have been made to improve particle size and 
improve image quality.   Agnew in 1984 quantified the pattern of non-uniform 
deposition  and  studied  the  depth  of  penetration.  This  study  reported  a 
relationship  with  the  extent  of  airways  limitation.  Agnew  discussed  CAL  in 
respect to this disease and suggested it may originate in the lesser airways and 
migrate to the larger airways.
1.5.3 Key diseases when reporting on CAL
Bronchiectasis: is an inflammation with infection causing damage to the airways 
with an alteration to the lining of the airways, becoming distorted and enlarged 
(Fogelman 1988).
Chronic Cough: prolonged non – productive cough lasting for more than six (6) 
weeks.
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Common Cold: includes Rhinoviruses which are seldom serious, para-influenza 
and  respiratory  syncytical  virus,  produce  mild  infection  in  adults  but  can 
precipitate  into  a  severe  lower  respiratory  infection  in  children.  The 
coronoviruses are believed to cause a large percentage of all adult colds.
Cystic Fibrosis (CF): a chronic, progressive and frequently fatal genetic disease 
of the body’s mucous glands. Patients with CF have a lifespan of about thirty 
(30) years.
Tuberculosis: infectious disease caused by a bacterium called mycobacterium 
tuberculosis. This bacterium affects the lungs and is contagious and spreads by 
inhaling the bacterium that has been sprayed by droplets into the air by the 
person with the active disease that coughs (FDA, 1999).
1.5.4 Mechanisms Underlying CAL
Most CAL patients have smoked for at least 20 years and commonly present in 
their sixties with a productive cough or an acute respiratory complaint. During 
their  sixties  onwards,  exertional  dyspnoea is  usually  a  feature and intervals 
between acute exacerbations become shorter as the disease progresses.  In its 
earlier  stages, slow, laboured expiration, plus wheezing on forced expiration 
may  be  apparent.  A  worsening  in  airflow  obstruction  is  associated  with 
hyperventilation and a gradual increase in the antero-posterior diameter of the 
chest.  The  underlying  causes  of  CAL  have  still  to  be  fully  elucidated, 
nevertheless  cigarette  smoking  is  felt  to  be  generally  the  most  important. 
Recent interest has seen recognition of the significant morbidity associated with  
CAL, greater understanding of the disease process,  advent  of  new effective 
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treatments, together with a gradual appreciation of the degree of misdiagnosis, 
have  served  to  focus  attention  on  clearly  defining  and  characterising  CAL 
(Brostoff, 1999).
Interest  has  also  been  promoted  by  a  change  in  emphasis  in  the  way  the 
efficacy of available treatments is assessed. Reduced useful lung volumes and 
slow forced emptying of the lungs are characteristics of CAL, hence the current 
policy  of  assessing  patients'  lung  function  by  measuring  Forced  Expiratory 
Volume (FEV1). However, many researchers feel such measurements of lung 
function may not  be the best  means of  assessing prospective  management 
strategies (Brostoff, 1999).
What is now felt to be clinically relevant is improvement in the patient's quality 
of life. Quality of life measurements have previously been ignored, due to their 
poor correlation with FEV1.  However, they are now incorporated into the new 
CAL management guidelines for this very reason, and are part of most new 
studies  into  CAL.  The  shift  in  the  'burden  of  financial  responsibility'  from 
secondary to primary medicare must also have helped sharpen doctors' interest 
in tackling CAL. Limited resources must be effectively targeted and CAL eats up 
a lot of medicare resources, particularly in hospital costs (Girodo, 1992).
1.6. Anatomy and Physiology of the Lung
The upper respiratory tract (URT) includes the mouth, nares (within the nasal  
cavity), paranasal sinuses and nasopharynx.  During inspiration and expiration, 
gases traverse through the URT and enter the lower respiratory tract, beginning 
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at the larynx.  This eventually bifurcates forming the bronchi, bronchioles and 
terminal  bronchioles.   Distal  to  the  terminal  bronchioles  are  the  respiratory 
bronchioles, alveolar ducts and alveolar sacs, which lead to the alveoli.  The 
alveoli  form  the  majority  of  lung  tissue,  where  gaseous  exchange  occurs 
between the inspired air and circulating blood.
The alveoli have a single layer of epithelial cells encased in a capillary network  
suitable for gaseous exchange; in normal human lungs there are between two 
hundred  and  fifty  (250)  and  three  hundred  (300)  million  alveoli  present 
(Roussos, 1995).  The pulmonary artery bifurcates into branches forming the 
segmental artery supplying blood to the capillary network in the alveoli.
During inspiration, the most important muscle is the diaphragm, which inserts 
into the lower ribs.  On contraction of the diaphragm, abdominal contents are 
forced downward and forward, and the vertical dimensions of the chest cavity 
are increased due to inspiratory intercostal muscles (Feselman, 1988).  The ribs 
are lifted and moved out,  causing an increase in the diameter of  the thorax 
(Roussos, 1995).
Breathing is usually involuntary but voluntary breathing is necessary when the 
person is performing activities such as walking, talking etc. (Roussos, 1995).  In 
these cases homeostatic changes in ventilatory rate and volume are adjusted 
automatically  by  the  nervous  system  to  maintain  normal  gas  exchange. 
Breathing is controlled and regulated by neural and chemical balances within 
the body.  Sensors and receptors form a highly complex ventilatory system.
The medulla oblongata of the central nervous system is responsible for both 
inspiratory  and  expiratory  neurons.   Within  the  pons are  the  apneustic  and 
pneumotaxic centres (these centres are in direct relationship with the medulla),  
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give  the  rhythmic  quality  to  respiration  (Roussos,  1995).   Chemosensitive 
regions are  also  housed within  the  medulla  and are  important,  as  they are 
sensitive  to  levels  of  carbon  dioxide  and  hydrogen  ion  concentrations  in 
cerebrospinal  fluid  (CSF).   Peripheral  chemoreceptors  known  as  aortic  and 
carotid bodies, respond to chemical changes in the blood, particularly in arterial 
oxygen  tension  (Early,  1995).  Hypoxia  stimulates  the  peripheral 
chemoreceptors,  which  in  turn  stimulate  the  respiratory  centres  to  increase 
ventilation.  These receptors are also sensitive to a reduction in arterial oxygen 
tension (Early, 1995).
The Hering-Breuer reflex (Garbe 1986) is well known as it aids in the control of  
respiration due to inflation and deflation of the lungs.  Receptor sites are located 
in the respiratory tract, mainly the bronchi and bronchioles.  These reflexes are 
activated by either stretching or a non-stretching and compression of the lungs. 
The inflation reflex inhibits inspiration preventing further inflation; as expiration 
begins the receptors are no longer stretched and therefore impulses are no 
longer sent, and inspiration commences (Garbe, 1986).
The external pressure exerted on the thorax is atmospheric, at sea level it is  
100  mmHg (Garbe,  1986).  When the  lungs  are  resting  with  no  airflow  the 
intrapulmonic  pressure  is  also  atmospheric.  There  are  different  types  of 
pressure changes in the lungs, which occur with different types of respiration. 
For air to flow in the lungs, intrapulmonic pressure has to be negative or less 
than  atmospheric  so  that  a  pressure  gradient  can  be  set  up  between  the 
atmosphere and the alveoli. 
Intra  pleural  pressure  exists  between  the  pleural  spaces,  which  is 
subatmospheric [-5mmHg] (Taylor, 1989). This is caused by the elasticity of the 
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lungs,  which  recoil  from the  thoracic  cage,  creating  a  vacuum between  the 
visceral and pleural space (West, 1990).  If air enters this intrapleural space, the 
“pull” is lost and a pneumothorax or lung collapse will occur, and the thoracic 
cage will expand.  On inspiration, it is the elastic recoil between the thorax and 
lungs  that  causes  chest  expansion  (Taylor,  1989).   As  the  thorax  expands 
during inspiration, intrapleural pressure becomes more negative (-8 mmHg), or 
subatmospheric, and inflation of the alveoli occurs as air moves from a point of  
high to low pressure (West, 1990).
The  lungs  are  innervated  by  the  autonomic  nervous  system  (ANS)  (West, 
1990).  Fibres of the sympathetic division in the lung, branch from the upper 
thoracic  and  cervical  ganglia  of  the  spinal  cord,  while  fibres  of  the 
parasympathetic division are carried in the vagus nerve, which is important in 
the regulation of ventilation (Taylor, 1989).  The respiratory centres in the brain 
stem control involuntary ventilation by transmitting impulses to the respiratory 
muscles causing them to contract or relax (Taylor, 1989).
1.6.1 Air Movement
Even the movement of air through the lungs requires a complex set of control 
mechanisms originating from the central nervous system (CNS), which can be 
affected by a range of physical boundaries (West, 1990). 
For example, the pneumotaxic centre in the upper pons functions to maintain 
rhythmic respiration’s sending inhibitory signals to the inspiratory centre causing 
inspiration  and  expiration  (West,  1990).   Strong  foci  from the  pneumotaxic 
centre result in shorter inspiration, and mild stimuli results in longer inspirations 
(West,  1987).   The apneustic  centre  sends stimuli  to  the  respiratory  centre 
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prolonging inspiration.  The pneumotaxic centre usually overrides the apneustic 
centre causing receptors to respond to physical changes in oxygen or carbon 
dioxide  concentrations.  This  is  achieved  through  both  the  sympathetic  and 
parasympathetic divisions of the ANS and respiratory centres in the brain stem 
(West, 1987).
Dimensions of the airway tree influence ventilatory flow of air in a number of 
ways (West, 1990). Airflow velocity is reduced along the airway tree as the total  
cross – sectional area of the airways increases with every generation of which 
there are 23 generations in total (West, 1990).
In the smaller airways, oxygen transport is slower than diffusion as molecules 
move through air at a velocity of approximately 5 cm per second. The airway 
size  also  determines  the  resistance  to  airflow  and  albeit  small;  it  is  the 
reciprocal of the ratio of ventilatory air - flow to the pressure difference between 
the mouth and the alveoli, normally no greater then 1cm of water (West, 1990).  
It  is,  however,  significant  enough  to  potentially  affect  the  distribution  of 
ventilation to the numerous gas exchange units. Poiseuille’s Law describes the 
resistance (R) of a bronchiole with radius “r” and length “l”: R = k .l/r  4  (West, 
1987).
Therefore, if  you double the airway diameter,  the resistance will  be reduced 
sixteen (16) fold (West, 1987). In a normal lung, the distribution of airflow to the 
periphery occurs, whereas in CAL patients, distribution is greatly disturbed, with 
airway  resistance  requiring  greater  work  to  ventilate  the  lung (West,  1990). 
Airway resistance to mass airflow is seen in the conducting airways and falls 
rapidly toward the periphery (West, 1987).
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As the diameter of the airways decreases, one would assume an increase in 
resistance towards the periphery, however this does not occur due to airways 
having a low resistance because of flow velocity being rapid as the airways 
branch. Further, thin walled bronchioles become widened as the lung expands 
on inspiration. Airway resistance is therefore seen to fall  as the lung volume 
increases (West, 1987).
1.6.2 Gas Exchange
Oxygen flow rate is dictated by the amount of oxygen in the mitochondria and 
the amount of mitochondria in the working muscle sets the limit for oxygen flow 
or VO2; also the mitochondrial volume is proportional to VO2. This is due to 
oxidative phosphorylation in the mitochondria,  which is the only pathway for  
adenotriphosphate or ATP production, by oxidative metabolism (West, 1990). 
However,  the  driving  forces  of  oxygen  flow  are  affected  by  homeostatic 
regulations.
Pulmonary diffusing capacity is the diffuse transfer of oxygen from alveolar air 
to  blood  which  meets  with  resistance  albeit  small,  therefore  the  diffusing 
capacity is an estimate of the global conductance or the reciprocal of the total 
resistance to the diffusion of oxygen being offered as a gas exchanger (West,  
1990).
The alveolar surface of the lung is immense therefore the barrier is extremely 
thin and this is why the diffusing capacity is so large, or the resistance so low. 
The alveolar capillary membrane is the perfect medium for oxygen exchange. 
This is due to the large total surface area, being about 70 to 100m squared and 
its  thinness,  0.5  micrometer.   Also  the  concentration  of  oxygen  molecules 
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(PaO2) is greater in alveolar gas than in capillary blood, which promotes rapid 
movement down the concentration gradient from the alveolus (West, 1990). 
The partial pressure of oxygen or oxygen tension in mixed venous or pulmonary 
artery blood is about 40 mmHg as it enters the capillary, and alveolar oxygen 
tension (PaO2) is 100 mmHg at sea level.  Therefore, the pressure gradient 
facilitates diffusion of oxygen from the alveolus into the capillary.  Blood remains 
in  the  pulmonary  capillary  for  a  shorter  period  than  needed  for  oxygen 
concentration to equalize across the alveolocapillary membrane (West 1987, 
Taylor 1989). 
Therefore, oxygen has less time to diffuse into the blood, even during increased 
cardiac output which speeds bloodflow, shortening the time blood remains in 
the  capillary.   As  oxygen  diffuses  across  the  alveocapillary  membrane,  it 
dissolves in the capillary blood where it produces pressure, which is the partial 
pressure of oxygen in arterial blood or PaO2.  As PaO2 rises, oxygen moves 
from  the  plasma  into  the  red  blood  cells  (erythrocytes)  and  binds  with 
haemoglobin  molecules  till  these  are  saturated.  Oxygen  then  continues  to 
diffuse across the semipermeable membrane until it equilibrates, eliminating the 
pressure gradient across the alveolocapillary membrane.  Here diffusion ceases 
(Taylor, 1989).
As mentioned previously, air enters the lungs via the nose and the mouth where 
it is humidified and filtered.  Pulmonary gas exchange involves inspired oxygen 
(O2) to  be  exchanged at  the alveolar  level  with  carbon dioxide (CO2).  The 
oxygen  then  binds  to  Haemoglobin  (Hgb)  in  the  pulmonary  capillaries. 
Pulmonary  gas  exchange  is  primarily  dependent  upon  three  processes, 
ventilation, diffusion and perfusion (West, 1990).
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Ventilation  occurs  when  air  moves  into  the  alveoli;  the  inspiratory  muscles 
contract  generating a force,  which  expands the chest  wall  and the lungs to 
overcome the resistance and inertia of the respiratory system.  Together, the 
respiratory muscles, lung parenchyma, airways and chest wall  will  determine 
the volume of gas that will reach the alveoli (Taylor 1989, West, 1990).  The 
amount of air that enters the lungs is known as the tidal volume (TV), and the 
amount  of  gas  retained  in  the  lungs  when  fully  expanded  is  the  total  lung 
capacity (TLC).  The maximum volume a person can exhale is the vital capacity 
(VC) and remaining gas is the residual volume (RV).  At the end of a normal 
breath, the amount left in the lungs is the functional residual capacity (FRC) 
(Taylor 1989, West 1990).
Structural  hierarchy of  the  airways  is  important  as  lung structure  is  defined 
through the hierarchial properties of the airways. The acinus is the complex of 
all  the  airways  distal  to  the  terminal  bronchiole  and  is  known  as  the  first 
respiratory order respiratory bronchiole. This therefore means it is the largest 
unit from which all airways participate in gas exchange (West, 1987). 
Diffusion is the movement of molecules from a region of high concentration to a 
region of lower concentration.   In  the lung, oxygen moves by diffusion from 
alveolar gas into the pulmonary blood. In patients with CAL oxygen diffusion will  
be impaired (West, 1987).
Perfusion describes the route of blood through the lungs. The right ventricle in 
the heart pumps blood into the pulmonary artery.  The branches of this artery 
supply the alveolar capillaries, which drain through the pulmonary veins into the 
left atrium.  Instances of obstruction, as is the case with PE or lung parenchyma 
(as seen in bronchitis, emphysema, and fibrosis) cause arterial hypertension.  In 
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both  scenarios  obstruction  and  vascular  resistance  to  blood  flow  increases 
(West, 1987, 1990). 
Ventilation and perfusion in an ideal pair of lungs would be supplied with equal  
volumes of air and would have a uniform gas composition during inspiration. 
Also,  all  the alveoli  would be supplied with  the same flow of  mixed venous 
blood.  Therefore ventilation  and perfusion would  be optimally  matched,  with 
optimal  gas  exchange  between  blood  and  alveoli  would  take  place  (West, 
1990).
In real lungs the above does not occur per unit of lung volume, ventilation and 
perfusion are both greater at the bases of the lungs compared to the apices. 
The ratio of ventilation to blood flow, the ventilation / perfusion (V/Q) ratio varies 
by a small amount throughout the lungs (West, 1990).
Pulmonary  capillaries  are  influenced  by  air  pressure  in  the  alveoli.  If  blood 
pressure within the capillary is less than the pressure of a gas in the alveoli  
adjacent to it, there is a tendency for the pressure in the alveoli to remain close 
to atmospheric during quiet breathing but may become positive during artificial 
ventilation or heavy breathing (West, 1990).
Pulmonary capillaries are influenced by air pressure in the alveoli that surround 
them. If blood pressure within a capillary is less than the pressure in the alveoli, 
this will  lead to pressure in the alveoli compressing the capillary and limiting 
blood  flow  through  it.  Alveolar  gas  pressure  may  have  an  effect  on  the 
distribution of pulmonary blood flow (West, 1987 & 1990).
Arterial  oxygenation  is  the  process  of  delivering  oxygen  to  the  cells,  and 
depends  on  several  factors.  These  include  cardiac  output,  the  amount  of 
haemoglobin present, oxygen saturation, and the oxygen binding capacity. This 
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is  normally  1.34  mililitres  of  oxygen,  per  one  (1)  gram  of  haemoglobin. 
Therefore, patients with life-threatening conditions should receive supplemental 
oxygen (West, 1987 & 1990).
Once oxygen is delivered to the cells,  it  needs to be utilized by the “Krebs 
Cycle“.  Oxygen failure is a respiratory crisis in which the primary problem is 
hypoxaemia,  PaO2<  or  =  60  mmHg.  Hypoxia  and  hypoaemia  are  often 
confused  or  used  interchangeably,  but  there  is  a  difference.  Hypoxaemia 
(PaO2)  is  defined  as  inadequate  oxygen  in  arterial  blood  and  hypoxia  is 
decreased oxygen supply to the cells or tissues (Taylor, 1989).
Hypoxaemia  occurs  when  there  is  a  decreased  arterial  blood  saturation  of 
oxygen (PaO2), and can occur anywhere from when oxygen is inspired to when 
it reaches the mitochondria, the powerhouse of the cell.  This may be due to a 
decrease  in  inspired  oxygen,  alveolar  hypoventilation,  diffusion  problems, 
ventilation/perfusion  mismatch,  or  shunt  and  increased  oxygen  consumption 
(Taylor, 1989). 
Hypoxia  is  the  decreased  oxygen  supply  to  cells  or  tissues,  Hillman  and 
associates  (1996)  reported  both  PaCO2  and  SaO2  measuring  adequate 
oxygenation of the body.  Hypoxia is a better indicator of an oxygen delivery 
problem. The most common cause of hypoxia in acute respiratory failure is a 
ventilation / perfusion mismatch.  Mismatching affects the exchange of oxygen 
and carbon dioxide.  In pulmonary embolism there is a decrease in perfusion in 
relation  to  ventilation.   This  results  in  dead  space  or  wasted  ventilation. 
Hypoxia may be improved with one hundred percent (100%) oxygen for ten (10) 
to fifteen (15) minutes to wash out all the nitrogen in the alveoli, leaving only 
carbon dioxide (CO2) and oxygen (O2) (Hillman, 1996).
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Pulse oximetry is used to measure oxygen (O2) saturation.  It is important to 
maintain saturation at least greater than ninety percent (90%).  A PaO2 of at 
least 80 mmHg indicates an adequate saturation. Measuring a patient’s arterial  
blood gas will measure pH, PaO2, PaCO2, HCC3 (bicarbonate) levels.  This will  
assist in the regulation of oxygen therapy, determine the severity of respiratory /  
metabolic disorders, and may reflect local disturbances (Hillman, 1996, James, 
1992).
1.7 Pathophysiology of the Lungs
1.7.1 Balance between perfusion and ventilation
In  a  normal  human,  we  aim  to  be  in  a  state  of  homeostasis  whereby  a 
physiological  balance  between  perfusion  and  ventilation  exists.   Respiratory 
diseases lead to imbalances between these two functions (Taylor, 1989).
Musculoskeletal deformities of the thorax are among the most common causes 
of  respiratory  failure.  Generally,  total  lung  capacity  will  be  reduced  in  all 
deformities of  the thorax,  and most of  the reduction in the lung is due to a 
decrease in chest wall  compliance.  However,  within  the total  lung capacity,  
different  subdivisions will  demonstrate  slight  variations  that  help  identify  the 
individual mechanical disorders characteristic of that type (James, 1995).
Except  for  fibrosis  and  bronchiectasis,  most  thoracic  deformities  are  not 
characterized  by  airway  obstruction  or  intrinsic  lung  disease.  Ventilation-
perfusion  abnormality  therefore  is  attributable  to  local  deflation  and  poor 
ventilation of the lung. To support this there has been much research in thoracic 
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deformity of regional ventilation and perfusion by radioisotopic methods (James, 
1995). PE is usually multiple occurring in the lower lobes of the lung.
Thoracic function can be evaluated indirectly by measurements of the function 
of  the  lungs,  which  reflect  movements  of  the  chest  wall.   However,  such 
measurements are non-specific, as lung function tests reflect not only disorders 
of the thorax, but the lung themselves. All subdivisions of lung volume, including 
total  lung  capacity  (TLC),  vital  capacity  (VC),  residual  volume  (RV),  and 
functional residual capacity (FRC), are determined by the mechanical function 
of the chest wall and lung (Danjun, 1994, Roussos, 1995).
Complete  inspiration  and  expiration  require  vigorous  muscular  efforts  and 
therefore, TLC, VC, and RV are influenced by inspiratory and expiratory muscle 
strength.   FRC  in  healthy  people  is  a  balance  of  passive  elastic  forces 
generated by the lungs and chest wall.  Chest wall recoil is influenced by the 
tone in the muscles of the rib cage (Danjun, 1994, Roussos, 1995).
Primary infections such as bronchitis, broncho pneumonia and other forms of 
pneumonia  are  seen  in  clinical  and  pathologic  practice.  Smoking  and  air 
pollution, chronic bronchitis and emphysema have greatly increased within our 
society. Lung malignancy, seen on autopsy, shows some degree of pulmonary 
oedema, atelectasis, or broncho pneumonia (Fogelman, 1988). Bronchogenic 
carcinoma  causes  a  decrease  or  absence  in  pulmonary  blood  flow  to  the 
affected segment of lung (Danjun, 1994, Fogelman, 1988).
Obstructive lung diseases are characterized by increased resistance to airflow 
(Danjun, 1994, Fogelman, 1988).  Acute diseases include asthma or bronchitis;  
these affect the conducting airways and involve ciliary dysfunction.
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1.7.2 Chest Wall and Respiratory Muscles in CAL Patients
CAL  patients  have  an  increased  airflow  resistance  and  reduced  dynamic 
pulmonary compliance, making respiratory muscles work constantly against an 
increased load (Taylor,  1989).   Inspiratory muscles therefore generate more 
pressure to move air into the lung.  Ventilation is increased in CAL patients 
compared  to  healthy  people.  CAL  patients  have  an  increase  in  functional 
residual capacity (FRC) so inspiratory muscles operate at shorter lengths than 
normal  and  have  a  reduced  ability  to  lower  intrathoracic  pressure  (Taylor, 
1989).
Analysis  of  respiratory muscle function in  CAL requires an understanding of 
“length-tension”  relationship  of  muscle  (West,  1990).   Active  tension,  which 
occurs during contraction, is a function of resting length of muscle. The relaxed 
length of muscle increases active tension increases until a maximum length is 
reached  (West,  1990).   Passive  tension  results  from  the  elastic  forces  of 
connective  tissue,  the  sarcolemma,  blood  vessels  etc.   Passive  tension 
continues to  rise as  resting  length  is  increased (Taylor,  1989,  West,  1990). 
Thus the length tension relationship determines the influence of hyperinflation of 
the diaphragm (Taylor, 1989).
Arora (1987) suggested studies of structures of the diaphragm of CAL patients 
at autopsy have a loss of diaphragm weight and thickness, which might be due 
to general muscle wasting observed in these patients.
End expiratory volume is considerably larger in CAL patients as they may not 
have  time  to  expel  all  the  air  through  their  airways  (Taylor,  1989).   A 
considerable reduction in maximal inspiratory pressure has to be present for a 
significant fall in vital capacity to occur.  Generally, volume measurements are 
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less  variable  and  better  standardized  than  maximum  pressures,  and  most 
patients  with  respiratory  symptoms  from  skeletal  abnormalities  or  muscle 
weakness have a distinctive restrictive ventilatory defect.
Weakness in CAL patients is  reflected in the shape of  their  maximum flow-
volume curves (Taylor, 1989). Airflow depends on effort such as the maximum 
expiratory flow and maximum inspiratory flow, which are independent on effort 
and are most affected by CAL (Taylor, 1989, West, 1990). In both normal and 
CAL patients the shape of the inspiratory flows over much of the vital capacity 
are larger than expiratory flows.  Therefore FIV1 (forced inspiratory volume from 
RV) is greater than FEV1 (Taylor, 1989).
CAL  patients  with  acute  respiratory  failure  due  to  underlying  PE  will  have 
symptoms  of  hypoxaemia  present  in  varying  degrees  (James,  1992). 
Treatment  for  CAL  patients  includes  controlled  low  flow  oxygen,  moisture 
delivered to the airways and methods to improve alveolar ventilation with  or 
without mechanical means. Finally for severe CAL, intubation and ventilatory 
management are options for patients requiring supportive care (James, 1992).
1.8 Pulmonary Embolism
1.8.1 Causes and Diagnosis
Pulmonary Embolism (PE)  is  not  only  the  impaction  of  thrombus within  the 
pulmonary arteries but may be caused by a variety of reasons e.g. fat embolus 
(Roussos,  1995).  The  thrombi  usually  originate  from systemic  veins,  in  the 
Ileofemoral system. However, the aetiology of venous thrombosis is mainly from 
venous stasis, trauma to veins and abnormalities of coagulation.  Venous stasis 
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can occur due to patient immobilization, heart failure (reduced cardiac output),  
venous pressure and compression of calf muscles. Other ways venous blood 
flow can diminish include obesity, varicose veins, and inactivity (Danjun, 1994, 
Roussos, 1995).  
Differential diagnosis of PE is varied and depends upon the clinical scenario 
(Taylor,  1991). This includes pneumonia, pneumothorax, pulmonary oedema, 
pericaritis, rib fracture, myocardial infarction, and septicaemia. Key diagnostic 
investigations may include lung scintigraphy, chest x-ray, ultrasound, spiral CT, 
Pulmonary  Angiography,  Magnetic  Resonance  Imaging  (MRI),  and  objective 
tests for proximal DVT.
Objective testing for DVT is useful in patients with suspected PE, particularly 
those  with  non-diagnostic  lung  scan  results,  therefore  intermediate, 
intermediate or low probability categories, as a negative result do not exclude 
PE  (Taylor,  1991).  If  a  patient  has  adequate  cardiorespiratory  reserve, 
ultrasound imaging may be used as an alternative to pulmonary angiography 
(Rumack, 1998). The rationale is that the clinical objective in such patients is to 
prevent  recurrent  PE,  which  is  unlikely  in  the  absence  of  proximal  vein 
thrombosis  (Rumack,  1998).  For  patients  with  inadequate  cardiorespiratory 
reserve,  the  clinical  objectives  are  to  prevent  death  and  morbidity  from an 
existing embolus and to allow further investigations for the presence or absence 
of PE (Howarth, 1999, Palla, 1988).
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1.8.2 Hypercoagulable states
Pregnancy can cause venous thrombosis as the enlarging uterus obstructs the 
inferior vena cava. Economy Class Syndrome has been attributed to prolonged 
periods of inactivity in long flights causing venous stasis (James, 1995).
Other  hypercoagulable  states  include  antithrombin111  deficiencies,  defective 
fibrinolysis  and obesity,  recent surgery,  and oral  contraceptives contribute to 
primary DVT.
1.9 Clinical Signs of Pulmonary Embolism
The  majority  of  patients  with  pulmonary  emboli  have  an  underlying  clinical 
predisposition  (James,  1995).  Less  than  10%  of  the  patients  have  no 
discernible  cause  for  deep  venous  thrombosis  at  the  time  of  presentation 
(Murray, 1998).The common predispositions found in patients with pulmonary 
embolus  include  immobilization,  surgery,  fracture,  malignancy, 
thrombophlebitis, trauma, oestrogen therapy, obesity, myocardial infarction, and 
stroke (Murray, 1988).
Regrettably,  the clinical  diagnosis  of  PE is  unreliable  as the symptoms and 
signs of PE are non-specific. The classical clinical triad of haemoptysis, pleuritic 
chest pain and dyspnoea occurs in only 20% of patients (Botnar, 2004).
The greater  majority of  patients who are proven to have a PE present  with  
dyspnoea and chest pain are more often pleuritic when the clots are peripheral  
(James, 1995). Cough is another non-specific sign of lung disease and presents 
in  slightly  less  than  half  of  the  patients  (James,  1995).  It  is  also  a  well  
established fact that the clinical evidence of DVT is usually absent in patients 
Chap 1 - 41
with lower extremity clots (James, 1992). Haemoptysis, which often suggests a 
diagnosis of PE, is only present in the minority of cases. Palpitations, wheezing 
and angina – like pain, are all seen in a small number of cases (Fedullo, 2003,  
Botnar, 2004.
Physical  examination  is  important  in  diagnosing  PE  (Fedullo,  2003).  The 
majority of  patients will  present  with  an increased respiratory rate and have 
audible rates on auscultation, and an increased second heart - beat is common 
(Botnar, 2004). The remainder of clinical signs include: increased heart rate, 
elevated  temperature,  physical  evidence  of  phlebitis,  cardiac  gallop, 
diaphoresis, oedema, cardiac murmur and cyanosis and are found in less than 
50% of the patients who present with PE.
It is therefore not surprising that the clinical diagnosis of PE is fraught with error; 
the signs and symptoms serve only to raise the suspicion of PE (Botnar, 2004).  
Those patients with  PE have essentially the same symptoms as those who 
were  initially  suspected  of  having  an  embolic  event,  but  did  not.  Clinical 
assessment  alone  will  be  unreliable  and  further  investigation  is  required  to 
reach the correct diagnosis (Early 1995, Botnar, 2004).
The  pathophysiologic  response  of  PE  depends  on  the  extent  to  which  the 
pulmonary artery blood flow is obstructed, size of occluded vessels, number of 
emboli and the release of thromboxane from platelets that accumulate at the 
site of the thrombus (West, 1987). The two pathophysiological consequences of 
emboli are respiratory compromise (non perfusion of ventilated segment), and 
haemodynamic  compromise (increased  resistance to  pulmonary  blood flow), 
(West, 1987).  If a patient’s PO2  is 60% or below depending on their pathology 
(therefore patient history of CAL, pneumonia etc.), and if the patient is hypoxic,  
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a differential diagnosis of PE will be made until further confirmation.  The normal 
PO2 is 80 - 100% (James, 1992).
Consideration needs to be given to conditions that predispose the patient to 
DVT and PE. Sonographic evidence of DVT is only reported in fifteen (15%) of  
patients  with  diagnosed  intermediate  probability  post  lung  scintigraphy, 
therefore  a  negative  Doppler  ultrasound  was  reported  in  eighty-five  (85%) 
(Rumack, 1998). This should not deter attention away from making a diagnosis 
of PE.  Sonographic evidence of DVT is seen in only twenty-three (23%) of 
patients with angiographically confirmed PE (Leiper et al., 1998).
Patients with massive PE usually have a dramatic presentation with a sudden 
onset of severe shortness of breath (SOB), hypoxaemia and right ventricular 
failure.  Symptoms  include  central  chest  pain,  often  like  angina,  severe 
dyspnoea and frequently syncope,  confusion and less frequently  coma. The 
patient  on  examination  will  also  have  severe  tachypnoea,  cyanosis  and 
hypotension. The increase in pulmonary vascular resistance will lead to acute 
right ventricular failure (Habibian 1999, Rubinstein, 1988). 
With pulmonary hypertension, there is a marked right ventricular dilatation with 
a shift in the patient’s septum, decreasing cardiac output, and therefore further 
decreasing coronary perfusion, which may result in cardio-respiratory arrest. If 
patients  with  a  massive  PE  survive,  they  are  at  great  risk  of  further 
thromboembolism (Rubinstein, 1988).
Emergency management of  severe PE which could prove fatal  must include 
intravenous heparin, oxygen, mechanical ventilation, volume resuscitation and 
the use of inotropic agents or even vasodilators (Rubinstein, 1988). In addition 
to these supportive measures, if the patient survives a severe, life-threatening 
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PE,  the  patient  must  have  thrombolysis,  pulmonary  thrombectomy,  with  or 
without  coronary  bypass  (CABG),  travenous  catheter  embolectomy  or  clot 
dissolution, and the insertion of an inferior vena cava filter (Rubinstein, 1988).
1.10 Diagnostic Tests to detect PE
Tests  to  exclude  PE  and  DVT  include  angiography,  lung  scintigraphy, 
venography  and  Doppler  ultrasound  (Rays,  1996).  Although  angiography  is 
definitive for PE, it comes with a risk, albeit small, of anaphylactic reactions, as 
well as morbidity associated with the contrast injections, which makes it high 
enough  to  warrant  alternative,  less  accurate  but  much  safer  diagnostic 
procedures, which are also preferred (Rays, 1996, Clinical Imaging 1994).
Effective cost (EC) of each diagnostic test represents the amount spent per unit 
of diagnostic information and is defined as the ratio of the expected direct cost  
(EDC)  compared  to  its  diagnostic  performance  (DU  representing  the  test 
sensitivity and specificity) (PIOPED, 1990).  EDC refers to the direct cost for 
performing the test and the estimated cost is the morbidity and mortality that 
can be incurred while having the procedure. With this methodology, allowances 
are made for comparison of individual procedures as well as determination of 
the  maximum  cost  and  minimum  performance  characteristics  for  any  new 
procedure to be competitive with those that already exist (EJNM, 1999, PIOPED 
1990).
As PE and DVT account for many hospitalizations annually, prevalence of DVTs 
and PEs increase with age, and as our aging population will be more prone to 
this condition; an accurate diagnosis is critical (Botnar, 2004). Physicians must 
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learn  to  be  skilled  in  risk  stratification  of  their  patients  with  suspected  PE. 
Recent  advances  in  medicine  have  entailed  improvement  in  the  method  of 
diagnosis and in clinical management of PE and DVT (Freeman, 1999).
Lung scintigraphy is a noninvasive, reliable method of diagnosing patients who 
present  with  suspected PE (Murray,  1988).   Lung scintigraphy entails  a  low 
amount of  radiation exposure to the patient and remains one of the primary 
forms  of  investigating  PE;  this  is  based  on  35  years  of  reliable  clinical 
experience in the diagnosis of PE (James, 1995, Murray, 1988, Taylor, 2000). 
In a controversial article in 1977, Robin published a paper titled "Overdiagnosis 
and overtreatment of pulmonary embolism: the emperor may have no clothes" 
which  highlights  pulmonary  embolism as  being  overdiagnosed  in  previously 
healthy patients due to the inappropriate use of diagnostic studies (PIOPED, 
1990). Since then, clinical investigations have established the diagnostic role of 
ventilation-perfusion  scintigraphy,  pulmonary  angiography,  impedance 
plethysmography, and compression ultrasound evaluation of lower extremities 
for venous thromboembolism (PIOPED, 1990). 
Clinical  signs alone are unreliable in the diagnosis  of  both acute pulmonary 
embolism  and  deep  venous  thrombosis,  underscoring  the  importance  of 
diagnostic testing (Freeman, 1999, Howarth 1999).
Robin’s  article  reviews  the  clinical  utility  of  current  diagnostic  modalities 
(pulmonary angiography, ventilation-perfusion scintigraphy, and ultrasound) and 
of  new  diagnostic  procedures  (spiral  computed  tomography  (CT),  D-dimer 
assays,  and  magnetic  resonance  imaging  (MRI)  in  the  diagnosis  of  venous 
thromboembolism.
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Robin (1977) placed some of the blame for over-diagnosis and over-treatment 
of  PE  in  previously  healthy  patients  on  ventilation-perfusion  imaging. 
Retrospective  diagnostic  accuracy studies  of  ventilation-perfusion  imaging in 
patients  with  suspected  PE  led  to  funding  of  a  prospective  multi-centre 
diagnostic accuracy study PIOPED, 1990.
There was a flaw with the PIOPED 1990 study as it was a diagnostic accuracy 
study rather than a patient outcome study.  The results of ventilation-perfusion 
imaging were  compared with  the  results  of  pulmonary  angiograms,  and the 
treatment of patients based primarily on the results of pulmonary angiograms. 
Therefore, for  lung scans to survive,  and for the diagnosis and treatment of 
patients suspected of PE to improve, these two widely held, overly simplistic 
views of PE must change (PIOPED, 1990).
Ventilation scans improve the specificity of the perfusion scan by locating areas 
of non ventilated lung, which is necessary for diagnosis of  PE in regions of 
absent perfusion and identifying ventilation perfusion mismatches or segmental 
perfusion  defects  (Taylor,  2000).  Lung  perfusion  images  can  provide  a 
quantitative estimate of total lung perfusion as they mimic regional blood flow 
(Palla et al,  1988). An interpretation criterion which is based on mismatched 
defects seen on perfusion scintigraphy is low, intermediate or high probability 
for PE based on the PIOPED study.
Scintigraphy is an important diagnostic first line adjunct in diagnosing patients 
with suspected PE (Danjun, 1994).  There are several diagnostic tests available 
to assist in the diagnosis, including: ultrasound, spiral CT, angiography, arterial  
blood gases and chest radiographs (CXR). CXR acquired within 24 hours of 
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lung scintigraphy can be inconclusive or of minimal value to the physician due 
to its insensitivity for PE (Rays, 1996).
Ultrasound, using Doppler is non- invasive and has a proven high accuracy rate 
in diagnosing DVT.  Physiological  methods rely on detecting altered venous 
flow  haemodynamics  (Rumack  1998).   Duplex  Doppler  and  Colour  Flow 
Doppler provide objective anatomic information similar to venography as well as 
physiologic  information  of  venous  haemodynamics  (Taylor,  2000,  Rumack, 
1998).  Doppler sonography includes both quantitative duplex spectral analysis 
and qualitative colour flow Doppler sonography (Rumack, 1998). 
The addition of  colour  flow Doppler  is  a  useful  modification of  the standard 
compression study.   In normal veins, colour should fill  the vessel lumen and 
venous flow augmentation  is  usually  necessary  to  completely  fill  the  vessel 
lumen from wall to wall (Rumack, 1998).
Examination of  the calf  veins is  considered by some to be controversial.  In 
some centres the lower leg is not evaluated, as it is rare for the isolated calf 
DVT to cause significant PE.  However in other departments the calf is routinely 
evaluated due to a 20% incidence of proximal clot propagation (Rumack, 1998). 
The gray-scale compression sonographic findings of DVT are based on direct 
visualization of a thrombus and lack of venous compressibility (James, 1995, 
Rumack, 1998).  There is a negative for using Doppler ultrasound; the potential 
for  false  positives  is  real  due  to  the  inability  to  visualize  central  veins  and 
reliance on blood flow haemodynamics to detect  venous occlusions (James, 
1995, Rumack, 1998).
While Doppler venous flow detection only provides information about blood flow, 
real-time ultrasound provides a two-dimensional, cross-sectional representation 
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of  the  lower  extremities  (Rays,  1996).  Compression  ultrasound with  venous 
imaging (real-time B-mode imaging) has a sensitivity of 89% to 100% and a 
specificity of 86% to 100% for detection of proximal deep venous thrombosis in 
symptomatic  patients  (Rays,  1996,  Clinical  Imaging  1994).  In  addition, 
compression ultrasound with venous imaging is widely available, non-invasive, 
and  accurate  for  the  diagnosis  of  symptomatic  proximal  deep  venous 
thrombosis (Rumack, 1998). 
The  combination  of  Doppler  venous  flow  detection  and  real-time  B-mode 
imaging is called duplex scanning (Rays,  1996).  New technology has led to 
colour  display  of  Doppler  frequency,  called  colour  duplex  scanning.  Duplex 
scanning is highly accurate for diagnosis of proximal deep venous thrombosis in 
symptomatic  patients;  both  sensitivity  and  specificity  are  greater  than  95% 
(Rumack, 1998, 26). In addition, the Doppler analysis allows differentiation of  
fresh thrombi from older thrombi (Rumack, 1998). 
Tapson and associates (1999) studied the diagnostic accuracy of compression 
ultrasound  and  reported  that  it  was  limited  in  patients  with  deep  venous 
thrombosis of the calf (Rumack, 1998). Compression ultrasound with venous 
imaging,  duplex ultrasound,  and colour  duplex studies all  vary in  technique, 
cost, availability, and operating characteristics (Rumack, 1998). Tapson’s 1999 
article suggests despite these differences, as long as compression is used, no 
single technique has demonstrated an advantage over another in prospective 
clinical  trials  for  the  detection  of  proximal  deep  venous  thrombosis  in 
symptomatic  patients (Tapson,  1999).  For  asymptomatic  patients,  ultrasound 
techniques are not sensitive enough to exclude a diagnosis of deep venous 
thrombosis (Rumack, 1998). 
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Spiral  CT is another method of diagnosing PE, providing parallel  projections 
and x-ray images without  distortion.  Following intravenous bolus  injection of 
contrast medium, the pulmonary arterial phase and venous phase are clearly 
separated. Spiral imaging has introduced the concept of volumetric imaging with 
ionizing radiation (Early, 1995).
Spiral CT has taken CT from what was primarily an anatomic tool to one that 
offers  physiologic  and  pathogenic  information  (Rays,  1996).  Greater  lesion 
detection  (ability  to  reconstruct  overlapping  cross-sectional  images)  creates 
high  quality  multiplanar  3D  reformatted  images  (Annals  of  Emergency 
Medicine,1999). Spiral or helical CT uses ‘slip-ring’ technology eliminating the 
old step and shoot phase allowing uninterrupted scanning during continuous 
patient advancement through the gantry.  Once a volume of data is acquired, 
images  can  be  reconstructed  at  any  point  along  that  volume  (Annals  of 
Emergency Medicine, 1999).
The creation of overlapping slices can lead to studies of greater sensitivity since 
small lesions which otherwise would have fallen between continuous slices may 
now be detected on the overlapping images (Clinical Imaging 1994).  The actual 
time taken to acquire a complete Spiral CT to the production of interpretable 
images is essentially a sum of the two components: the time it takes to carry out 
the scan (scan time), and the time necessary to reconstruct the individual 2-D 
images  from  3-D  data  (image  reconstruction  time)  (Annals  of  Emergency 
Medicine, 1999).
The latter is longer, seconds versus minutes.  An extra sharp filter is used for 
reconstructing a Spiral CT (Clinical Imaging 1994).  Spiral CT enables an exact 
demonstration of thrombosis if there are severe, centrally localized emboli.  In 
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completely occluded vessels, estimation of the degree of location of perfusion 
defects is far better with scintigraphy (Clinical Imaging 1994).  The conclusion, 
based on clinical results and technical equipment necessary to run CT, is that  
lung  scintigraphy  remains  the  first  choice  for  diagnosing  PE  (Annals  of 
Emergency Medicine, 1999).
Pulmonary emboli are sometimes seen on conventional contrast-enhanced CT 
scans.  However,  such  a  finding  is  usually  serendipitous  and  depends  on 
catching  the  intravenous  contrast  bolus  at  the  exact  time  it  arrives  in  the 
pulmonary vasculature (Rays, 1996).
Spiral  CT scanning (also  known as helical  CT)  was  introduced in  the  early 
1990s and involves an x-ray beam and a coupled array of detectors rotating 
continuously in a spiral manner (Rays, 1996). This spiral technique results in 
reduction in examination time compared with conventional CT scanning. During 
a single breath-hold, spiral CT is capable of imaging nearly the entire thorax.  
Therefore,  intravenous  contrast  can  be  timed  to  arrive  in  the  pulmonary 
vasculature to give vascular opacification (Rays, 1996, Clinical Imaging, 1994).
Since its introduction, spiral CT scanning has gained popularity for diagnosis of 
pulmonary embolism (Rays,  1996).  In studies comparing spiral  CT scanning 
with pulmonary angiography as the diagnostic standard, spiral CT scanning had 
a sensitivity of 64% to 93% and a specificity of 89% to 100% (Rays, 1996). The 
greatest sensitivity and specificity were achieved when a pulmonary embolism 
involved the main, lobar, or segmental pulmonary arteries (Howarth, 1999).
Given the limitations of ventilation-perfusion scanning, it is not surprising that 
spiral  CT  scanning  has  gained  popularity  (Annals  of  Emergency  Medicine, 
1999).  Spiral  CT  scanning  actually  visualizes  the  clot,  whereas  ventilation-
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perfusion scanning only displays the secondary effects of the pulmonary emboli 
on the pulmonary vasculature bed (Annals of Emergency Medicine, 1999). In 
addition, the majority of patients undergoing ventilation-perfusion scanning have 
non-diagnostic results and require further testing (Early, 1995). 
Other key advantages of spiral CT over ventilation-perfusion scanning include 
the ability to identify other disease states that can mimic pulmonary embolism 
(e.g., lung tumours, pleural disease, pericardial disease) (Rays, 1996). In one 
study,  11%  of  patients  undergoing  spiral  CT  scanning  for  suspicion  of 
pulmonary embolism had unequivocal abnormalities of lung parenchyma that 
could explain the clinical presentation (Clinical Imaging, 1994). Given that most 
patients being evaluated for pulmonary embolism do not have emboli, spiral CT 
can  sometimes  provide  an  alternative  diagnosis  (Clinical  Imaging,  1994). 
Although evidence suggests that spiral CT may be cost-effective, information is 
insufficient to make firm recommendations at this time (EJNM, 1999). In terms 
of  cost,  a  ventilation-perfusion  scan  is  about  one  and  a  half  times  and  a 
pulmonary angiogram is six to eight times as expensive as a spiral CT scan 
(EJNM, 1999).
There  has  been  widespread  discussion  amongst  radiologists  and  nuclear 
physicians suggesting the selective substitution of spiral computed tomography 
(CT)  for  lung  scintigraphy  for  the  diagnosis  of  PE  (Annals  of  Emergency 
Medicine,  1999).  Radiologists  suggest  spiral  CT  is  more  accurate  than 
combining  ventilation  and  perfusion  lung  scintigraphy  and  the  nuclear 
physicians “best judgement” (Annals of Emergency Medicine, 1999). This is due 
to  the  fact  nuclear  medicine  physicians  classify  lung  patients  in  groups 
according to their probability of having PE, whereas a thrombus is visible using 
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spiral CT (Rays, 1996).  Lung scintigraphy research has been undertaken over 
many years and as yet a large- scale research project has not been conducted 
on spiral  CT on these criteria (Annals of Emergency Medicine, 1999).  Most 
referring physicians are aware of the strengths and limitations of an assessment 
that relies primarily on lung scintigraphy, as this has the backup of many years  
research.  Spiral CT will have an interesting role to play in patient evaluation for 
the diagnosis of PE (Annals of Emergency Medicine, 1999).
The negative aspects of spiral CT are the high radiation doses received by the 
patient and the increasing number of x-rays ordered by clinicians (Rays, 1996). 
The absorbed  dose  in  tissues from CT is  high  and  is  within  the  range of  
10 – 100 mGy (Annals of  Emergency Medicine, 1999).   Clinicians therefore 
need to justify patients having x-ray examinations and ask if  these tests will 
affect patient management.  Reducing patient doses should remain a priority;  
CT doses are quite high and have not reduced over time, as has conventional  
radiology  (Clinical  Imaging,  1994).  Computerized  Tomography  (CT)  and 
magnetic  resonance  have  a  limited  ability  to  detect  occlusion  of  the  distal 
pulmonary arterial branches that exclude PE (Clinical Imaging, 1994).
Despite  being  a  sound  diagnostic  tool,  spiral  CT  scanning  is  not  without 
limitations. The main limiting feature is the inability of spiral scanning to detect 
pulmonary embolism in subsegmental pulmonary arteries (Rays, 1996). Using 
data  from  six  studies,  Mullins  et  al.  (2000)  found  a  sensitivity  of  29%  for 
detection of subsegmental pulmonary embolism by spiral CT, compared with 
pulmonary angiography (Annals of Emergency Medicine, 1999).
The question arises as to the prevalence of subsegmental emboli. Data from 
the  PIOPED  (1990,1995)  study  showed  that  5.6%  of  patients  had  isolated 
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subsegmental emboli. Other studies indicated this number was likely to be 5% 
to 36% (Van Beek, 1996, Fedullo, 2003). The clinical significance of isolated 
subsegmental emboli is not clearly known, but they may be markers for larger 
clots residing in the lower extremity veins (Fedullo, 2003). In addition, treatment 
of isolated subsegmental emboli in patients with poor cardiopulmonary reserve 
can result in clinical improvement.
1.11 Clinical Guidelines
To date, there are insufficient multi-centre studies to support the use of spiral 
CT as an initial diagnostic technique for detection of venous thromboembolism 
(Annals of Emergency Medicine, 1999). Although the exact role of spiral CT in 
the diagnostic algorithm for pulmonary embolism is still  not clear,  a few key 
observations can be made to help guide clinical judgment.
Given the wide range of sensitivities of spiral CT for diagnosis of pulmonary 
embolism, it  should be used as a "rule-in"  modality,  rather than a "rule-out"  
procedure  (Rays,  1996).  Hence  a  normal  spiral  CT scan  does  not  exclude 
pulmonary embolism with certainty.  If the spiral CT is normal and the clinical 
suspicion  of  pulmonary  embolism  is  high,  further  testing  is  strongly 
recommended  (compression  ultrasound,  D-dimer  assay,  or  pulmonary 
angiography) (Fedullo, 2003, Botnar, 2004).
Since the investigation of venous thromboembolism can be tedious, invasive, 
and expensive, there has been an increased focus on D-dimer assays, which 
are  rapid,  noninvasive,  and  inexpensive.  Fibrin  is  the  main  component  of 
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thrombus  formation,  and  degradation  of  cross-linked  fibrin  results  in  fibrin 
degradation products including D-dimers (Clinical Imaging, 1994).
D-dimers are commonly found in the circulation when venous thromboembolism 
is present. However, this finding lacks specificity, since D-dimers are also found 
in  other  disease  states,  including  cancer,  congestive  heart  failure,  and 
inflammatory conditions (Clinical Imaging, 1994).
Tapsen and associates in 1999 used two general  methods of measuring D-
dimers.  The  original  enzyme-linked  immunosorbent  assay  (ELISA)  methods 
have been well studied and in general have a 95% negative predictive power 
(Rays,  1996).  In 1998, Janssen et al.  studied the limitations associated with 
classic ELISA methods including cost and inability to perform the test rapidly.  
Janssen developed rapid ELISA assays (VIDAS DD [Biomerieux, France] and 
Instant IA DD [Stago, Asniere, France]). The VIDAS DD has been extensively 
studied and has a sensitivity of 94% to 100% and a negative predictive value of 
92% to 100% (Rays, 1996, Clinical Imaging, 1994).
The other method of measuring D-dimer fragments is latex agglutination testing, 
which is both rapid and economical (Clinical Imaging, 1994). However, the latex 
testing methods are subjective and can be difficult to read. Most of the latex 
methods have inadequate sensitivity and negative predictive value for clinical 
use  (Clinical  Imaging,  1994).  New  latex  tests  have  been  introduced  with 
sensitivities and negative predictive values approaching classic ELISA methods 
such  as  Simple  Red  [Agen  Diagnostics  Limited,  Australia]  and  Tinaquant 
[Boehringer, Mannheim, Germany]. Janssen’s results for the Simple Red assay 
show a sensitivity of 89% to 100% and a negative predictive value of 95% to 
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100%. The Tinaquant assay has a sensitivity of 99% and a negative predictive 
value of 93% (Botnar, 2004). 
Evidence supporting use of D-dimers in clinical practice is rapidly emerging. 
Perrier and colleagues (1997) evaluated the role of an ELISA D-dimer assay in 
198 patients suspected of having a pulmonary embolism. Using a cut-off value 
of less than 500 g/L as normal, these investigators reported that of the 198 
patients  with  a  normal  D-dimer  value,  only  one  patient  had  a  pulmonary 
embolism and one was lost to follow-up (Rays, 1996). The negative predictive 
values of the D-timer test in this study were 99% (196 of 198 patients).
Elevated  D-dimer  fragments  are  too  non-specific  for  diagnosis  of  venous 
thromboembolism by themselves (Rays, 1996). With negative predictive values 
close  to  100%,  certain  D-dimer  assays  have  the  potential  to  be  the  only 
screening test necessary to rule out venous thromboembolism (Rays,  1996). 
However,  many authors and experts have been reluctant to propose such a 
diagnostic strategy (Clinical Imaging, 1994). 
The American Thoracic Society's  clinical practice guidelines (1999) on acute 
venous thromboembolism reaffirm the emerging value of D-dimers assays but 
currently  do  not  endorse  widespread  use  (Rays,  1996).   At  present,  assay 
performance varies  widely,  and different  assays  cannot  be  clinically  applied 
interchangeably (Rays, 1996).
If  D-dimer assays are to be used in a diagnostic strategy,  the details of the 
assay  should  be  known,  including  type  (latex  or  ELISA),  operating 
characteristics  (sensitivity  and  negative  predictive  value),  and  outcomes  of 
clinical  studies supporting  the particular  assay (Clinical  Imaging 1994).  Until 
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further studies emerge, testing for D-dimers should be restricted to patients in 
whom clinical suspicion of venous thromboembolism is low or moderate (Rays, 
1996, Clinical Imaging, 1994). 
Given that the majority of patients with abnormal chest x-ray studies have a 
nondiagnostic  ventilation-perfusion scan,  spiral  CT scanning is  an option for 
initial study in these patients (Annals of Emergency Medicine, 1999). Finally, if 
an alternative diagnosis is being considered in addition to pulmonary embolism, 
spiral  CT scanning  can  provide  new information  that  a  ventilation-perfusion 
scan  cannot  (Clinical  Imaging,  1994).  Further  prospective,  multi-institutional 
investigations  can  help  clarify  the  role  of  spiral  CT  for  the  diagnosis  of 
pulmonary embolism.
Newer equipment, however, will mean reduced patient dosage, as anatomical 
based on-line adjustment of exposure factors should be used (EJNM, 1999). 
Management  of  dose  means  a  reduction  of  mA  (tube  current),  which  is 
determined by the inherent characteristics of the scanner, size of the patient, 
the  anatomical  region  for  investigation  and  technique  used  (EJNM,  1999). 
Therefore, absorbed dose should be sufficient to meet all the aforementioned 
criteria  (Madan,  2000).   Patient  dose depends on the radiation of  the x-ray 
beam, and is linearly related to the product of the tube current (mA) and scans 
time(s) (Clinical Imaging, 1994).
Scan length also controls the volume of patient irradiated, unfortunately with 
new fast scanners there has been a tendency to increase scan length so that 
scans of the thorax, abdomen and pelvis are common.  Effort should be made 
to restrict the areas of scanning to those clinically essential (Madan, 2000).
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In the future there may be another scintigraphic approach to diagnose more 
directly thromboembolic disease and PE (Leiper, 1998).  Research indicates the 
99mTc peptide imaging of activated platelet receptors may help in the detection 
of acute DVT and PE.  Lung scintigraphy however, will continue to be widely 
used to assist with the diagnosis of PE, as it is cheap, easy, non-invasive and 
readily available for use (Leiper, 1998). Arterial Blood Gases (ABG) assist in the 
diagnosis  of  PE,  and  other  associated  conditions  such  as  respiratory 
acidosis/alkalosis or metabolic acidosis/alkalosis (Fahey, 1995). ABGs do not 
only identify a specific problem but can also help identify possible strategies to 
correct for these imbalances (Fahey, 1995). The oxyhaemoglobin curve shows 
the  relationship  between  percentage  of  haemoglobin  saturation  (SaO2)  and 
partial pressure of arterial oxygen (PaO2) (Hess, 1996).
A normal oxyhaemoglobin curve assumes certain parameters.  These are a pH 
of 7.4; temperature of 37°C and PaCO2 of 40 mmHg (Earis & Pearson, 1995). 
At  the  arterial  end  of  the  curve  the  slope  is  gentle,  reflecting  the  alveolar-
capillary O2 transfer site.  PaO2 drops markedly with little change in SaO2 at 
this point.  At the steeper portion of the curve, venous disassociation occurs as 
O2 leaves the haemoglobin and is transferred to the cells (Earis & Pearson, 
1995).
At this site SaO2 drops dramatically with little change in PaO2.  Oxygenation at  
the cellular level depends on the ability of O2 to bind with and be released from 
the Haemoglobin (Hb) in the blood (Adams, 1984, Earis & Pearson, 1995).
Thus  pH  is  the  measurement  of  acidity  of  a  solution  (Hydrogen  ion 
concentration).  The  optimal  pH is  7.4  (Range  7.36  -  7.45)  (Hillman,  1996). 
Death can result when the pH is less than 6.8 or greater than 7.8. Buffers in the 
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body will  always  try  to  maintain  homeostasis  and restore  the  pH to  normal 
(Earis & Pearson, 1995).
This process is called compensation and is controlled by the use of buffers 
(Earis & Pearson, 1995). Buffers are weak acids or bases that prevent sudden 
change  in  pH.   Examples  of  buffer  systems  are:  phosphate  buffer  system, 
Hb/OxyHb system (Habibian 1999).  Hb releases oxygen and attracts H+ ions. 
There is a formula which summarizes the buffer system:
(Carbon dioxide+water  =carbonic acid = hydrogen + bicarbonate) e.g. 
CO2 + H2O Lungs = H2CC3 = H+ + HCC3- Kidneys (Adams, 1984).
Magnetic Resonance Imaging MRI or MRV for magnetic resonance venography 
may  be  considered  a  complementary  diagnostic  tool  to  the  less  expensive 
venous  sonography  (Rays,  1996).   It  is  the  complementary  use  of  MRV 
techniques at the level of the pelvis and mediastinum that offers the greatest 
cost benefit and part of a patient’s diagnostic workup (Rays, 1996).  A major 
consideration of DVT is the mortality and morbidity associated with PE (Earis & 
Pearson, 1995).
The long-term sequelae of  DVT include the development of  chronic  venous 
disease, venous insufficiency and associated trophic changes.  The incidence 
of upper extremity venous disease has increased in part due to the better use of 
central venous lines as they serve as a nidus for thrombus formation (Rumack,  
1998).
MRV images the central veins such as the inferior and superior vena cava, the 
iliac,  brachiocephalic  as  well  as  peripheral  veins.  The  future  of  MRI  in  the 
investigation of PE will depend on how integrated it can become with other non-
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invasive technologies (Clinical Imaging 1994).  MRV pulse sequences can be 
differentiated into either T1 or T2 weighted spin echo images as well as flow 
sensitive sequences (Rays,  1996, Clinical  Imaging, 1994).   The shift  in MRI 
today is to use rapid flow sequences; saturation pulses attenuate the signal 
intensity of moving blood within the veins (Rays, 1996).  Contrast infusions of 
Gadolinium (153Gd) with  concentrations of 0.1 - 0.2 mmol/kg can be used to 
increase the signals arising from moving blood in the vein lumen.  However 
there is no real justification for using Gadolinium (Rays, 1996). 
The presence of a filling defect in the lower extremities can be confirmed with 
flow sensitive sequences (Rays, 1996). With DVT and total obstruction of the 
veins,  T2  weighted  sequences  can  confirm  the  presence  of  inflammatory 
changes in the soft tissues due to a response associated with the presence of  
DVT. The negative aspect, however, is the high cost on a per patient basis and 
with respect to the diagnosis of isolated calf DVT, there is little data to justify the 
use of MRV, although it has a definite advantage at pelvic level (Rays, 1996, 
Clinical Imaging, 1994).
Forced Expiratory Volume or FEV1 is another useful diagnostic measurement, 
as FEV1 evaluates air resistance in the larger airways by using a spirometer. 
FEV1 is decreased in Chronic Airways Limitation (CAL) patients, as there is an 
increased  airway  resistance  (Hillman,  1996).   Forced  Vital  Capacity  (FVC) 
divided by FEV1 is a ratio used as it is independent of variations in lung volumes 
due to age, stature and restrictive lung disease (Hillman, 1996, Adams, 1984).
Lung function studies may support or exclude a diagnosis, but cannot make a 
diagnosis (Adams, 1984).  Early lung function tests may help both in the control  
of the condition and in the diagnosis.  Patients with CAL will undergo these tests 
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regularly  and  early  diagnosis  and  treatment  of  respiratory  defects  can 
significantly enhance and extend the life of large numbers of people (Adams, 
1984, Earis & Pearson, 1995).
Vital Capacity (VC) is the volume change at the mouth between the position of  
full inspiration and full expiration (West, 1987).  It is usually performed slowly 
from a position of maximum inspiration to full  expiration. Some patients may 
have  a  degree  of  broncho-spasm.  Increased  values  will  be  obtained  from 
patients with CAL; a reduction in VC indicated a pattern of restriction (West, 
1987).
Forced  Vital  Capacity  (FVC)  represents  the  volume  of  gas  which  can  be 
“squeezed” from the lung when maximum effort from a position of full inspiration 
(West, 1987).  Sometimes FVC can be less than VC as the forced manoeuvre 
can  raise  inter-pleural  pressure  causing  premature  closing  of  the  peripheral 
airways, called air trapping (FDA, 1999, West, 1987).
Forced Expiratory Volume (FEV1) is the amount of gas expelled from the lung 
over a timed period from a position of maximum inspiration with  the person 
making a maximum effort  with  a usual  time interval  of  one second  (West,  
1987). A reduced measurement indicates airway obstruction occurring in the 
larger airways from which the air is first expelled (West, 1987).
1.12 Lung Scanning
Ventilation lung scans provide images of regional ventilation (Habibian, 1999).  
Ventilation scintigraphy involves the use of a radioactive aerosol inhaled by the 
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patient using a commercially available Patient Administration Set (PAS), which 
is  connected  to  the  Technegas  Generator  (TcG)  (Leiper,  1998).   In  a 
Technegas ventilation study these radioactive particles are smaller than one 
micro  metre  (µm)  in  diameter  and  adhere  to  alveolar  structures  without 
appreciable movement for approximately forty (40) minutes (Isawa et al, 1996). 
Once the aerosol is administered, lung scintigraphy commences and provides 
both  quantitative  and  qualitative  information  for  studying  lung  physiology 
(Habibian 1999).  A concise explanation is given later.  Adequate ventilation is 
sought to optimise images and to provide high specificity for the diagnosis of PE 
(James, 1995,  Habibian 1999).
The ventilation-perfusion scan has long been considered the pivotal  test  for 
diagnosis  of  pulmonary  embolism (Habibian  1999).  Most  of  the  information 
regarding ventilation-perfusion scanning comes from PIOPED (1990, 1995), a 
prospective  multi-institutional  effort,  which  compared  ventilation-perfusion 
scanning with the standard diagnostic criterion of pulmonary angiography.
1.12.1 Oxygen Saturation
Due to transient hypoxia  during the first  inhalation of Technegas and Argon 
there  is  a  brief  instance of  anoxia  when  oxygen  levels  may fall  by  varying 
degrees in patients for a few seconds prior to returning to normal levels (James, 
1992). 
It  is  anticipated  that  the  majority  of  patients  will  undergo  some  temporary 
changes in  oxygen  saturation  levels  during  the  administration of  Technegas 
(Leiper, 1998). This is a common occurrence, not associated with any harmful 
symptoms.   Therefore,  oxygen  via  nasal  prongs  is  used  for  volunteer  CAL 
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patients who need supplementation to keep their oxygen saturation levels within 
normal range (99 - 100 %), making hypoxia less significant (Leiper, 1998).
The first spectrophotometric measurements of blood were made in the 1930s 
(James,  1992).  In  the  1950s,  a  spectrophotometer  was  used for  measuring 
haemoglobin and its derivatives. Specific instrumentation for measuring oxygen 
saturation was developed in the 1960s.  The use of ear and finger oximeters for 
continuous estimates of arterial saturation arose from aviation studies in both 
Germany and America during World War 2. Widespread use of pulse oximeters 
developed in the 1980s (James, 1992).
The oxygen saturation monitor provides continuous oxygen saturation readings, 
which are produced by measuring the absorption of different wavelengths of 
light  (James,  1992).   At  certain  known  wavelengths  both  oxygenated 
haemoglobin  (HbO2)  and  reduced  haemoglobin  (Hb)  absorb  light  (Hillman, 
1996).  The continuous pulsation from the digital artery modulates light, which is 
passed through the probe thereby enabling calculation of the delivered oxygen 
saturation  levels  while  ventilating  the  patient.   The  digital  display  from  the 
monitor  is  updated  every  twenty-five  (25)  seconds,  the  range  is  0  -  100% 
(Hillman, 1996, James, 1992).
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Figure 1.2 Non-invasive Monitoring of Oxygen
Nickerson et al. (1988) studied the reproducibility of oximeter measurements in 
normal volunteers and suggests variations of 1% in the range of saturations 
above 90%, and 2% in the range below 90%, indicating that a clinical change 
has occurred. 
  Figure 1.3 The Nellcor pulse oximeter 
Routine monitoring of oxygen saturation will  help prevent,  although rare, any 
side effects, and ensure the safety of all patients who may be at risk (Leiper, 
1998). Using the Nellcor oximeter, oxygen saturation levels are monitored at the 
beginning,  trough  (middle)  and  end  of  the  ventilation  stage.  Valuable 
information  can  be  obtained  by  reading  patients’  saturation  levels  prior  to 
ventilation.  The initial saturation is important, as it is the duration and degree of 
hypoxia  induced  and  the  patient’s  ability  to  withstand  changes  in  oxygen 
saturation levels that will require monitoring (Hillman, 1996, Leiper, 1998).
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Historically  there  are  two  basic  ways  to  measure  haemoglobin  oxygen 
saturation  levels  in  blood:  1)  gasometrically  and  2)  spectrophotometrically 
(Adams, 1984, Earis & Pearson, 1995). The development of spectrophotometric 
methods dates back to Isaac Newton’s studies of light in the 1600s. Research 
undertaken by Lambert in 1760 and Beer in 1852 resulted in the Beer-Lambert  
Law that describes the transmission/absorption of light as a logarithmic function 
of the concentration of the absorbing molecules in solutions.
1.12.2 Measured Saturation
An  oximeter  is  a  spectrophotometer  designed  to  measure  blood  oxygen 
saturation (Fahey, 1995). Each type of haemoglobin molecule has its own light 
absorption spectrum. Oximeters contain light sources at selected wavelengths 
that correspond to the absorption spectra of the haemoglobin molecules to be 
measured  (Hillman,  1996).  Therefore,  a  basic  oximeter  that  can  measure 
saturated oxygen needs to determine the absorption at only two wavelengths, 
one for haemoglobin and one for oxyhaemoglobin. Pulse oximeters use two 
wavelengths that can be transmitted through the skin (e.g., a finger, ear or toe), 
allowing non-invasive monitoring of saturation (Adams, 1984). However, two–
wavelength oximeters can give misleading estimates of the oxygen content of 
blood in the presence of elevated levels of Carboxyhaemoglobin (COHb) and 
Methaemoglobin (MetHb) (Adams, 1984, Earis & Pearson, 1995).
1.12.3 Chest X-Ray and PE in Nuclear Medicine
The chest x-ray is often the first imaging screen obtained when a patient is 
admitted  to  accident  and  emergency  with  dyspnoea  (Fogelman,  1988).  In 
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patients  that  are  positive  for  PE,  their  chest  x-ray  will  be  abnormal.  Much 
research has been carried out to establish that a normal chest x-ray only occurs 
in a minority of cases of PE (Fogelman, 1988, Early, 1995).
In the chest x-ray,  atelectasis and parenchymal densities are quite common. 
The areas of atelectasis are more common in the lower lobe of the lung as are  
the areas of parenchymal density (Wade, 1982). Most of these densities are 
caused by pulmonary haemorrhage and oedema and may be confused with 
infectious  infiltrates  or  malignancies  (Early,  1995  and  Wade,  1982).  These 
effusions are usually visible when the patient is examined, mostly small  and 
occupying less than fifteen percent (15%) of a hemithorax and rarely increase in 
size after the third day. Any size increase should raise a suspicion of pulmonary 
infection or re-embolization.
Pleural-based opacities with convex medial margins are known as Hampton’s 
Hump,  which  maybe  an  indication  of  a  lung  infection  (Roussos,  1995, 
Fogelman, 1988). The rate of resolution of these densities is a good method of  
judging  if  lung  tissue  has  infracted.  Areas  of  pulmonary  oedema  and 
haemorrhage resolve in a few days to a week (Roussos, 1995). Linear scars 
are  found  when  the  infarcted  lung  has  decreased  over  weeks  to  months 
(Fogelman, 1988 and Early, 1995). 
If  the  central  pulmonary  artery  is  prominent,  this  is  either  from  pulmonary 
hypertension  or  the  presence  of  a  clot  in  those  arteries  (Adams,  1984). 
Cardiomegally is a non-specific finding but may imply an enlarged right ventricle 
as seen in patients who present with large bilateral pulmonary emboli (Earis & 
Pearson, 1995). In conclusion, the chest x-ray can be normal in a minority of 
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patients  and  abnormalities  when  present  are  often  non-specific  (Earis  & 
Pearson, 1995).
1.13 PE and Nuclear Medicine
The early 1970s were indeed a turning point for nuclear medicine, bringing to 
mind Whitehead’s statement: “It is a well founded historical generalization that 
the last thing to be discovered in any science is what the science is really about” 
(taken from Taylor, 1989).
Approximately one patient in three hospitalised will  have a nuclear medicine 
diagnostic procedure performed in which a radioactive isotope or tracer has an 
essential  role  (Murray,  1988).  One  example  is  lung  scintigraphy,  when  a 
decreased blood flow to the lungs is observed, which may indicate the presence 
of PE. The use of the radioactive tracers in diagnostic and therapeutic medicine 
has become so widespread that nuclear medicine is a “speciality” department 
(Habibian 1999, Isawa, 1991).
1.13.1 Indications for Lung Scintigraphy
Indications for both ventilation and perfusion lung scintigraphy are to evaluate 
possible pulmonary embolism (PE) and the evaluation of pulmonary flow post 
heparin for patients with confirmed PE (Murray, 1988).  PE is usually multiple 
and produces more than two scintigraphic perfusion defects (a defect being a 
reduction in  perfusion)  accompanied by a normal  ventilation scan and clear 
chest x-ray (Habibian 1999, Murray, 1988). Both lung ventilation and perfusion 
scintigraphy have a high specificity for PE. 
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The typical pattern seen in PE is of perfusion defects with normal ventilation, 
whereas  matching  perfusion  and  ventilation  defects  are  typical  of  other 
respiratory diseases (Taylor, 2000). In patients with CAL, their image quality is 
poor, showing considerable particle deposition in the major airways and little 
penetration to the lung parenchyma (Taylor, 2000). Attempts have been made 
to improve aerosol production systems in order to reduce the particle size and 
therefore improve image quality (Taylor, 2000). The use of a positive pressure 
device known as TEBA assists CAL patients as Technegas is gently “pushed” 
into the patients’ lungs, requiring no effort from the patient and giving a more 
uniform image for interpretation (Leiper, 1998).
Technegas used for lung ventilation should not show significant clearance or 
redistribution over the time of image acquisition (Murray, 1988). Technegas has 
the distinct advantage that it remains fixed in the lung, having an effective half – 
life of 335 minutes, which is equivalent to the half – life due to physical decay 
(Burch, 1986).
1.13.2 How Lung Scans are interpreted in Nuclear Medicine
Perfusion  defects  of  PE  are  wedged  shaped  and  pleural  based;  therefore 
seeing  a  centrally  located  defect  “stripe  sign”  is  evidence  against  PE. 
Segmental perfusion defects are important characteristics of PE.  Defects of 
irregular shape are unlikely to be due to PE.  The size of the perfusion defect is 
also an important clue to the diagnosis of PE (Early, 1995).  Defects are usually 
large and occupy more than seventy-five percent (75%) of a segment.  Twenty-
five to seventy five percent (25 - 75%) are moderate and segmental, whereas 
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defects  less  than  twenty-five  percent  (25%)  are  usually  not  caused  by  PE 
(PIOPED, 1990).
Lung perfusion should not be used solely as a diagnostic modality.   A good 
medical history, recent chest x-rays and a ventilation study must also be sought 
(Botnar, 2004).
1.13.3 Why Nuclear Medicine procedures are useful
The single greatest value of nuclear medicine procedures is that they provide 
the unique ability to apply the tracer technique to humans; that is, to be able to  
track the course of labelled molecules or cells as they travel  throughout the 
human body (Murray, 1988). 
We can examine both the site and rate of important biological processes and 
detect abnormalities as regions of dysfunction or decreased perfusion (Howarth, 
1999).  If  we  say that  the  first  principle  of  nuclear  medicine is  the tracer  or 
isotope, the second is the “homogeneity principle” which states that the function 
of many body organs is relatively homogeneous (Murray, 1988). Disease can 
manifest itself as a region of local dysfunction that may occur prior to the overall  
function  of  the  organ  becoming  impaired,  which  often  results  in  an  earlier 
diagnosis.
Nuclear physicians use a combination of applied physiology and biochemistry 
and  make  direct  measurements  of  regional  function.  This  is  known  as  a 
“working hypotheses”, in other words a means of predicting the outcome and 
optimum care for the patient (Habibian 1999). The patient’s physiological and 
biochemical  measurements  often  provide  the  essential  information  for  the 
diagnosis to be made (Murray, 1988).
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With the use of radio isotope scanning, it is not necessary to achieve the high 
concentration  necessary  to  produce  opacity  to  X-rays.  It  is  the  relative 
concentration within the organ e.g. lung with respect to its surroundings that is 
important  in  nuclear  medicine  rather  than simply  the  absolute  concentration 
(Taylor, 1989).
The  use  of  radioactive  tracers  in  nuclear  medicine  has  made  possible  an 
improvement in perception and conceptualisation of disease (Roussos, 1995). 
Nuclear medicine gives us symbolic representations of patterns and changes in 
the spatial and temporal distribution of chemicals that make up living organisms 
(Roussos, 1995, Fogelman, 1988, Early, 1995).
Limiting our perception to static images is equivalent to assuming that nothing 
ever changes, therefore our images have to be concerned with time, with the 
order of events and duration (Taylor, 2000). When we report on an image, we 
are investigating what is happening in that patient’s body and looking at the 
spatial and temporal distribution of isotope in nuclear medicine (Taylor, 2000, 
Garbe, 1986).
Approximately one hundred percent (100%) of the diagnostic studies performed 
with radioactive tracers in nuclear medicine use a radionuclide (Murray, 1988). 
Together with the use of the gamma camera and computer, technetium – 99m 
has played a major role (Palla et al, 1988). There are several reasons for its  
widespread use: (1) its short half–life and mode of radioactive decay keep the 
radiation  dose  to  the  patient  low  (ALARA);  (2)  it  is  readily  available  as  a 
daughter product of the radionuclide, molybdenum – 99, with a 67 hour half-life; 
(3) it forms chemically stable complexes with a wide variety of molecules.
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Most radioactive drugs are administered to provide diagnostic information rather 
than to produce a therapeutic effect, although the use of radioactive iodine to 
suppress  thyroid  function  is  an  important  exception  (Habibian  1999).  In  a 
nuclear medicine study,  diagnostic information is encoded in gamma rays,  a 
type of electromagnetic radiation that has the ability to penetrate tissues of the 
body  and  be  detected  by  the  gamma  camera  also  known  as  an  Anger 
Scintillation camera (Habibian 1999, Taylor, 2000). In the case of therapeutic 
radiation, the gamma rays transfer energy to the cells being irradiated in order 
to reduce their function or kill them, as is the case for cancer therapy (Taylor,  
2000).
In  diagnostic  studies,  the  aim is  to  maximise  the  number  of  photons  being 
recorded while minimizing the associated radiation dose to the patient. From the 
viewpoint of minimizing the latter, the shortest possible half – life, which permits 
measurement of the diagnostic information, is desired (Taylor, 2000).
Most biochemicals that we investigate consist of carbon, hydrogen, nitrogen, 
oxygen, phosphorus and sulphur (Behrens, 1959). Hydrogen, phosphorus and 
sulphur have no suitable gamma emitting isotopes. Carbon – 11, nitrogen – 13, 
and oxygen – 15, decay by emitting positrons, which combine with electrons to 
emit two 511keV photons in almost exactly opposite directions (Behrens, 1959). 
Their production requires the availability of a particle accelerator known as a 
cyclotron, which is only available at major centres (Murray et al, 1988).
Advances in  nuclear  medicine  over  the  years  have  been along three lines: 
better  chemicals,  better  instruments  and  better  quantification  (Subramanian, 
1975). With the introduction of emission tomography,  quantification improved 
significantly (Rays, 1996). There are two types of emission tomography: Single 
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emission  tomography  known  as  SPECT  and  positron  emission  computed 
tomography or PET. The latter permits a more accurate quantification, and the 
former provides significant improvement over planar imaging, where the three 
dimensional distribution of radioactivity is projected onto a single plane (Rays,  
1996).  Whether imaging performed with the planar or SPECT technique, the 
positive predictive value of a high-probability scan is sufficiently high (96%), and 
that of a low-probability scan in the setting of low clinical suspicion is sufficiently 
low (4%), that many patients can be managed with  V/Q scans alone (Maki, 
2011).
1.13.4 Non-specific signs and symptoms
The problems in clinical diagnosis of PE relate to the non-specificity of clinical  
signs and symptoms: the most common symptoms reported are unexplained 
dyspnoea, light-headedness, and chest pain (Botnar, 2004). A routine anterior /  
posterior  chest  X-ray  will  also  be  acquired  within  the  first  24  hours  after 
admission. This X-ray will accompany the patient having a lung scan which will  
assist  in  the  diagnosis  along  with  the  acquired  images  from  the  lung 
scintigraphy (Rays, 1996).
Other  diagnostic  tests  may  be  requested  if  the  lung  scintigraphy  report  is 
intermediate and the chest x-ray non specific for PE. The “Gold Standard” is 
Spiral  CT, which may give a definitive diagnosis for PE. The decision about 
which  combination  of  tests  to investigate  this  disease  is  subject  to  various 
debates (Rays, 1996, Clinical Imaging, 1994).
Since the clinical presentation of PE is usually non-specific, the findings on CT 
are often the first clinical indication that the patient may be suffering from PE. In 
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addition  to  being able to  visualise the  infarction,  the area where  the clot  is 
located can also be visualised (Clinical Imaging, 1994).
1.14 Lung Scintigraphy
Lung  scintigraphy  continues  to  be  a  useful  diagnostic  tool  and  is  a  logical  
imaging investigation to obtain post chest radiography (Clinical Imaging, 1994). 
The lung scintigraphy report  will  be categorized as low, intermediate or high 
probability for PE (PIOPED, 1990). A normal perfusion scan is characterized by 
even distribution of radiotracer throughout both lungs. It is also important to note 
that  the  accuracy  of  any  diagnostic  investigation  is  dependent  on  its 
reproducibility  (Taylor,  2000,  Clinical  Imaging,  1994).  A  high  probability 
perfusion  scan  is  represented  by  multiple  segmental  or  larger  defects  with 
normal ventilation in at least one area of abnormal perfusion. This is known in 
nuclear medicine as a ventilation / perfusion mismatch. A lung scan report with  
high probability may show multiple segmental defects and normal ventilation 
(Rays, 1996, Clinical Imaging, 1994).
Various  forms  of  the  PIOPED criteria  have  been  used  since  the  1990s  by 
nuclear physicians as a reliable method of diagnosing PE. It  is  important to 
recognise that a minority of patients with a PE have a high probability scan and 
that this pattern of events is not pathogenomic for acute embolism especially if 
there is a history of PE. A minority of emboli do not resolve and the perfusion 
study may not return to normal (Clinical Imaging, 1994).
Chap 1 - 72
If a ventilation / perfusion scan does not fit into the normal or high probability 
category, then it is a non–diagnostic report for PE. The majority of patients fall  
into this category due to the presence of subsegmental defects, or defects of 
any  size  matching  abnormalities  seen  on  a  chest  x-ray,  and  further 
investigations may be necessary  (Clinical Imaging, 1994).
A low probability category is not particularly reliable as suggested by PIOPED 
data. Disagreement amongst experienced nuclear physicians is common when 
perfusion  defects  are  small.  Lung  scans  are  sensitive  investigations  that 
eliminate  the  diagnosis  of  PE  when  they  are  normal.  Patients  with  high 
probability  lung  scans  can  be  treated  without  further  often  more  invasive 
investigations (Rays, 1996).
1.14.1 Heparinise prior to a lung scan
It is interesting to see how many doctors pre-heparinise their patients prior to 
diagnostic lung scanning. Pre-heparinising patients may lead to misdiagnosis 
as the patient has already commenced anticoagulant treatment.  Faced with an 
inconclusive lung scan result of intermediate probability, the next step may be a 
contrast  enhanced spiral  CT or pulmonary angiogram.  Most  doctors would 
probably agree that  the costs  of  additional  diagnostic  tests  to  diagnose PE 
outweigh  the  benefits  of  basing  anticoagulant  therapy  on  a  well-founded 
diagnosis. 
The incidence depends largely on the population sampled.  Patients with CAL 
are more likely to have an intermediate probability for PE, or non-diagnostic 
scans. The almost nonexistent morbidity and relatively low cost compared with 
spiral  CT  and  pulmonary  angiography  make  the  V/Q  lung  scan  the  most 
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desirable first  line diagnostic test  for  PE, after  the CXR, which  may identify 
pathology and which is needed to correlate with the lung scan (EJNM, 1999).
The risk of morbidity for the patient commencing anticoagulation therapy is low, 
but  in contrast  morbidity from anticoagulant  therapies is high (EJNM, 1999). 
There is also the medico-legal risk to the doctor in the event that the patient  
dies on anticoagulant treatment before a diagnostic test is done. Haemorrhage 
is a side effect of heparin-induced thrombocytopenia. All patients commenced 
on anticoagulant therapy face months of treatment, which creates a cost burden 
and inconvenience to the patient (EJNM, 1999, PIOPED, 1990).
Most  doctors,  besides  ordering  a  lung  scan,  also  like  to  look  at  duplex 
ultrasound to diagnose DVT prior to commencing anticoagulation therapy when 
a lung scan is intermediate or the scan is delayed for twelve hours until  the 
morning.  A large number of patients with PE have positive ultrasound studies 
for DVT (Rumack, 1998).
Complications  of  heparin  therapy  include  bleeding,  thrombocytopaenia  and 
osteoporosis (Taylor, 2000). Patients at risk of bleeding include those who have 
had recent surgery or trauma or who have other clinical factors that predispose 
to  bleeding,  such  as  an  ulcer,  liver  disease  or  age  >  65  years.   The 
management of bleeding will depend on its severity, and the risk of recurrent 
venous thromboembolism (Taylor, 2000).
Heparin  induced  thromocytopaenia  is  a  well  recognised complication,  which 
may occur 5 - 10 days post heparinization (West, 1987). Approximately 1 - 2% 
of patients receiving unfractionated heparin will experience a fall in their platelet 
count to less than the heparin on platelets and is of no consequence (West, 
1987).  This  mild  to  moderate  thrombocytopaenia  may  be  a  direct  effect  of 
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heparin on platelets and is of no consequence. However, 0.1 - 0.2% of patients 
may develop an immune thrombocytopaenia that can also be accompanied by 
arterial  or  venous  thrombosis,  which  may lead  to  death  or  limb amputation 
(West, 1987).
Osteoporosis has been reported when a patient received unfractionated heparin 
in doses of 20,000 U per day (or more) for more than six (6) months. 
Demineralisation of bone can progress to fracture of the vertebral bodies or long 
bones (Adams, 1984). 
1.15 The History of Technegas
1.15.1 How Technegas was invented
Up till  the  1980s,  the radioaerosol  used in  lung scintigraphy for  the prompt 
diagnosis of  Pulmonary Embolism (PE) was Xenon-133, an inert  radioactive 
gas. At the first Asia and Oceania Congress of Nuclear Medicine held in Sydney 
in1976, Taplin’s paper on “Lung Imaging in Pulmonary Disease” highlighted the 
mismatch  between  the  quality  of  the  perfusion  agent  and  different  other 
ventilation  agents;  this  eventually  led  to  Burch et  al.  discovering  a  superior 
ventilation tool.
Burch and colleagues introduced Technegas in November 1984 and described 
it  as  a  sub-set  of  nano-encapsulated  carbon  composites  or  aggregates. 
Technegas is produced in a Technegas Generator, which is purpose built for 
lung scintigraphy.  Its production requires an apparatus capable of heating a 
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graphite crucible to 3000°C, thereby eliminating the concern of inhalation of 
tungsten  oxide.  It  was  concluded  after  several  experiments,  that  all  the 
technetium–99m  absorbed  on  the  surface  of  the  graphite  crucible  and 
simultaneously volatilised to become coated with graphite above 2200°C. The 
structure of Technegas consists of hexagonal flat crystals of technetium metal 
encapsulated within a carbon capsule to be within a range of 30 – 60 nm in 
size.  Prior  to  ventilation,  these  technetium-99m  particles  coagulate  into 
aggregates with a median diameter of 100 to 160 nm.  Depending on the time 
of Technegas generation and ventilation, the longer the time, the larger the 
particles. These particles can be as large as 225 nm measured at 8.5-minute 
generations  (Burch  1996).  Technegas  particle  size  and  the  amount  of 
deposition  in  the  lung  will  determine the  mucociliary  clearance  rate  of 
technetium (Lloyd 1997).
In  studying  the  structure  of  Technegas,  Senden  et  al.  (1997)  reported 
Technegas was a coalescence of metal atoms which are encapsulated with 
intercolating hexagons of carbon on a pure graphite surface. 
1.15.2 Technegas Characteristics
Technegas  is  an  aerosol  consisting  of  a  gaseous  continuous  phase  and  a 
discontinuous phase of individual  particles.  The discontinuous phase can be 
either solid, liquid or both. There are many terms used to denote different types 
of aerosols. One term used by Lloyd (1994) is smoke, which is solid and derived 
from a combustion process. Another term used is mist, which is a liquid process 
as used in Technegas.
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The behaviour of an aerosol is dependent on size, shape and composition and 
the collective properties that include: size distribution, number density, etc.
Previous research work on the chemical nature of Technegas proposed that 
Technegas ultra fine aerosol particles range in size from a few nanometres to a 
few hundred μm. Lloyd  (1994)  suggests that  the lower  end of  the range of 
aerosol particles represents the transition from molecules to particles, whereas 
particles of the upper end of the scale do not remain airborne for long enough to 
form an aerosol. The largest useful size for studies of the lung is approximately 
10 µm; inhaled particles greater than this will deposit in the upper airways.
Although  the  nature  of  Technegas  is  still  uncertain,  it  has  proved  to  be  a 
satisfactory imaging agent for ventilation lung studies (Taylor 2000). Technegas 
is  a  structured  suspension  of  ultra  fine  carbon  particles  which  have  been 
labelled with technetium, and has both the characteristics of an aerosol and a 
gas. Particle size ranges from 5 – 25 nm with good alveolar deposition, minimal  
central deposition and no mucociliary clearance (James 2002). Distribution of 
Technegas is determined by regional ventilation, therefore providing an insight 
into lung physiology.  Lemb and Oei  (1992) suggest that the combination of 
ventilation  and  perfusion  scintigraphy  has  been  shown  to  produce  a  high 
sensitivity and specificity in the diagnosis of PE.
This radioaerosol is in the form of a mist, which is a liquid aerosol. Aerosols are 
dependent both on particular properties such as size, shape and composition, 
and collective properties which include size distribution, density etc. The size of 
Technegas particles ranges from a few nanometres to a few hundred μm, the 
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lower end representing the transition from molecule to particle (Lemb & Oei 
1993).
Aerosol  particle  size  distributions  are  mostly  skewed and generally  cover  a 
large range of sizes, and so geometrical progression of size intervals is useful. 
A continuous size distribution function, n(r) is obtained and the integral of this 
function will  give the number of particles in that range (Lloyd 1997). Various 
measures  are  used  for  the  average  size  and  spread  of  sizes.   The  modal 
diameter  is  the  size  associated  with  the  peak  in  size  distribution  and  the 
arithmetic mean is used for the sum of all diameters divided by the number of 
particles (Lloyd 1997).
Deposition  of  Technegas  particles  in  the  lung  has  been  of  interest  to  the 
nuclear  medicine  community  over  the  years  (Lloyd  1997).  Measurement  of 
deposition is relatively straightforward but there are different clearance rates 
and multifarious pathways of exit  from the lung (Lloyd 1997).  In a study by 
Howarth (1999), Technegas was seen to have the characteristics of both an 
aerosol and a gas and mimic the regional distribution of a gas.  According to 
research  by  Burch  (1993),  the  hexagonal  shape  of  Technegas  particles 
undergoes significant structural change post inhalation. However, the reasons 
for this change are not well known. 
Burch and associates (1986)  suggest  that  although Technegas is  frequently 
referred to as an ultra-fine aerosol, inferences based on studies with regard to 
the behaviour of ultra fine particles in the respiratory tract should be made with  
caution.
There is also a distinction between patient dose and ventilation dose, a medium 
diameter  of  20  nm  versus  200  nm  being  quite  significant  (Senden  1997). 
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Particle size affects the site and amount of particle deposition as well as the 
clearance  of  Technegas.  Kim  et  al.  (2000),  reported  that  where  deposition 
occurs,  particle  size  will  be  affected  as  the  lung  shifts  proximally  with 
decreasing particle size below 100 nm.  This proximal shift in deposition affects 
both tissue dose to the airways as well as the mucociliary clearance rate, which 
has a shorter path length for clearance from the lung. Deposition fraction or DF 
of aerosol is measured in the lung by: DF = 1 - AEX / AIN where AEX and AIN  are 
exhaled  and  inhaled  activity  respectively.  James  and  Brown  (2002)  found 
patients  with  Chronic  Airway  Limitation  (CAL)  have  an increased deposition 
relative to healthy subjects, some of which occurs in the airways, although most 
deposition is thought to occur in the parenchymal lung.
Given that CAL subjects have heterogeneous ventilation within their lungs, they 
may receive a dose to their parenchymal lung that is many times greater than 
that occurring in the normal lung.  James (2002) found no evidence of  rapid 
pulmonary  clearance  for  carbon  ultra  fine  particles  into  the  circulation.   An 
increase  in  the  parenchymal  dose  may  therefore  be  attributable  to  an 
exacerbation  of  airway  inflammation  but  not  due  to  rapid  movement  of  a 
significant number of insoluble particles in the circulation. 
1.15.3 Technegas equipment and potential in diagnostics
The Technegas Easy Breather Accessory (TEBA) has been designed as an 
accessory  to  the  Technegas  Generator.  The  generator  is  a  mobile, 
microprocessor controlled device.  TEBA provides positive pressure while the 
generator  provides  the  correct  atmospheric  conditions  for  the  production  of 
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Technegas.  The system delivers Technegas, to frail-aged, ventilated patients 
or patients who are otherwise unable to undertake a normal ventilation study. 
The  Technegas  Generator  is  a  micro-processor  operated  electromechanical 
device that provides the correct atmospheric conditions for the production of 
Technegas.  The  NSC 800/810  series  carries  out  checks  for  the  generation 
procedure, including: 
Front plate assembly
 Chamber cap assembly
 Front plate assembly
 Main circuit board
 Display circuit board
 Transformers
 Final assembly items
 Drawer Assembly
 Front frame and control
 Rear box and cover
Operation
The graphite crucible is positioned between the electrodes located at the base 
of the drawer assembly.  The crucible is then loaded with pertechnetate (500 – 
900 MBq) to a maximum volume of 110µl.  It is important not to overload the 
crucible  as  a  flat  surface  or  meniscus  is  required  to  prevent  splashing  of  
radioactive material.  Air bubbles are trapped in the graphite crucible, which will  
expand and ascend to  the  surface,  causing  the  eluant  to  expand,  spill  and 
possibly  splash  out  of  the  crucible.   Therefore  overfilling  the  crucible  may 
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actually  result  in  less  radioactivity  being  simmered  and  burnt  (Vita  Medical 
Manual).
The drawer  is closed and for safety precautions,  a two-handed operation is 
required.  A prompt appears on the display panel to initiate the simmer.  The 
Technegas Generator  checks  for  the  presence  of  Argon  gas and a  routine 
check for gas leaks are done.  Gas leaks are found by monitoring the pressure 
in the chamber over time and this program allows for a 50% drop in pressure. 
The generator will not proceed to the next step with any fall below this level.  
The  unit  will  open  and  close  the  inlet  valves  if  all  the  checks  are  done 
satisfactorily, and simmer/ purge stage commences. The simmer/ purge stage 
dries the pertechnetate onto the walls of the well in the graphite crucible.  This 
is  achieved  by  a  small  current  passing  through  the  crucible,  increasing  the 
temperature to seventy 70°C and Argon gas is pushed across the top of the 
crucible to disturb the surface of the pertechnetate.  Concurrently, the chamber 
is purged of any air leaving an inert atmosphere.  The simmer / purge stage 
lasts six minutes. When finished the generator will recheck for Argon gas and 
the prompt display appears. At this stage the burn generation is initiated (Vita 
Medical Manual).
After the start, a high voltage current passes through the crucible raising the 
temperature  to  2500°C,  lasting  fifteen  (15)  seconds,  vaporizing  the  dried 
pertechnetate off the crucible wall.  An ultra fine dispersion of labelled carbon is 
produced, which is the Technegas. The purge process is now initiated to clean 
out the system for the next patient.
Once Technegas is produced, the user is instructed to  disconnect  the main 
power and Argon gas supply.  The Technegas is stored in the chamber until  
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delivery to the patient.   The user  has ten minutes to  deliver  the gas to the 
patient. Technegas particles aggregate due to collisions and become too large 
to be useful;  consequently the patient valve  is locked with  the solenoid, ten 
minutes after generation.  The purge process is initiated to clean out the system 
for the next patient (Vita Medical Manual).
Technegas  ventilation  studies  play  a  significant  role  in  the  diagnosis  of 
pulmonary disease however, a percentage of the patient population, especially 
patients with  CAL and unconscious patients,  pose a number of  problems in 
obtaining  ventilatory  images  of  reasonable  diagnostic  quality.  The  main 
problems relate to the dead space in the manifold of the Technegas generator.  
The delivery of Technegas through the manifold becomes variable, leading to 
turbulence and deposition of the aerosol in the pharynx or central airways (West 
1999).  There  are  also  other  factors  of  contamination,  leakage  and  undue 
radiation exposure to the operator if the delivery of Technegas is obstructed 
(Murray 1998).
Previous  research  by  Leiper  (1998)  Technegas  Easy  Breather  Accessary 
(TEBA): A New Concept in Lung Ventilation Scintigraphy for Nuclear Medicine, 
evaluated the efficacy and safety of the device known as the Technegas Easy 
Breather  Accessory  (TEBA).  These  results  found  image  interpretability  for 
intubated patients using TEBA was good or adequate. Peripheral distribution 
was adequate, while central  deposition was mild to moderate. Image quality 
was  based  on  mean  central  deposition,  peripheral  distribution  and  image 
interpretability,  and  was  generally  superior  for  intubated  patients.  TEBA 
improved interpretability of ventilation images and consequently increased the 
reporting  physician’s  confidence  in  diagnosing  PE.   The  TEBA  system  will  
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provide images as good as or better than conventional images in a relatively 
sick population of patients at risk of PE.  
The positive attributes of TEBA such as ease of set-up and application may 
indicate its potential to allow intubated unconscious patients to undergo Nuclear 
Medicine lung scintigraphy, whereas in the past, this procedure would not have 
been  attempted  on  these  patients  who  are  perhaps  in  greatest  need  of 
determining the diagnosis of PE.
Ian Tetley, co-founder of Technegas with Christene Leiper, Principal 
Investigator (right) and her assistant (left).
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1.16 Aims of this research
Lung scintigraphy in particular ventilation scanning in its present form has been 
shown to have limitations because some CAL patients with moderate to severe 
dyspnoea cannot use the conventional method for lung ventilation. This study 
examines whether positive pressure ventilation techniques will overcome these 
limitations for CAL patients. 
The achievement of optimal ventilation studies on all patients, especially those 
with pulmonary disease, such as CAL, has the potential to improve the overall 
specificity of lung scintigraphy for the diagnosis of PE. 
This  research  also  aims  to  demonstrate  that  the  TEBA system  will  provide 
images  as  good  as  or  better  than  conventional  images  in  a  relatively  sick 
population of patients at risk of PE. 
The following five studies and their objectives comprise this research:
1. How well does Technegas Easy Breather Accessory (TEBA) perform  
with  normal  volunteers  and  Chronic  Airways  Limitation  (CAL)  
patients
 To determine whether TEBA could provide ventilation images as good 
as or better than conventional ventilation scans in a group of normal 
volunteers and also in a group of patients with CAL.
2   Using TEBA for Pulmonary Embolism
 To determine whether TEBA could provide ventilation images as good 
as or better than conventional ventilation scans in a group of patients 
with Pulmonary Embolism (PE). 
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3   Positive Pressure Ventilation for Intubated Intensive Care Patients
 To determine whether TEBA can allow ICU patients to undergo a V/Q 
scan
 To determine whether TEBA has a role to play in the 
management/diagnosis of PE or COAD in intubated / ICU patients
 To verify/assess the quality of images of ICU patients using TEBA.
4   Technegas at the Cellular Level
 To analyze the technegas particle.
5   Sputum and Bronchial Washings at the Cellular Level
 To analyze the sputum cells and determine if they have the same 
characteristics as Technegas from bronchial lavage washout 
specimens
 To measure activity of Technegas remaining in sputum post 
bronchoscopy
 To investigate under EM the structure of Technegas in sputum.
The findings from these experiments will  increase our present  knowledge in 
Nuclear Medicine.
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CHAPTER 2 EXPERIMENT 1
How well does Technegas Easy Breather Accessory (TEBA) 
perform with normal volunteers and CAL patients
2.1 Introduction
A significant publication from the British Thoracic Society’s Audit of February 
2005 stated, “…more than one in ten patients with CAL admitted to hospital are 
dead within ninety days of admission, and over one in three are re-admitted 
during that time…”  (Nilsson et al 2005).  Due to the high prevalence of this 
chronic condition, which affects a large proportion of the working population, 
more attention needs to be paid to improving the diagnosis of CAL. While TEBA 
has been used successfully in  a number of  clinical  settings (Cook & Leiper 
1998),  few  formal  studies  have  been  published  that  demonstrate  the 
usefulness,  effectiveness,  and  efficacy  of  TEBA  in  normal  volunteers  or  in 
patients with a range of respiratory pathologies such as Pulmonary Embolism 
(PE) or CAL.  Let us first look at the symptoms and how we report on CAL, 
Deep Vein Thrombosis (DVT) and PE.
2.2 Understanding Chronic Airways limitation (CAL
Chronic Airways Limitation has had many names in the past including: Chronic 
Obstructive Airways Disease (COAD), Chronic Obstructive Pulmonary Disease 
(COPD) and Chronic Airflow Obstruction (CAO).  CAL comprises two related 
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diseases,  chronic bronchitis and emphysema, one rarely occurring without  a 
degree of the other (Lippincott 1991 and Miller, 1997). 
Lung imaging is an accurate, non-invasive way of evaluating ventilation and 
perfusion. Ventilation and perfusion to broncho-pulmonary segments is matched 
in a healthy individual, in CAL matched ventilation and perfusion, defects occur. 
In diagnosing PE, segmental reduction in perfusion occurs with maintenance of 
normal ventilation. This leads to the mismatch of perfusion and ventilation in the 
broncho-pulmonary  segment.  In  acute  infection  seen with  CAL patients,  the 
ventilation defect may exceed the perfusion defect (Van Beek & Cate, 1996). 
In CAL patients, airway quality is poor as seen on lung scintigraphy images (see 
Chapter  4),  at  the  time  of  reporting  due  to  particle  deposition  in  the  major 
airways  and  minimal  penetration  to  the  lung  parenchyma.  Refining  the 
Technegas particle size may assist in improving the overall image quality of the 
ventilation scan for CAL patients (Strong & Agnew, 1989). 
The ability to image lung ventilation using technetium 99m labelled Technegas 
is  well  documented  (Murray  et  al,  1988,  and  Taylor,  2000).  In  particular 
Technegas has been used to  advantage,  being  able  to  distinguish  between 
patients  with  no  lung  disease  and  patients  with  CAL  (Strong  et  al,  1989). 
However, like any ventilation imaging study, Technegas is limited by the ability 
of the patient with lung disease to inhale and exhale. Unfortunately many of  
these patients have difficulty with respiration thus limiting their ability to meet 
ventilation lung scan requirements.
As discussed in chapter 1, Technegas Easy Breathing Accessory (TEBA) was 
developed to overcome the imaging problem inherent in ventilating patients with 
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lung diseases (Leiper, 1999).  TEBA has the potential to enhance the quality of  
ventilation imaging as demonstrated in initial studies (Howarth & Lan, 1993).
2.3 Varying Reporting Methods
Deep Venous Thrombosis (DVT) and Pulmonary Embolism (PE) are separate 
but  related  aspects  of  the  same  disease  process  known  as 
venousthromboembolism (VTE). Even with heparin given prophylactically, VTE 
is a medical issue with VTE remaining constant at 1 event per 1000 persons per 
year since 1979 and 1 event per 100 persons for those aged 85 and over (Gray 
2002 USA).
In  2002,  Seminars  in  Nuclear  Medicine  published  Gray’s  article,  which 
investigated the Prospective Investigation of PE Diagnosis II or PIOPED II. This 
was a prospective multi-centre study and PIOPED II was used as a composite 
reference test  for  DVT that  is  based on lung scintigraphy,  bilateral  Doppler 
ultrasound of the lower extremities, digital subtraction pulmonary angiography, 
and contrast venography in various combinations to obtain a diagnosis of PE 
status in the patient.
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2.3.1 PIOPED I & II lung ventilation/perfusion scans using the same 
criteria
The PIOPED study database has been extremely useful  because it contains 
precise descriptions of a large number of ventilation-perfusion scans and their 
corresponding andiograms.  The criteria for this experiment will be:
1.   A single moderate perfusion defect is categorized as intermediate, rather 
than as low probability.
2.   Extensive matched V/Q abnormalities are categorized as low  probability, 
provided that the chest x-ray (CXR) is clear.
3.   Two  segmental  mismatches  or  more  may  be  considered  for  high 
probability,  and  in  some  cases  two  mismatches  should  be  considered for 
intermediate probability.  However, due to the small number of cases with this 
finding,  no  definite,  statistically founded recommendation  can  be  made 
(Gottschalk 1993).
2.4 Aims
The aim of this experiment is:
 To determine whether TEBA could provide uniform ventilation, which was 
as good as or better than conventional ventilation in a group of normal 
volunteers and also in a group of patients with CAL.  Refer to section 2.7 
of this chapter.
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The  research  was  designed  to  achieve  optimal  ventilation  studies,  as  CAL 
patients tend to have varying degrees of abnormal distribution of Technegas 
within  their  lungs  due  to  poor  breathing  patterns  and  varying  degrees  of 
dyspnoea, which will be tested in Chapter 3 and compared. 
The purpose of this study was to evaluate the use of positive ventilation for CAL 
patients using TEBA and verify how the qualities of images produced by this 
system compare to CAL conventional ventilation images (see figures in Chapter 
4).  Adequate ventilation images are desirable to improve the specificity of lung 
scintigraphy in the diagnosis of PE.
2.5 Methods
2.5.1 Protocol for conventional lung scintigraphy
During conventional ventilation / perfusion scintigraphy,  the medical radiation 
scientist  rehearses  the  patient  with  the  Patient  Administration  Set  (PAS), 
independent of the Technegas Generator, to allay the patient's concern. The 
volunteer has the test in two phases: ventilation (V) and perfusion (Q). When 
ventilating, the volunteer breathes in radioactive aerosol or gas (refer Chapter 
1). Images of lungs are acquired using six projections for both ventilation and 
perfusion  phases.  In  the  perfusion  phase,  technetium  99m-labelled  macro-
aggregated  albumin  (MMA)  was  injected  into  a  peripheral  vein.  These  tiny 
aggregates  then lodge in  the  lung pre-capillaries  and provide  a  high-quality 
representation of the lung perfusion. Images in the same six projections as for 
the ventilation scan were then acquired. The V/Q scan gives images of regional 
perfusion and ventilation (see image 2.1).  Pulmonary Embolism reported on 
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lung scintigraphy is seen as decreased perfusion with normal ventilation, known 
as a “V/Q mismatch”.
2.5.2 Inclusion and Exclusion Criteria
Pregnant or breast-feeding females, under the age of eighteen years (18) of 
age were excluded from the study. Other exclusion criteria included:
 The ability to understand directions given.
 Ability to use the TEBA system i.e. no contraindications such as:
1)  Claustrophobia,  2)  Low  oxygen  saturation  levels,  3)  Unwillingness  to 
participate.
Informed Consent was obtained from each volunteer following an explanation of 
the purpose of the aims of the research, expected duration of participation, and 
a full description of the procedure, which included a small amount of radiation to 
the  volunteer  patient.  Ethics  was  approved  (see  Appendix  B).  This  study 
included 25 volunteers (13 healthy males and 12 healthy females with a mean 
age of 54.5 years with no lung disease) and 25 volunteers with CAL (16 males 
and 9 females with  a mean age of  62.5 years).  The method of  recruitment 
consisted of posters placed in Bankstown Hospital Sydney, word of mouth, and 
actively asking people both within and outside the hospital to enrol. 
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Figure 2.1 VQ (Ventilation / Perfusion) Mismatch, 
Nuclear Medicine, Bankstown, Sydney
The image of a ventilation/perfusion scan shows multiple defects (see figure 
2.1, arrow points  to  PE) consistent  with  Pulmonary Emboli  in  a  patient with  
chronic pulmonary hypertension. It illustrates inhomogeneous flow pattern in a 
patient with primary pulmonary hypertension.
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Wedge shaped 
defects, indicative 
of PE
2.5.3 Patient positioning for lung scintigraphy
The patients are positioned supine or with two pillows to assist with dyspnoea, 
for both the inhalation and the MAA injection phase of the lung scan procedure, 
and for image acquisition. The reasons for laying the patient supine include:
1. The patient will relax, which in turn minimizes movement resulting in better 
image quality for interpretation between ventilation and perfusion studies.
2. Diaphragmatic  breathing  occurs  when  the  patient  is  positioned  supine 
leading to better registration of the lung fields and the medical radiation 
scientist can accurately measure how much Technegas has been inhaled.
3. Need for consistent position since posture affects ventilation distribution in 
the lungs (Krieg et al., 2007) 
4. Ventilation continued until count rate on the gamma camera reached 2000 
counts/s, corresponding to about 37 MBq inhaled activity.  All  volunteers 
had  a  conventional  Technegas  ventilation  scan  and  perfusion  with 
technetium 99m MAA lung scintigraphy scan followed 5 to 7 days later by 
a TEBA ventilation scan only. Volunteers were scanned in random order. 
Therefore, the 25 healthy volunteers with no history of CAL and second 
group of 25 with CAL served as their own control.
2.5.4 Acquisition for TEBA lung ventilation
1. The volunteers were asked to lie supine on a gantry bed with two pillows if 
needed  for  both  the  ventilation  and  perfusion  lung  scan.  The  normal 
healthy  and  CAL  volunteers  were  instructed  in  the  same  way  by  the 
medical radiation scientists on the method for TEBA ventilation breathing 
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technique by demonstrating with TEBA PAS equipment independent of the 
Technegas Generator. Once volunteers understood what they needed to 
do, a facemask was placed over their nose and mouth, making sure there 
was  a  good  seal  so  no radiation  would  leak  into  the  room during  the 
ventilation procedure.
2. When TEBA commenced, volunteers continued to breathe at  their  own 
pace as positive pressure was “pushed” into their lungs in synchronicity 
with the individual volunteer’s breathing pattern. Ten litres of wall oxygen 
were connected to the reservoir bag to assist with the ventilation.
3. A  single  breath  was  not  usually  sensitive  enough  for  the  detection  of 
subsegmental ventilatory defects as it was essential to have enough count 
rate from the radioactive tracer inhaled into the lungs for acquisition. At 
Bankstown  Nuclear  Medicine  Department,  the  minimum  recommended 
end point count-rate was 2000 counts/s.
4. Areas  of  minimally  impaired  ventilation  may  be  masked  by  inherent 
inhomogeneous  distribution  of  Technegas.  Therefore  re-breathing  was 
necessary  until  the  required  rate  of  2000  counts/s  was  achieved.  The 
number of breaths, activity and time taken to ventilate each volunteer were 
noted.
5. Both healthy and CAL volunteers were connected to the Nellcor oxygen 
saturation  apparatus,  so  any  changes  in  oxygen  saturation  could  be 
monitored. The Nellcor pulse oximeter is a medical  device that is non-
invasive and provides continuous information on the percent  of  oxygen 
combined with haemoglobin. This precaution was designed to check for 
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hypoxia during ventilation and to monitor any changes during ventilation 
imaging procedures.
6. Lung ventilation scintigraphy consisted of 6 static images acquired for both 
ventilation and perfusion imaging: anterior,  posterior (this view provides 
the  largest  assessment  of  lung  tissue),  right  posterior  oblique,  right 
anterior  oblique,  left  posterior  oblique and left  anterior  oblique.   These 
planar  ventilation/perfusion  images  as  well  as  the  SPECT  study  were 
performed sequentially. The ventilation images were acquired first, then an 
intravenous injection of Tc-99m MAA was administered for the perfusion 
scan and the same six images as described above were acquired. After 
static  images  were  completed,  a  SPECT  perfusion  acquisition  was 
obtained for each healthy as well as CAL volunteer. SPECT acquisition 
was done using a triple head gamma camera with low energy all-purpose 
(LEAP) collimators, 40 projections at 15 seconds per view on a 64 x 64 
matrix  with  a  total  acquisition  time  of  10  minutes.  SPECT  results  in 
increased diagnostic accuracy over planar imaging because background 
activity  and  overlapping tissues interfere  far  less  with  activity  from the 
target structure when tomographic techniques are used (Early & Sodie, 
1995).
Before  each  volunteer  left  the  nuclear  medicine  department,  images  were 
checked by the researcher to ensure all were completed correctly. Images were 
also checked by the nuclear medicine physicians as part of the regular quality 
control of the procedure. This was to clarify that the volunteers’ scans were able 
to  identify  central  and  peripheral  deposition  of  the  Technegas.  Once  the 
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conventional and TEBA studies were completed, a comparison for concordance 
of the quality of  both sets of  images was sought from the nuclear medicine 
physicians.
TEBA delivery requires two medical radiation scientists, one at the distal end of 
the Technegas generator, the other at the front. By squeezing the resuscitator 
bag in synchronicity with the patient’s breathing pattern, Technegas is gently 
delivered into the lungs. TEBA has been approved for use on ventilated patients 
and the elderly and is undergoing clinical investigation for use in paediatrics 
(Vita Medical Ltd. 2002).
2.5.5 Generation of Technegas
During the simmering phase, technetium eluant is evaporated onto the carbon 
crucible (Hannan, 1982). The crucible is loaded with pertechnetate (TcO4_) until 
a meniscus / flat surface occurs and evaporates to dryness. Then the carbon 
crucible is heated to 2500º under an atmosphere of high purity Argon (99.99%) 
for fifteen (15) seconds. The carbon crucible is composed of high purity graphite 
only.  At  this  temperature,  carbon atoms aggregate  into  small  clusters,  each 
entailing a technetium atom. Each particle is a single, flat crystal of technetium 
metal encapsulated in carbon.  The total particle output of one Technegas dose 
is in the range of 3.4 x 106 particles per cc.  This corresponds to less than one 
(1) micron of carbon inhaled per Technegas administration (Burch, 1986). 
This  heating  procedure  is  also  similar  to  the  production  of  C-60  molecules 
named “buckminsterfullerene” and was originally thought that TcG may consist 
of “bucky balls” with a diameter of 5 nm or less (Burch, 1986). The prolonged 
storage of  Technegas,  once produced,  promotes aggregation to  form larger 
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particles with an initial small particle loss rate of about 20% per four minutes. 
Accordingly,  its use is preferred within  ten minutes of  preparation to  ensure 
reproducible studies (Strong, 1989 and Burch, 1986).
In an inert atmosphere of high purity Argon, the technetium generator eluate is 
evaporated to dryness in a graphite crucible or “boat”.  Autoradiography has 
confirmed that only one technetium atom is usually present per initial carbon 
cluster (Lemb, 1993).
The mass of carbon inhaled by the patient in a Technegas study,  has been 
measured as fifty micrograms (± 20%).  Based on resting tidal  volumes, an 
inhalation  of  Technegas  is  more  than  two  orders  of  magnitude  below  the 
permitted 24 hour pollution level (in the USA atmospheric pollution level is 75 
micro  gray continuous)  which  itself  is  set  to  account  for  chemically  noxious 
vapours from industry and motor vehicles (Vita Medical Manual, 1999). 
On the basis of an infinite residence time for Technegas particles in the lung, 
paryenchymal radiation exposure can be calculated to be 4500 microsieverts for 
37 MBq inhaled activity.  This should be included in any rationale that requires a 
perfusion dose to be “flooded” with Technegas when necessary.  Therefore in 
ventilation perfusion scintigraphy, ventilation is performed ensuring a four to one 
ratio with the perfusion (Taylor, 1991).  
The recommended activity of sodium pertechnetate (Tc-99m) to be deposited in 
the crucible  is  between 250 – 700 MBq.   For  adults,  adequate images are 
obtained after approximately 40 MBq of Technegas has been inhaled; however 
the activity present in the lungs will vary between patients (Vita Medical Manual,  
1999).
Chap 2 - 12
Technegas size, measured with a screen diffusion battery averaged a diameter 
of 5-25 nm. This analysis of particle size was also clarified by photon correlation 
spectrometer amplitude of the size distribution corresponded to a particle range 
between 60 – 225 nm (Lemb, 1993). Prior to ventilation these primary particles 
can be as large as 225 nm depending on the time between aerosol generation 
and ventilation delivery.  Inhaled radioaerosol is linked to particle size (patient 
with CAL); inhaled Technegas may penetrate to the alveolar regions of the lung.
The carbon crucible or “boat” is prepared by “wetting” it with absolute alcohol,  
and  drawing  back  the  excess  ethanol  with  the  same  syringe,  leaving  the 
crucible wet. Methylated alcohol is not used as it may leave residues on the 
evaporation process, which may lead to pyrolysis in the gas generation stage. 
While using forceps to hold the graphite crucible, it is aligned between the left 
and right contacts. Pushing the lever on the side of the Technegas Generator 
opens the contacts (Vita Medical Manual, 1999). 
Figure 2.2 Loading the 
Crucible
(Vita Medical Limited)
500 – 600 MBq of pertechnetate is loaded into the crucible.  On days when the 
generator activity is low, two or three simmers may be necessary to reach the 
amount  of  radioactive  concentration  necessary  for  achieving  an  adequate 
ventilation  count-rate.  This  is  achieved  by  interrupting  the  generation  cycle 
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following the evaporation phase, refilling and re-evaporating the crucible (Vita 
Medical Manual, 1999).
Technegas  has  a  power  supply  of  two  hundred  and  forty  (240)  volts  and 
withstands a fifteen-second power surge of 20A while the carbon crucible is 
heated.  It is important to use only ‘pure’ (> 99% pure) Argon.  If Technegas is  
burnt in an oxygen/Argon mixture, “pertechnegas,” a by product is produced. 
Gloves are worn as the lever and internal components of the Technegas are 
radioactive or “hot” during Technegas generation.  The start button is pressed 
which checks for sealing, then simmering and purging commences. This cycle 
lasts six minutes. “Double” simmering as mentioned earlier can commence at 
four minutes by interrupting the cycle. With every fifty (50) patients, the contacts  
and  filters  must  be  changed.  The  “start”  button  on  the  generator  begins  a 
sequence of events, which raises the crucible temperature above 2500° C for 
the  first  15  seconds.   Technegas  is  now prepared  for  the  patient  to  begin 
ventilation.  The display reads “verifying burn”, which holds for 3 seconds, then 
“disconnect mains” i.e. the Argon and power. Ten (10) minutes are allowed for 
Technegas ventilation of the patient after generation (Vita Medical Manual).
2.5.6 Technegas Generator
Repair  and  maintenance  of  the  Technegas  Generator  must  be  done  on  a 
regular basis by a qualified technician. Since the Technegas Generator is used 
in conjunction with radioactive isotopes, maintenance should be performed after 
decay of residual radioactivity to minimize exposure.
Chap 2 - 14
2.6 Reporting criteria
The three senior nuclear medicine physicians involved in this study have been 
trained in their speciality area of nuclear medicine to look at both conventional 
and TEBA lung scintigraphic images as well as SPECT studies and had greater 
than 20 years of combined reporting expertise.  The reporting criteria used for 
this  research  was  examined  by  the  three  nuclear  medicine  physicians  for 
correctness and for “ease” of use in reporting lung research studies and they 
considered the  criteria  covered all  necessary  areas  for  this  study.  A formal 
report  from the physicians for each volunteer was not  sought as this was a 
research study. 
The  reporting  criteria  below  provide  a  detailed  description  of  the  areas  of 
reporting for both conventional and TEBA studies undertaken in this research. 
2.6.1 Unblinded reporting
The nuclear physician on duty viewed the research ventilation scans for any 
abnormality before the volunteers or patients left  the department. The TEBA 
assisted  ventilation  images  were  viewed  and  compared  with  the  baseline 
ventilation scan.
2.6.2 Blinded reporting
 Coded  images  of  baseline  ventilation  and  TEBA  assisted  ventilation 
scintigraphy were studied by the nuclear physicians in a blinded fashion with 
particular  attention  to  visual  scoring  of  central  and  peripheral  distribution  of 
Technegas, and image interpretability.   Both conventional and TEBA images 
were read without prior knowledge of which method of ventilation created the 
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image.  The  primary  objective  was  to  compare  conventional  and  TEBA 
ventilation  images  with  respect  to  overall  image  quality,  the  occurrence  of 
central deposition and the ability to clearly define lung margins, thus peripheral 
penetration and any lung ventilation defects. Also evaluation of the safety of 
TEBA was  made by considering any adverse affects  and oxygen  saturation 
levels.
The secondary objective  was  to  compare  ventilation lung scintigraphy using 
conventional versus TEBA for concordance of quality of the image, peripheral  
penetration,  definition  of  lung  defects  if  any,  and  the  occurrence  of  central  
deposition  in  various  disease  settings.  Readers  are  Nuclear  Medicine 
Physicians who are blinded to  the images.   Prior  to  reading the scans,  the 
blinded readers agreed on the appropriate method for experimental evaluation 
of both conventional and TEBA images. This included identifying the anatomical 
divisions  which  define  the  lung  regions,  reviewing  the  critical  criteria  for 
determining lung scan diagnosis, and defining the criteria for comparing overall 
image quality and lung margin definition of the studies.
Blinded assessment studies included a comparison of both normal and CAL 
images using the following four factors: 
1.  Concordance of the quality of the images
2.  Peripheral penetration
3.  Definition of lung defects, and 
4.  The occurrence of central deposition in conventional versus TEBA.
Image Quality Assessment was rated by the three blinded readers on a scale of  
0 - 2 for overall clinical quality of the image.  Image quality was assessed as a 
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comprehensive evaluation of the scans’ ability to delineate ventilation defects, 
the  occurrence  of  central  deposition,  and  the  peripheral  penetration  of  the 
tracers.
0 = image quality is poor
1 = image quality is acceptable
2 = image quality is excellent
For  assessment  of  ventilation  abnormalities,  blinded  readers  were  asked  to 
evaluate each of the images independently for possible abnormalities in divided 
segments of the lungs.  These segments were each rated as defined below:
0 = No ventilation abnormality present (low probability)
1 = Possible abnormality (intermediate probability), mild, diffuse irregularity, or 
small/equivocal irregularity.
2 = Defined abnormality (high probability)
Blinded readers also assessed the degree of central deposition found in each 
lung image.
0 = High degree of central deposition that hinders the reading of the image
1 = Some central deposition present
2 = No central Deposition present
To assess peripheral penetration, blinded readers were asked to independently 
determine if the scans defined the margins of the lungs.
0 = Poor peripheral distribution of the lung ventilation agent
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1 = The ventilation image accurately defines the lung margins, but the edges 
are not crisply defined
2 = The ventilation accurately defines the lung margins.
2.6.3 Reviewers’ Assessment
Reviewers  are  nuclear  medicine  physicians who  review the  image after  the 
reader.   The reader  is  a  nuclear  medicine  physician,  who  is  blinded to  the 
experiment images.  Reviewers were asked to assess the quality of the image, 
whether the images define the margins of the lungs concordantly, the degree of 
central deposition present, and whether both images define any lung defects 
effectively.  They were then asked to assess whether or not the images were 
concordant for both ventilation and perfusion. 
The reviewers addressed the following questions for each study:
Quality:  Are  both  conventional  and  TEBA images  useful  and of  diagnostic 
quality?
Yes or No.  If no, which image is not diagnostic?  A or B, or Neither.
Peripheral Penetration:  Do both conventional and TEBA images define the lung 
margins accurately?
Yes  or  No.   If  no,  which  image  more  accurately  defines  the  lung  margin?
A or B or Neither.
Central Deposition:
Are  both  conventional  and  TEBA  images  concordant  with  regard  to  the 
presence and amount of central deposition?
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Yes or No.  If no, which image contains a greater quantity of central deposition? 
A or B or Neither.
Lung Defects: Both conventional and TEBA images define lung defects clearly. 
Yes or No or Neither image. If no, which image does not define lung defects 
clearly? - A or B or Neither.
Volunteers’  breathing time was collected by counting the number of  breaths 
taken for ventilation and recording this information (see section 2.7,  Results). 
The data consisted of:  number of  breaths, time taken for ventilation, activity 
loaded, and oxygen saturation. From these figures, tables show the results.
2.7 Results
Results  are  presented  in  the  following  order:  CAL  volunteers  for  both 
conventional  and  TEBA  lung  scans  (see  Figure  2.1).  Results  for  other 
parameters such as conventional breathing times are shown in Figure 2.3.
Figure 2.3 Bar Graph showing normal (conventional) and CAL (TEBA) 
Breathing Time in blue and Number of Breaths in purple
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The table below shows that both breathing times and the number of breaths are 
significantly less (p<0.05) for TEBA than the conventional method for PE. The 
final count rate and activity loaded show no significant difference.
Table 2.1: PE versus TEBA
PE TEBA P VALUE
BREATHING TIME (S) 21.64  ±   8.53 15.96   ±   9.57 P = 0.037
NUMBER OF BREATHS 4.88    ±  1.83 2.92     ±   2.58 P = 0.0026
FINAL COUNT RATE 
(k COUNTS)
2.47    ±  0.99 2.03     ±   1.17 P = 1.1712
Table 2.2:  Normal versus PE
Normal Subject PE P VALUE
BREATHING TIME (S) 16.00  ±   9.50 21.64   ±   8.53 P = 0.01
NUMBER OF BREATHS 2.89    ±  2.50 4.88     ±   1.83 P = 0.01
FINAL COUNT RATE 
(k COUNTS)
2.00    ±  1.09 2.47     ±   0.99 P = 0.01
Table 2.3  One-Sample t-test : Breathing Times for CAL volunteers
VARIABLE Mean St. Dev Se Mean 95% CI P value
BREATHING 
TIMES
13.8000 8.4311 1.6862 10.3198,17.2802 0.000
Table 2.4  One-Sample t-test: Number of Breaths for CAL volunteers
Test of mu = 5.538 vs not = 5.5
VARIABLE St.Dev SE Mean 95% CI P value
No. BREATHS 1.35647 0.27129 2.00008, 3.11992 0.000
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2.8 Discussion
We will  now discuss how our research demonstrated conventional ventilation 
versus positive pressure ventilation in healthy and CAL patients, showing the 
difference in number of breaths taken. The time taken for healthy patients to 
ventilate is equivalent or sometimes more than positive pressure TEBA patients 
(as shown in above tables).
2.8.1 Healthy Volunteers
Healthy  volunteers  were  reported  as  having  a  relatively  even  distribution  of 
Technegas  throughout  their  lung  fields  for  both  conventional  and  TEBA 
ventilations. Several healthy volunteers experienced some slight hypoxia due to 
the anoxic nature of Technegas and Argon in the first few seconds of ventilation 
(see  Figure  2.1).  SPECT  studies  of  the  healthy  volunteers  showed  good 
contrast and edge definition, and a good target to background ratio.
2.8.2 CAL Volunteers
CAL  volunteers  in  the  study  were  reported  as  having  varying  degrees  of 
abnormal distribution of Technegas throughout their lung fields as reported by 
the nuclear medicine physicians in their overall image interpretation at the end 
of  scanning.  Peripheral  deposition  had  improved  using  TEBA in  areas  that 
normally would be reported as poorly ventilated. According to West (1990) poor 
ventilation of the lungs is a characteristic of CAL. The clearance ratio is slower 
in CAL volunteers in relation to normal lung scan clearance. Technegas is not 
distributed as evenly in CAL due to the limited airflow into the lungs and filling 
volume of CAL patients (West 1990). Some CAL patients experienced Hypoxia 
Chap 2 - 22
and CAL images had varying degrees of abnormal distribution reported in their 
lung scans. 
SPECT reported improved contrast, edge definition and target to background 
ratio. Breathing times improved in CAL TEBA ventilation as they could breathe 
in Technegas at their own pace as Technegas is “pushed” into the lungs in 
synchronicity with the volunteers breathing rate.
2.8.3 Number of Breaths
As this experiment involved a comparison of two measurements from the same 
ventilation  imaging  study,  conventional  ventilation  imaging  versus  TEBA 
ventilation imaging, the paired t-test was used where the mean differences fell 
within a normal range. If the mean differences departed from normality the non-
parametric  Koch’s  adaptation  of  the  Wilcoxon-Mann-Whitney  rank  sum  test 
would be used. The two sets of data can be obtained at different times and 
under a different set of conditions, which suited this experiment as TEBA used a 
slightly different procedure for the ventilation inhalation process (Gosling, 1998).
The most common test to explain a statistical inference is the two sample paired 
test  which  compares  two  independent  samples.  The  results  from  the  One 
Sample t-tests (see Table 2.2) for breathing times, number of breaths and final 
k-counts the p value is 0.000 implying that the null hypothesis proved that there 
was no difference in TEBA and the conventional lung scintigraphy images, both 
were satisfactory, therefore the null hypothesis was accepted. Observing both 
the conventional and breathing times in table 2.2, p-value was 0.000, which 
implies that the null  hypothesis (Ho) is true and therefore in the acceptance 
region of the test. The number of breaths for the conventional method for lung 
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ventilation and TEBA also fell into this category of acceptance. Therefore we 
can say that there was little or no change and the null hypothesis was accepted.
With the healthy volunteers, CAL volunteers and high probability PE patients it 
was not possible to take arterial blood gas studies (ABGs) as this would have 
been invasive and was not necessary to verify the usefulness of the positive 
ventilation, TEBA.  However, the oximeter results provided continuous oxygen 
saturation readings throughout the lung scintigraphy (Table 2.3).
CAL patients had an increased deposition rate relative to healthy volunteers, 
some  of  which  occurs  in  the  airways,  although  mostly  occurred  in  the 
parenchymal lung.
Given that CAL patients have heterogeneous ventilation within their lungs, they 
may receive a dose to their parenchymal lung that is many times greater than 
that occurring in the normal lung.  James (2002) found no evidence of  rapid 
pulmonary  clearance  for  carbon  ultra  fine  particles  into  the  circulation.  An 
increase  in  the  parenchymal  dose  may  therefore  be  attributable  to  an 
exacerbation on their airway inflammation but not due to rapid movement of a 
significant number of insoluble particles into the circulation (Brown, 2002).
2.8.4 CAL Limitations
As most CAL patients have an underlying predisposition to PE due to being 
immobilized,  they  are  vulnerable  both  physically  and  emotionally  from  the 
beginning of the procedure. This is due to the patients experiencing moderate to 
severe  chest  pain  and dyspnoea and they may feel  as  though they cannot 
tolerate a mouthpiece or nose peg as is used for the conventional method of 
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lung ventilation because they find it difficult to inhale with a neutral ventilation 
pressure.
In this study CAL TEBA patients may use air instead of oxygen for patients with 
CO2 retention (ref Table 2.3). This minimized the risk of respiratory depression 
secondary  to  suppression  of  hypoxic  drive  had  pure  oxygen  been  used  to 
provide positive pressure. For CAL patients the likely outcome of using TEBA 
showed significant improvement in the ventilation count rate over the baseline, 
conventional method. Breathing time was significantly shorter and compliance 
enhanced with the utilization of TEBA.
In about 90% of patients (including CAL) referred for lung scintigraphy, the lung 
scan will either confirm or exclude PE. However, in 10 to 15% of patients, the 
lung scintigraphy will be reported as non diagnostic or intermediate. According 
to Annals of Medicine 33(5) 1999, the incidence of PE in these patients was 
documented on pulmonary angiography as 30 to 35%.  An intermediate result 
should raise the importance of further investigation and that there may still be a 
real risk of PE. There is concern that positive pressure ventilation may create 
false positive diagnoses of PE, by improving peripheral penetration of tracer in 
poorly  ventilated  areas  associated  with  reflex  vasoconstriction  and  hypo-
perfusion, not due to vascular obstruction.
When  inhaling  Technegas,  there  may  be  a  transient  lowering  of  oxygen 
saturation levels. This is a common occurrence, not associated with any harmful 
symptoms.  Leiper, 1999 demonstrated that patients may experience transient 
dizziness, but this does not appear to correlate with age, sex, smoking history, 
number of inhalations required, or a history of respiratory disease.  Therefore it 
is  difficult  to  determine  which  volunteers,  if  any,  will  experience  this  fall  in 
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oxygen saturation.  Despite transient falls in oxygen saturation, there has been 
no published data of any serious reactions following Technegas administration 
since it  began in  1986.  Normal lungs will  have a relatively even distribution 
throughout;  however,  in  cases  of  lung  disease  or  CAL,  varying  degrees  of 
abnormal distribution are seen (Isawa et al., 1991).
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2.9 Conclusion
The results show that TEBA  provides quality uniform ventilation for both normal 
volunteers and patients  suffering  from CAL. In  addition,  the results  for  both 
groups of patients showed close concordance between TEBA ventilation and 
conventional  ventilation.  Thus,  we  were  able  to  achieve  the  aim  of  the 
experiment that TEBA could provide ventilation which was as good as or better 
than conventional ventilation in a group of normal volunteers and a group of  
patients with  CAL. This  result  could potentially  broaden the number of  CAL 
patients who may benefit  from using this method. TEBA has the potential to 
provide a more accurate diagnosis and to broaden the number of potential CAL 
patients who could benefit from a lung scintigraphy study. 
Experiment Two includes patients with a possible diagnosis of PE to further test 
the utility  of  TEBA in  the clinical  context.  It  also  looks at  concordance with 
conventional PE volunteers and TEBA volunteers.
The  finding  of  better  quality  images  in  both  healthy  and  CAL  volunteers 
suggested  that  hypothesis  I  (null  hypothesis  (Ho):  TEBA  could  provide 
ventilation  as  good  as  or  better  than  conventional  ventilation  in  a  group  of  
normal volunteers and a group of patients with CAL) should not be rejected. 
Finally,  the  close  concordance  of  both  TEBA  and  conventional  ventilation 
suggests that hypothesis II (alternate hypothesis Ha: there will be no difference 
in  the  quality  of  the  scan  between  TEBA  CAL  or  the  healthy  volunteers’ 
conventional lung scintigraphy) is supported by the data.
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CHAPTER 3 EXPERIMENT 2
Using TEBA for Pulmonary Embolism
3.1 Introduction
As PE accounts for many hospitalisations per year, and this number is increasing 
apace  with  the  aging  population,  an  accurate  diagnosis  is  critical.  It  is  well 
documented that  the  majority  of  patients  presenting  with  PE have  an  underlying 
clinical predisposition. However, the clinical diagnosis of PE is unreliable and signs 
and  symptoms  are  non-specific  (Wade,  1982),  therefore  it  is  not  surprising  that 
clinical  diagnosis  is  fraught  with  error.  Recent  advances  have  been  needed  to 
improve the method of diagnosis and the TEBA positive pressure device may prove 
to be an invaluable tool.
3.2 Detecting Pulmonary Embolism
Nuclear  Medicine  physicians  must  acquire  skills  in  risk  stratification  for  patients 
suspected of  PE (Dietlein,  1999).  In  general,  lung scintigraphy scans for  PE are 
interpreted  using  the  parameters  established  by  the  Prospective  Investigation  of 
Pulmonary Embolus (PIOPED, 1980, Gottschalk et al., 1993, Worsley & Alavi,1995). 
The PIOPED interpretation criteria are based on matched defects seen on perfusion 
lung scintigraphy as being low, intermediate or high probability for PE, based on the 
original paper by Biello (1979) and PIOPED (1995). 
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All  participants  in  this  study  presented  with  moderate  to  severe  dyspnoea 
accompanied with  varying  degrees of pleuritic  chest  pain and were  subsequently 
referred  for  a  lung  scintigraphy  scan  as  PE  was  suspected.  Most  patients  with 
minimal dyspnoea are able to tolerate the conventional method of ventilation (see 
chapter 1 on Technegas) but moderate to severe patients found the nose-peg and 
mouthpiece  too  difficult  to  tolerate.  The  conventional  method  of  administering 
Technegas for a ventilation scan requires the utilisation of the breath hold for five  
seconds was also a problem as patients with moderate to severe dyspnoea could not  
manage this technique. 
We will now look at the various symptoms in: 
1) Conventional PE patients
2) PE patients having a lung scan
3) Intensive Care Patients
PE may present as no symptoms.  However, when the patient does have symptoms 
of PE, the challenges of obtaining a scan are comparable with the same symptoms 
experienced by PE patients and Intensive Care patients.
3.2.1 Conventional PE Patients
The clinical features of PE can be diverse and confusing, ranging from no symptoms 
to  sudden  death.  The  symptoms,  when  present,  depend  upon  the  extent  of 
pulmonary arterial occlusion. The most common symptoms are dyspnoea and chest 
pain. Some patients may experience sudden apprehension of impending doom with 
tachypnoea and elevation of right heart pressures with or without syncope, which 
usually  indicate  massive  PE.  (James J.,  Nucl.  Med.  Comm 1995).  The fear  and 
uncooperativeness  is  thought  to  be  related  to  the  dyspnoea  becoming  worse. 
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Positive pressure administration of Technegas using the TEBA has the potential to 
allay the patients’ fears as they do not have to take breaths or have a nose peg or 
tube in their mouth. When using TEBA a face - mask is placed over the patient’s 
nose and mouth and they continue to breathe with air or oxygen.
The  amount  of  the  radionuclide  injected  into  the  vein  for  the  perfusion  study or 
inhaled into the lungs for the ventilation procedure is so small that there is no need 
for precautions against radioactive exposure.  Allergic reactions to the radionuclide 
are rare, but may occur. For some patients, having to lie still on the scanning table for  
the length of the procedure may cause some discomfort or pain as lying supine is 
difficult for patients suffering from breathlessness.
3.2.2 PE Patients having a Lung Scan
There are groups of patients in whom ventilatory images of diagnostic quality are 
difficult to obtain. These include PE patients with moderate to severe dyspnoea or 
those who are distressed, frail and unable to cooperate fully.  PE patients develop a 
moderate or severe dyspnoea and high temperatures. Dsypnoea is most noticeable 
during  any  physical  activity  and  can  be  heightened  during  a  conventional  lung 
ventilation scan as some PE patients who may be distressed know they will not be 
able  to  breathe  with  a  peg  on  their  nose  and  a  mouthpiece,  thus  causing 
apprehension.. TEBA presents the possibility to deliver sufficient levels of Technegas 
for optimal image acquisition while at the same time reducing patient anxiety and 
breathlessness. This is because TEBA’s use of positive pressure with a face - mask 
over the patient’s nose and mouth ensures the patient receives the required air or 
oxygen during the administration of the Technegas for each ventilation scan.
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3.2.3 Intensive Care Patients
Physical examination is often difficult in the intensive care unit (ICU) setting and for 
many years has been complemented by the portable chest radiograph (CXR) and the 
portable 300GE gamma camera. The gamma camera was mainly used for cardiac 
work and not for lung scanning. The interpretation of portable ICU radiographs and 
Nuclear Medicine cardiac images may also be difficult. This is due to the limitations 
of applying optimal radiographic and nuclear imaging technique in the ICU setting, as 
well  as the patient's  condition and the presence of monitoring and other devices 
(either in or on the patient) that might obscure portions of the chest.  Thus it was 
unheard of for the intubated ICU patient to be transported to the nuclear medicine 
department for a diagnostic lung scan. However, by using TEBA, a positive pressure 
device,  this  has  changed  as  unconscious  ICU  patients  can  be  momentarily 
disconnected from their ventilators and connected to the TEBA apparatus.
There is minimal discomfort to the patient as they are receiving 100% oxygen for the 
entire ventilation procedure after which the patient is reconnected to their portable 
ventilator. The only discomfort noted is that the patient’s arms must remain above 
their head for the entire procedure; this is to allow the ventilation tubing and many 
intravenous leads to be placed distal to the patient so the gantry can be pushed into 
the gamma camera for imaging.
Factors  such  as  increased  dead  space  from  the  connection  to  the  Technegas 
chamber, variable efficiency of inhalation and variable delivery flow rates, may lead 
to turbulence and deposition of the agent in the upper aero-digestive tract and central  
airways. TEBA avoids the problem of introducing dead space by its location distal to 
the Technegas generator. TEBA is safe and well tolerated by PE patients and other 
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spontaneously  breathing  patients.  TEBA  has  been  successful  for  ventilating  the 
unconscious patient. TEBA requires less time to achieve an adequate count rate, and 
improved diagnostic quality of ventilation images.
3.3 Aim
The aim of this experiment was: to determine whether TEBA could provide ventilation 
as  good  as  or  better  than  conventional  ventilation  in  a  group  of  patients  with 
Pulmonary Embolism (PE). This experiment aimed to test two hypotheses:
TEBA has the potential to provide a more accurate diagnosis in patients with no lung 
disease (Null hypothesis, Ho).  There will be no difference in the lung scintigraphy 
image quality for TEBA assisted patients and healthy volunteers without TEBA. If this 
hypothesis is correct, this could potentially broaden the number of patients who may 
benefit from lung scintillation scan. The alternate hypothesis (Ha) evaluates whether 
TEBA is better than conventional lung scintigraphy in patients.
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3.4 Materials and Methods
Clinical  diagnosis  of  PE  has  to  address  the  non-specificity  of  clinical  signs  and 
symptoms,  therefore it  is  usual  to have several  diagnostic procedures such as a 
chest X-ray (CXR) and a lung scan. The CXR is typically the first imaging procedure 
performed when a patient presents with dyspnoea and a lung scan is usually the 
second diagnostic test.
The CXR accompanies the patient to the nuclear medicine department as an aid in 
diagnostic reporting. A CXR acquired within 24 hours of lung scintigraphy can be 
inconclusive or of  minimal  value to the nuclear medicine physician due to its low 
sensitivity for PE (Taylor, 2000).
This  experiment  recruited  50  volunteer  participants,  [25  normal  subjects  and  25 
patients with known PE].  The participants were asked to lie in a supine position on 
the gantry bed, to allow uniform distribution of Technegas throughout both lung fields.  
The  subjects  were  monitored  for  their  oxygen  saturation  using  a  Nellcor  N180 
throughout the procedure. Normal lung scintigraphy using 6 projections was obtained 
for ventilation and perfusion imaging: anterior, posterior, right posterior oblique, right  
anterior  oblique,  left  posterior  oblique  and  left  anterior  oblique.  These  planar 
ventilation  /  perfusion  images  as  well  as  a  SPECT  study  were  performed 
sequentially. TEBA was administered between 5 to 7 days post conventional scan 
with no accompanying perfusion scan.
SPECT acquisition used the triple head gamma camera with low energy all - purpose 
(LEAP)  collimators,  40  projections at  15  seconds per  view on a 64 x 64 matrix, 
acquisition time of 10 minutes.
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3.4.1. Stages of Preparation for Technegas Generation
The crucible was removed from its package using gloves and forceps; the crucible 
well  was  filled  with  95% or  absolute  ethyl  alcohol  and drawing  back the  excess 
ethanol with a 1ml syringe, leaving the crucible wet. Methylated alcohol was not used 
as it may leave residues from the evaporation process, which could lead to pyrolysis 
in the gas generation stage (Tetley Medical Ltd. Users Manual 1999). The syringe 
was drawn back so there was no excess alcohol left in the crucible. The crucible was 
positioned so that  one end was at  the left  hand contact  and the  other  end was  
aligned with the right hand contact of the Technegas machine. There must be good 
contact  or  a  low  yield  of  Technegas  may  result,  and  rotation  of  the  crucible  is 
required to make sure the well cavity is in the upright position. Pushing the lever on 
the side of the Technegas Generator opened the contacts to enable proper mounting 
of the crucible.
Figure 3.1 Loading the Crucible
(Vita Medical Limited)
Figure 3.2 The crucible 
or “boat” and contacts
Overfilling the crucible may cause air  bubbles to  become trapped in the graphite 
crucible. Any unwanted bubbles will expand and ascend to the surface, causing the 
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eluant to spill  and possibly splash out of the crucible. Overfilling the crucible may 
actually result in having less radioactivity being simmered and burnt.
Approximately 700 – 900 MBq of technetium-99m pertechnetate in a 1ml syringe in 
lead glass syringe shield was injected into the crucible. The crucible was filled to a 
meniscus, concave or flat but never convex.  On days when the generator activity 
was low, two or three simmers of the crucible was sometimes necessary to reach the 
amount of radioactive concentration necessary for achieving an adequate ventilation 
count-rate. This re-simmer was achieved by interrupting the Technegas generation 
cycle following the evaporation phase, refilling and re-evaporating the crucible. The 
drawer was closed and for safety precautions, a two handed operation was required 
to close the door of the Technegas generator, allowing the start to be pressed to  
initiate the simmer phase.
The Technegas Generator automatically checked for the presence of Argon gas or 
any  gas  leaks.  The  Technegas  Generator  detects  gas  leaks  by  monitoring  the 
pressure in the chamber over time allowing a tolerance range of up to a 50% drop in 
pressure. Once all checks were completed satisfactorily, the generator commenced 
the simmer/purge stage, which dried the technetium pertechnetate onto the walls of 
the  well  in  the  graphite  crucible.  This  was  achieved  by  a  small  current  passing 
through the crucible, increasing the temperature to 70°C and then pushing a flow of 
Argon gas across the top of the crucible to disturb the surface of the pertechnetate.  
Concurrently, the chamber was purged of any air, ensuring an inert atmosphere was 
created. The simmer/purge stage lasted six minutes. When finished, the generator 
rechecked for Argon gas contamination and then the burn generation was initiated.
During the  simmering phase,  technetium eluant  was  evaporated onto the  carbon 
crucible  composed of  high  purity  graphite,  which  was  heated to  2500º  under  an 
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atmosphere of high purity argon (99.99%) for15 seconds. At this temperature, carbon 
atoms aggregate into small clusters each entailing a technetium atom. Each particle 
was  a single,  flat  crystal  of  technetium metal  encapsulated in  carbon.   The total 
particle output of one Technegas dose was in the range of 3.4 x 10 6 particles per cc. 
This corresponded to less than one (1) micron of carbon inhaled per Technegas 
administration (Tetley Medical Ltd. Users Manual 1999). 
The Technegas generator  had a power supply of  240 volts  and withstands a 15 
second power surge of 20A while the carbon crucible is heated.  It was important to  
use only ‘pure’  (>99% pure) Argon.  If  Technegas is burnt in an oxygen /  Argon 
mixture, “pertechnegas,” a by-product is produced. Gloves were worn as the lever 
and  internal  components  of  the  Technegas  were  radioactive  or  “hot”  during 
Technegas generation. 
The generator then checked for sealing, then simmering and purging commenced. 
This  cycle  lasted  six  minutes.  “Double”  simmering  as  mentioned  earlier  can 
commence at four minutes by interrupting the cycle.  The simmering/purging circle 
raised the crucible temperature above 2500° C for the first 15 seconds. Technegas 
was then available for the patient to begin ventilation.  When the generator display 
verified the burn, the Argon and power were disconnected.  The generator allowed 
10 minutes for Technegas ventilation of the patient after generation.
Technegas ventilation levels in each patient/subject were monitored until a count rate 
of  between  1000-2000  counts  per  second  has  been  reached.  When Technegas 
ventilation was commenced, each subject was asked to take in a breath and hold it  
for 5 seconds, representing total lung capacity,  then breathe out (Isawa, 1991). A 
single breath was not usually sensitive enough for the detection of subsegmental  
ventilatory defects  because it  essential  to  ensure a minimum count  rate  of  1000 
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counts per second from the radioactive tracer inhaled into the lungs.  Also, areas of 
minimally  impaired  ventilation  may  be  masked  by  inherent  inhomogeneous 
distribution of Technegas (Leiper & Cook, 1998).
The major components of the positive pressure ventilation delivery system or TEBA 
included a 1.6  litre,  self-inflating  resuscitator  bag that  was  mounted distal  to  the 
Technegas Generator.  The Patient Administration Set (PAS) connected the patient 
to the front of the Technegas Generator. A pneumatic control line was connected 
between the PAS and check valve assembly in TEBA.  Depressing the valve opened 
the Technegas flow to the patient via the PAS in a series of one-way valves, which 
prevented the patients’ exhaled air from returning to the unit.  An anaesthetic mask 
was fitted to the patient’s nose and mouth, depressing the valve; this opened the 
Technegas flow to the patient via the PAS (Tetley Medical Ltd.1999).
The 1.6 litre bag was squeezed with one hand in synchronicity with the patients’ 
breathing cycle, thus pushing oxygen from the bag to the patient.  As the bag was 
squeezed, control valves opened and / or closed from the pressure of squeezing the 
bag.  The same pressure from the bag also operated the PAS check valve. TEBA 
avoided the problem of introducing dead space by its location distal to the Technegas 
Generator.
The rapid re-inflation of the resuscitation bag required reduced ventilatory time which 
in turn improved patient compliance. Patient discomfort was minimized, as assisted 
ventilatory time was generally less than one minute.  The risk of  Barotrauma (the 
sequelae of a ventilator–induced lung injury, a mismatch between the volume of gas 
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delivered and the amount of lung available) was also reduced due to the smaller  
volume of oxygen or air required during TEBA operation (Earis & Pearson, 1995). 
According to Hillman (1996) air may be used with PE volunteers if their inherent CO2 
retention is required to maintain their usual oxygen saturation, and reduce severity of 
Technegas  induced  Hypoxia.  Air  reduces  the  risk  of  respiratory  depression 
secondary to  suppression of  the hypoxic  drive if  pure oxygen  is  used to  provide 
positive pressure (Hillman, 1996).
3.4.2 Image Quality Ranking
The  image  quality  ranking  of  the  lung  scintigraphy  scans  were  reported  by  the 
nuclear medicine physicians using the same criteria and methodology as described 
in chapter 2 of this thesis. The nuclear medicine physicians  had no prior knowledge 
of which method of ventilation created the images. The physicians considered TEBA 
images to be as good and in some cases superior to the conventional scans. 
Unblinded reporting: nuclear medicine physicians reported on each subject’s scan.
Blinded reporting: we used coded images of conventional and TEBA scans. The 
primary objective is for nuclear medicine physicians to pay particular attention to the 
visual scoring of central deposition, the ability to define lung margins and peripheral  
penetration of Technegas, and image interpretability. The secondary objective was to 
look at concordance of quality of lung scans, peripheral penetration, definition of lung 
defects if any, and occurrence or central deposition in various disease states (PE).
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3.5 Inclusion and Exclusion Criteria
Exclusion:
Exclusion criteria included:
 Pregnant or breast-feeding females, or anyone with:
 An inability to understand directions or use the conventional ventilation PAS
 Contraindications for the study included claustrophobia
 Hypoxia or unwillingness to co-operate.
Inclusion:
Written consent was obtained from each subject prior to the commencement of the 
Lung  TEBA  ventilation  and  perfusion  scan.  Adults  who  have  read  the  Informed 
Consent form explaining the purpose of the aims of our research, expected duration 
of participation and a full description of the procedure which includes a small amount 
of radiation to the volunteer patient. 
Ethics:
Ethics approvals can be found in Appendix B.
Study Cohort:
The study group totalled 50 participants who met the criteria; 25 volunteers (13 males 
and  12  females),  with  a  mean  age  of  55.6  years  with  no  lung  disease  and  25 
volunteers (15 males and 10 females) with a mean age of 60.5 years with PE. The 
volunteers returned 5 to 7 days after the conventional scan and SPECT to undergo 
TEBA ventilation scan. The volunteers were scanned in random order.
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3.6 Results
Clinical  Investigation  of  Positive  Ventilation  Delivery  System  –  TEBA on  Normal 
subjects and patients with PE – for results see Table 3.1. There are 25 conventional 
subjects and 25 TEBA patients in this table. We used a sample size of 50 as too  
many can result in unnecessary exposure of humans to risk; and to underestimate 
the sample size will lead to no “clear cut” result at the conclusion of the study. Having 
too  many  or  too  few  participants  also  requires  re-adjusting  of  the  p-values  or 
significance levels.
We were also interested in the breathing times, number of breaths and final count 
rates of both the conventional and TEBA patients. Review of breathing times and 
number of breaths seen in table 3.1 show the utilization of TEBA to be significant. 
This may be due to the positive pressure we used to deliver the Technegas to the 
lungs. Final  count  rate  was  similar  for  both  conventional  and  TEBA.  Adequate 
ventilation images are desirable to improve the specificity of lung scintigraphy in the 
diagnosis of PE.
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Table 3.1 Breathing times, number of breaths and final count rate for both 
conventional and TEBA ventilation
Breathing time s No. of breaths Final count rate
Conventional TEBA Conventional TEBA Conventional TEBA
24 14 4 3 2.0 2.2
23 12 4 2 1.8 2.1
18 14 3 2 2.0 2.2
22 16 3 2 1.8 1.9
20 18 3 2 1.7 2.1
23 16 3 3 1.1 2.2
26 15 2 2 2.0 2.0
18 7 2 2 1.7 2.3
12 9 3 2 1.5 2.0
16 16 3 1 2.1 2.2
32 22 2 1 1.8 2.1
18 7 3 2 2.1 2.3
14 8 2 2 1.7 1.9
17 14 3 2 1.0 1.9
10 8 2 2 1.8 1.9
6 6 2 2 2.0 2.2
5 12 2 2 2.6 2.2
22 10 10 2 2.3 2.1
13 10 5 3 2.0 2.1
10 8 6 3 2.3 2.2
9 7 7 3 2.0 2.3
6 6 4 3 2.0 2.0
5 4 3 2 2.1 2.3
12 11 2 2 1.2 2.0
14 12 2 2 2.0 2.1
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Table 3.2  Mean Breathing, Number of Breaths and Final Count rate
CONVENTIONAL TEBA Value p=(0.05)
Breathing Time (S) Mean =15.8 Mean = 11.28 0.005 
Number Of  Breaths Mean = 3.4 Mean = 2.16 0.005 
Final Counts (K Counts) Mean =1.86 Mean = 2.1 0.005 
Table 3.3 Activity loaded and oxygen saturation rates for conventional and TEBA
Activity Activity Start Start Trough Trough End End
C T C T C T C T
850 800 99 99 98 96 99 99
800 870 98 99 94 96 98 99
840 890 97 99 93 96 99 99
860 890 98 99 96 96 98 99
800 850 98 98 96 91 98 98
850 880 97 94 94 97 97 98
900 920 97 100 95 97 98 100
800 850 97 99 96 94 98 99
850 840 98 99 94 96 98 99
850 860 96 97 92 95 97 99
800 870 98 97 96 99 98 99
860 980 98 99 96 98 98 99
880 860 99 98 98 96 99 99
800 990 99 100 96 97 98 99
850 960 98 99 95 96 98 98
900 830 97 96 96 96 98 99
850 890 99 99 98 98 99 99
900 920 98 99 96 97 98 98
900 930 98 97 93 96 98 99
850 990 98 99 93 98 98 100
900 960 99 100 92 96 99 100
900 970 97 99 96 96 98 99
850 890 98 98 93 96 98 99
800 880 99 99 98 98 99 99
850 900 99 99 96 97 99 100
Activity loaded in the crucible for the conventional  (C) and the TEBA ventilation is  
800  –  950  MBq  sodium pertechnetate  (Tc-99m).  For  adults,  adequate  images  are 
obtained after approx. 40 MBq of Technegas is inhaled; however activity in the lungs 
varies between participants (Kim, 2000).  Oxygen saturation is important  to measure 
especially with TEBA, as this introduces positive pressure into lung fields. As seen in 
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the table above, there is no significant difference in the baseline. The trough, however,  
shows saturation levels  decreased then returned to  their  initial  value within  a short 
period. Oxygen saturation reached a trough after first and second inhalation, which may 
be associated with inhaling the anoxic Technegas mixture. The use of oxygen to drive 
the positive pressure without  CO2 retention assisted in  reducing the severity  of  the 
Technegas induced hypoxia. It is important to maintain saturation levels above 90% as 
red cells must carry sufficient oxygen through the arteries to all internal organs in order  
to sustain life (West, 1987).  Usually,  when red blood cells pass through the lungs,  
95 - 100% of them are saturated with oxygen. If there is lung disease or other lung 
conditions (PE), fewer red blood cells will be carrying their normal load of oxygen and 
therefore oxygen saturation will be reduced.
Figure 3.3  Oxygen Saturation in both conventional and TEBA patients 
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The  initial  oxygen  saturation  may  be  a  predictor  of  how  well  the  subject  can 
withstand a change in oxygen saturation and the duration and degree of hypoxia.  
The table shows that most participants will  undergo some temporary changes in 
oxygen  saturation  during  the  administration  of  Technegas  due  to  temporary 
hypoxia. 
Figure 3.4  Line Graph using a different interpretation to show Oxygen Saturation
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Figure 3.5 Conventional versus TEBA Oxygen Saturation
The  graphs  show  the  percentage  of  oxygen  saturation  during  Technegas 
administration. It is clear that during lung ventilation at midpoint or trough, oxygen 
saturation may dip quite low. This is due to hypoxia, which is transient, then oxygen 
saturation returns to normal. Hypoxia is improved by 100% oxygen administration to 
assist in washing out all the nitrogen in the alveoli, leaving only carbon dioxide and 
oxygen  (West  1990).  Using  oxygen  to  drive  the  positive  pressure  in  participants 
without CO2 retention helped reduce the severity of the Technegas induced hypoxia.
Blue bar  columns,  TEBA show mean values for  oxygen  saturation during a lung 
scintigraphy at start, trough (middle) and end of scan. This can then be compared to 
the conventional scintigram, where bar columns are purple. The vertical axis signifies 
oxygen saturation and horizontal axis the number of subjects. 
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Figure 3.6  Breathing Times for both Conventional and TEBA
Figure 3.7  Drop Plot showing Breathing Times for Conventional and TEBA
These two charts above give a good representation of using TEBA. The breathing in 
figure  3.6  (large  blue  column)  shows  conventional  breathing  time  is  longer  than 
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TEBA. The smaller purple column identifies the number of breaths. TEBA uses fewer 
breaths to achieve an adequate count rate for lung scintigraphic acquisition.
The  advantage  of  using  a  drop-plot  graph  in  figure  3.7  is  that  it  is  clear  from  
c (conventional) and T (TEBA) that we are plotting two variables. We can see from 
the  cluster  and  height  of  the  conventional  dots  that  breathing  time  measured  in 
seconds is increased compared to TEBA.
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3.7 Discussion and Conclusion
Lung scintigraphy plays  a  first  line role  in  the diagnosis  of  PE. Previous studies 
(EJNM, Vol 26; 1999) showed its efficacy in the diagnosis and follow-up progress in 
reducing clinical uncertainty, in directing treatment and in lowering health care costs 
(EJNM, Vol 26; 1999).
Normal lungs have a relatively even distribution of Technegas throughout, however in 
this  experiment,  PE  showed  varying  degrees  of  abnormal  distribution.  Adequate 
ventilation of patients is sought to optimise images and to provide high specificity for 
the diagnosis of PE.
There are many reasons why PE may not be clinically significant, such as subtle 
abnormalities, which were diagnosed as PE and were subsequently found to be false 
positives. However, in the future, as diagnostic equipment improves, smaller PE may 
be detected.
TEBA for both normal volunteers and volunteers with PE showed breathing times 
and number of breaths were less than the conventional method (see above tables 
and  graphs  in  results  section  which  support  this).  TEBA  has  shown  to  provide 
ventilation images which are as good and in some patients superior to conventional 
images in patients with PE and normal volunteers. 
Therefore the alternate hypothesis (Ha) is seen to be true as lung scintillation quality 
in  some  patients  is  superior  for  TEBA  assisted  PE  patients  and  conventional 
subjects.  As the alternate hypothesis proved to be correct, this potentially means we 
would see an increase in the number of PE patients having lung scintillation scan 
using TEBA.
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CHAPTER 4 EXPERIMENT 3
Positive Pressure Ventilation for Intubated Intensive Care Patients
4.1 Introduction
There  is  not  an  objective  definition  of  clinically  important  Deep Vein  Thrombosis 
(DVT)  in  critically  ill  patients  because,  to  our  knowledge,  no  studies  have 
systematically  correlated  clinical  or  radiographic  characteristics  of  acute  venous 
thrombosis with patient outcomes. Despite the lack of such data, the concept of a 
clinically important DVT in the critically ill is vital as an assessment can determine 
whether it should be treated and could prove useful in future clinical research. 
Routine  thromboprophylaxis is  provided  to  critical  care  patients based  on  an 
individual assessment of their thrombosis and bleeding  risks but without  definitive 
diagnostic  tests  to  confirm  venous  thromboembolism  (VTE).  This  is  due  to  the 
immobility of the intubated unconscious patient, who is not able to have a lung scan 
to confirm or deny the diagnosis of Pulmonary Embolism (PE). Accordingly, the level  
of anti–coagulant therapy in this group is high, resulting in an increased incidence of 
anti-coagulant side effects.  Positive ventilation with TEBA can be successfully used 
to diagnose PE in intubated patients.
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4.2 Predisposing factors for DVT
Venous thromboembolism (VTE), which includes both deep vein thrombosis (DVT) 
and pulmonary embolism (PE), is a common complication of critical illness. Critically 
ill  patients  harbour  many  coincident  risk  factors  for  DVT,  such  as  the  need  for 
surgery,  catheters,  immobility and use of sedatives and paralytic agents (Hillman, 
1996). As in the non-critically ill population, it is likely that most episodes of DVT are 
asymptomatic and confined to the deep veins of the calf. However, in time, 20–30% 
of untreated calf vein thrombi extend proximally into the thigh, where they pose a 40–
50% risk of PE (Fahey, 1995). According to Van Beck (1996), early studies of the 
natural history of PE suggest that untreated PE has a mortality rate of at least 25%.
Geerts (2006) suggests the prevention of VTE in patients who are unconscious and 
intubated recovering from critical illness is often challenging. Neither D-dimer levels 
nor  tests  of  hypercoagulability  (activated  protein  C  resistance  ratio,  Prothrombin 
20210A gene mutation, levels of protein C, protein S, or antithrombin, anticardiolipin 
antibody titer, and lupus anticoagulant) had any predictive value for DVT in  critically ill 
patients. 
Thrombotic  risk  factors  that  may  be  acquired  during  the  ICU  stay  include 
immobilization, pharmacologic paralysis,  central venous lines, surgical procedures, 
sepsis,  mechanical  ventilation, vasopressor  use,  and hemodialysis.  These patient 
groups share a high risk for VTE, they often have at least a temporary high bleeding 
risk, and relatively few thromboprophylaxis trials have been carried out with these 
specific intubated unconscious patients.
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The TEBA apparatus enables the intubated patient to be attached to the Technegas 
generator in safety, allowing ventilation for the lung scan and acquisition to continue 
for a definitive diagnosis. The risk of haemorrhage (and associated complications) is 
the  major  adverse  effect  of  VTE  prescribing  anticoagulation  to  the  unconscious 
intubated patient in the ICU without having a diagnostic test (Van Beek, 1996).
A lung scintigraphy scan was ordered for these critically ill patients due to the amount 
of intubated, unconscious patients in ICU that were commenced on anticoagulant 
therapy without the use of diagnostic aids in the past.
4.3 PE not always detected
One large study by Faiad in 1996 found PE at autopsy in 59 out of 404 hospitalized  
patients (14.6%). Among the 20 patients who died from PE, this diagnosis was not 
suspected in  14 (70%).  In  a 25-year  longitudinal  study by Hillman (1996),  9% of 
patients  had  autopsy  evidence  of  PE  and  again  the  diagnosis  of  PE  was  not  
suspected in  84% of  patients  before  autopsy.  A study by Moser  and associates 
(1994),  further  emphasised this  problem in  critical  care  practice,  where  13 of  34 
(38%) of ICU patients with known DVT who had no symptoms of PE, were diagnosed 
with PE by ventilation-perfusion scans. 
It  is  possible that many mechanically ventilated patients with  sudden episodes of 
hypotension,  tachycardia,  or  hypoxia  may  have  undetected  PE  as  reported  by 
Fedullo 2003. Unsuspected PE may also contribute to difficulty in weaning patients 
from mechanical  ventilation (Laghi  and Tobin, 1995).  Douketas and associates in 
1998 suggested that in critically ill patients with impaired cardiopulmonary reserve, a 
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small PE, which might be of minimal clinical importance in patients who are less ill,  
might have severe or fatal consequences. Thus, the clinical consequences of DVT 
has the potential to be particularly serious, but may be unrecognized in the ICU. It is 
also possible that ICU patients undergoing treatment for DVT are more likely than 
other patients to suffer serious complications from anticoagulant therapy, according 
to a report by Douketas (1995).
Earis  and  Pearson  (1995)  suggested  ICU  critically  ill  patients  cannot  reliably 
communicate their symptoms of DVT as clinically important episodes are defined as 
symptomatic  events,  and  intensivists  rarely  use  the  reference  standard  of 
venography to  diagnose DVT.  Furthermore,  physical  signs such as unilateral  leg 
oedema,  which  are  important  clinical  features  of  DVT  outside  the  ICU,  are 
uncommon in the ICU because many critically ill patients are supine and frequently 
have severe bilateral oedema. These observations suggest that the classic definition 
of a clinically important DVT is not suitable in the ICU setting.
4.4 Comparing TEBA with conventional methods
Lung  scintigraphy  is  a  well  established  diagnostic  tool  for  the  diagnosis  of  PE. 
However, it has not previously been utilized for intubated intensive care patients, as 
these patients are critically ill, intubated and not able to be easily transported to the 
nuclear medicine department for lung scintigraphy.
As discussed in chapter 1 of this thesis, the use of TEBA with ICU patients has the 
potential to minimize discomfort and lessen the risk of Barotrauma (Leiper, 1998) as 
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ventilatory time due to the rapid re-inflation of the reservoir bag, is less than one 
minute. Barotrauma is the sequelae of a ventilator induced lung injury resulting from 
a mismatch between the volume of  gas delivered and the lung volume available 
(Hillman,  1996).  This  is  due to  the  smaller  volume of  oxygen  or  air  required  for 
respiration during the TEBA operation.
4.4.1 Four types of ventilatory equipment for Intubation
There are four types of ventilatory systems used for intubation.
1) Pressure cycled ventilation
In this type, the ventilator is manually set to reach an upper pressure limit; once the  
the patient reaches this level,  inspiration ceases and expiration commences. The 
inspiratory  time,  inspiratory  flow  rate  and  tidal  volume  vary  with  every  breath, 
depending on the patient’s resistance and compliance according to Hess (1996).
2) Volume cycled ventilation
In the volume cycled system, the ventilator is set to reach a set tidal volume, once 
this tidal volume is reached, inspiration ends and expiration commences. The airway 
pressure attained, inspiratory flow rate, and inspiratory time vary with each breath, 
depending on the patient’s resistance and compliance.
3) Time cycled ventilation
If  using  time  cycled  ventilation,  inspiration  ends  and  expiration  begins  after  a 
predetermined  time interval  has been reached.   Generally  an  inspiratory  time,  a 
respiratory  pause  or  plateau,  or  an  I-E  ratio  (inspiration  /  expiration)  are  set,  
depending on the specifications of the ventilator used, to determine time cycling. The 
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airway pressure attained, the inspiratory flow, and the tidal volume vary with every 
breath, depending on the patient’s resistance and compliance.
4) Flow cycled ventilation
Flow cycled ventilation uses the principle that inspiration ends and expiration begins 
when the flow rate drops to a predetermined percentage of its peak value. The tidal  
volume  and  inspiratory  time  vary  with  every  breath,  depending  on  the  patient’s 
resistance and compliance (Fahey, 1995).
Every patient will be different regarding which classification and mode of ventilation 
will be required, and this will change at different stages of their disease. In addition,  
Intermittent  Positive  Pressure  (IPPV)  has  two  distinct  pathways,  either  volume 
controlled  ventilation  or  pressure  controlled  ventilation;  from  both  these  groups, 
depending on both the pathological and physical condition of the patient, there will be  
varying  modes.  The following section outlines the four  main types  of  mechanical 
ventilation systems.
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4.4.2 Mechanical ventilation systems
Mechanical ventilation includes the following four systems: 
1. CMV and ACMV
2. IMV
3. SIMV
4. CPAP and PEEP
1.  Controlled  Mechanical  Ventilation  and  Assist  Controlled  Mechanical 
Ventilation (ACMV) is available in both pressure control or volume control ventilation 
depending on the type and mode of the ventilator available. In this system a preset  
tidal  or  inspiratory  volume  is  delivered  to  the  patient,  who  in  turn  receives  a 
mandatory or assisted breath. 
2. Intermittent Mandatory Ventilation (IMV). For this system the patient receives a 
pre-set rate and tidal volume. In between these mandatory breaths, the patient may 
initiate  spontaneous  breaths,  but  there  is  no  synchrony  between  patient  and 
ventilator.  The volume of the spontaneous breath is dependent on the respiratory 
muscular effort that the patient is able to generate. 
3. Synchronized Intermittent Mandatory ventilation (SIMV) – (includes PSV and 
PEEP) is  available  in  both  pressure-controlled,  and  volume-controlled  ventilation 
depending on the type and model of the ventilators available.  The patient receives a 
preset rate and tidal volume or inspiratory pressure. In between mandatory breaths 
the patient may initiate spontaneous breaths in synchrony with the ventilator.
SIMV is different to IMV as it uses a window of time in which a breath is due and will  
look  to  deliver  this  breath  within  the  timing  window.   The  ventilator  delivers  the 
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mandatory breath simultaneously as it senses the patient’s inspiratory effort (Laghi, 
1995).
When using SIMV systems the patient’s level and type of breathing must also be 
assessed and considered to  ensure the most  appropriate ventilation technique is 
used. There are three different types of breaths during SIMV: 
1) Mandatory  breath  is  used,  when  the  patient  does  not  initiate  sufficient 
inspiratory  effort  within  the  timing window.  The mandatory  SIMV breath  is 
delivered at the scheduled time and the ventilator will then reset to respond to 
the next spontaneous inspiratory effort. 
2) Assisted  breath,  is  used  when  a  mandatory  SIMV  breath  is  due  as 
determined by the rate control, the assist or timing window opens and waits for 
the patient’s inspiratory effort.  Upon sensing the patient’s inspiratory effort,  
the  ventilators  deliver  the  preset  tidal  volume  or  inspiratory  pressure  in 
synchrony  with  the  patient.   As  soon  as  the  mandatory  breath  has  been 
triggered the assist window closes.  Once the assist breath has been delivered 
subsequent patient effort results only in a third type of breathing known as 
spontaneous or pressure breath.
3) Spontaneous or pressure breaths, occur until the next mandatory breath is 
due.  Hess  (1996)  suggests  that  the  intensive  care  patient  may  initiate  a 
spontaneous  breath  in  synchronicity  with  the  ventilator.  Spontaneous 
breathing will be dependent on the respiratory muscular effort that the patient 
can generate. 
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Advantages of SIMV
The advantages of using SIMV as suggested by Laghi (1995), are that synchrony 
improves the patient’s comfort level and reduces the competition between ventilator 
and  patient.  SIMV  prevents  breath  stacking  and  barotrauma  and  decreases 
respiratory muscle  atrophy;  the  patient  uses the ventilatory muscles  to  a greater 
degree than with CMV or ACV. The haemodynamic effects of IPPV are less with 
SIMV than  CMV or  ACV.   Using  this  method  will  also  decrease  the  amount  of  
sedation required and makes the weaning process easier.
A pressure support level must always be set while the patient is in the SIMV mode. If  
the  patient  wakes  and  tries  to  take  a  breath  without  the  assistance  of  pressure 
support, he / she will feel as though they are suffocating, and become distressed.
Pressure  support  ventilation  (PSV)  is  only  functional  when  the  patient  is 
spontaneously breathing.  Pressure support is active only during inspiration and is 
triggered by the sensitivity control, of the ventilator. 
According  to  Hess  (1996)  ventilators  are  classified  as  either  flow  or  pressure 
generators, depending on their mode of operation.  A preset flow of gas is delivered 
to flow generators, regardless of any opposing forces; any impedance of the total  
respiratory system will be seen as a difference in airway pressure.  
As outlined earlier in this chapter ventilators can operate in many different ways.  In 
the control mode, the ventilator controls the volume and timing of ventilation, in the 
assist  mode inspiratory efforts  trigger  the start  of  inflation.  Intermittent  mandatory 
ventilation (IMV) is when the patient performs most of the work of breathing. The 
mechanical inflation of the lungs occurs at various intervals and is predetermined 
during spontaneous breathing. If the IMV is not applied in the correct way severe 
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muscle  fatigue  will  result.  When  synchronous  intermittent  mandatory  ventilation 
(SIMV) is used the lung inflation’s during IMV are synchronized to coincide with the 
patient’s own inspiratory efforts (Hillman, 1996).
4. Continuous Positive Airway Pressure (CPAP) and Positive End Expiratory 
Pressure (PEEP)
Fahey (1995) referred to continuous airway pressure (CPAP) as the addition of a 
fixed amount of positive pressure throughout a spontaneous breath. The pressure is 
never allowed to return to atmospheric pressure, by contrast positive end expiratory 
pressure (PEEP) specifically refers to the application of a fixed amount of positive 
pressure during expiration only.  Positive End-Expiratory Pressure (PEEP) can be 
used in conjunction with mechanical ventilation. Some patients spontaneously have 
an  increased  end  expiratory  pressure  and  lung  volume  due  to  the  activation  of 
inspiratory muscles or through adduction of the vocal chords. Endotracheal intubation 
may lead to a loss of the PEEP and a reduced end expiratory lung volume (Hess 
1996).
CPAP and PEEP are not modes of ventilation, as they do not provide ventilation.  
Rather, PEEP is used in conjunction with other modes of ventilation and CPAP is  
used during spontaneous breathing to improve oxygenation and decrease the work 
of breathing.  According to Fahey (1995) the main advantage of using PEEP and 
CPAP is  that  they  provide  positive  pressure  at  end  expiration,  improve  alveolar 
ventilation  and  increase  functional  residual  capacity  (FRC).  Increasing  the  FRC 
increases oxygenation and decreases the work of breathing (Fahey, 1995).
Chap 4 - 10
Hess (1996), reported that PEEP can be used to improve arterial oxygenation. The 
end expiratory lung volume is a decreased in patients with acute respiratory failure. 
In these patients closure of the small airways is associated with a low lung volume, 
especially in the dependent lung regions.  Lung regions that have closed airways are 
not ventilated, and perfusion of these regions results in arterial hypoxaemia.  PEEP 
can hold the airway open throughout the respiratory cycle and may restore ventilation 
to previously perfused but unventilated regions, therefore improving oxygenation.
A disadvantage of PEEP is hyperinflation of previously expanded alveoli, which can 
damage  perfusion,  resulting  in  an  increase  dead  space.   PEEP can  also  lower 
arterial  PO2 levels  results  from increased  perfusion  to  the  lung  regions  with  low 
ventilation to perfusion ratios.  This happens as PEEP causes blood flow to move 
from well-ventilated non-dependant lung regions to the less ventilated regions. 
PEEP  also  decreases  tissue  oxygenation  by  decreasing  cardiac  output;  this  is 
caused by a lowering  in  venous return.  The intraventricular  septum can also  be 
shifted  with  high  levels  of  PEEP;  the  septum  becomes  flat,  reducing  the  left 
ventricular size. If this occurs an increased pressure is required to fill the left ventricle 
to a given volume (Hess, 1996).
Continuous positive airway pressure or CPAP is the positive end expiratory pressure 
administered during spontaneous breathing.  CPAP is administered to the patient via 
an endotracheal tube or appropriate facemask.  When CPAP is used, resistance to 
gas flow in the inspiratory circuit should be low enough to ensure inspiratory effort  
does not lower the airway pressure. Gas flow to the patient should be kept in excess  
of  the  patient’s  need;  therefore,  the  physiological  effects  of  CPAP are  similar  to 
PEEP (Hillman, 1996).
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4.5 Physiology cardiac/respiratory systems for ventilated patients
Both the cardiac and the respiratory systems are affected by mechanical ventilation. 
Increased airway pressure is accompanied by an increase in alveolar gas and pleural 
pressures  during  the  inspiratory  phase  of  mechanical  ventilation.   Airway  and 
alveolar  gas  pressures  during  the  expiratory  phase  decrease  to  normal  levels. 
Venous  return  to  the  heart  can  become  impeded  with  any  rise  in  intra-thoracic 
pressure  during  mechanical  ventilation,  patients  with  a normal  blood volume and 
nervous system can re-establish the necessary pressure gradient by increasing the 
peripheral venous pressure (West, 1990).  Patients with low blood volumes cannot 
utilize this compensatory mechanism to increase their peripheral venous pressure as 
they are already constricted. This means that in these patients mechanical ventilation 
decreases cardiac output.
During spontaneous breathing in a healthy patient, gas distribution remains uniform 
when  the  lungs  are  passively  inflated.  However,  in  ICU  ventilated  patients,  
intrapulmonary distribution of inspired gas is different during mechanical ventilation 
than during spontaneous breathing. Ventilation of dependent lung regions is greater 
than non-dependent regions of spontaneous breathing patients when inspiration has 
been initiated from lung volume equal  to or greater than the Functional  Residual  
Capacity  (FRC).  During  mechanical  ventilation  under  general  anaesthesia,  the 
respiratory muscles are usually paralysed, and gas distribution is altered in all but the 
prone position (Laghi 1995).
During  spontaneous  breathing,  the  movement  of  the  dependant  portion  of  the 
diaphragm  is  greater  than  the  non-dependant  portion  of  the  diaphragm.  This 
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alteration  in  gas  distribution  is  seen  during  mechanical  ventilation,  which  is 
associated with a different pattern of diaphragmatic motion. 
Conversely,  the  nondependent  portions  of  the  diaphragm  move  more  than  the 
dependent  portions  during  mechanical  ventilation  in  a  paralysed  patient.   The 
addition  of  the  rib  cage  to  the  tidal  volume  is  also  changed  during  mechanical 
ventilation.  In the recumbent position, the patient’s relative contribution of the rib 
cage  is  greater  during  mechanical  ventilation  than  during  spontaneous  breathing 
(Hess, 1996).
The  balance  between  the  regional  muscular  expanding  forces  and  the  regional 
impeding  forces  determines  the  pattern  of  chest  wall  breathing  in  spontaneous 
patients. The alveolar gas pressure used for mechanical ventilation means that the 
forces are no longer reliant on muscle contraction, therefore the pattern of motion 
during mechanical ventilation is constant by the distribution of “regional elastances” 
which are reciprocal of compliance within the lung and chest wall (Hess, 1996).
Gas distribution therefore will be altered in non-uniform lung disease by mechanical 
ventilation.  The  altered  gas  distribution  during  mechanical  ventilation  provides 
evidence that the operation of the respiratory muscles is an important determinant of  
inspired gas distribution during spontaneous breathing. Furthermore, the observation 
that  body position  alters  gas distribution  during  mechanical  ventilation  maybe  an 
indicator that gravity is a determinant of gas distribution in normal respiration.
4.6 Additional considerations in caring for ICU patients 
The care of patients in the ICU requires a specialised team of nurses and medical 
staff with expertise in the use of both a wide range of equipment and the monitoring  
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and appropriate treatment of unconscious critically ill patients. Therefore intervention 
of these patients,  such as performing lung scintigraphy outside the ICU, requires 
additional precautions and constant monitoring to ensure the patient’s health is not  
compromised. These activities are generally undertaken by ICU nursing staff but all  
staff involved in performing lung scans on ICU patients need to be cognisant of the 
detailed monitoring requirements. Church (1998) summarised the major activities that 
must be maintained while a patient is outside the ICU. The ICU nurse and Registrar 
must remain with patient for the duration of the scan to:
 Continuously monitor patient’s oxygen saturation levels, blood pressure 
and pulse
 Monitor airway pressure for any sustained increase to prevent barotrauma
 Observe amount and type of airway secretions and document
 Make sure the scanning room has wall oxygen and suction for the patient 
before commencement of the test
 Ensure a filter is used on the inspiratory and expiratory limb to protect the 
patient and equipment.  It is only during the ventilation stage using 
Technegas that this filter is removed.  After this procedure it is replaced
 Assess the patient for pain relief and / or sedation requirements
 Ensure that the stomach has been deflated; placement of a gastric tube 
either nasal or oral is required post intubation
 Ensure ETT tapes (tapes to secure oral endotracheal tubes) are firmly 
tied; a tube falling out or becoming dislodged is a medical emergency.  All 
tubing is supported so as to reduce damage to oral / nasal mucosa and 
prevent displacement.  (Church, 1998). 
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4.6.1 Cuff Pressures
All  intensive  care  patients  should  have  the pilot  tube cuff  inflated  at  all  times to 
prevent an air leak unless specially requested by the physician.  The cuff pressure is 
routinely checked and is rechecked if a cuff leak is heard (pressures range from  
20 to 30 mmHg).  Tracheal  ischaemia can occur if  the cuff  pressure exceeds or 
approaches  capillary  pressure,  which  is  approximately  32  mmHg.   Using  low-
pressure  cuffs  has  reduced  the  incidence  of  tracheal  ischaemia,  but  it  is  still  
necessary to routinely observe the patient (Hess, 1996).
If the cuff is under-inflated, the patient will experience loss of ventilatory volumes and 
PEEP, and possible aspiration of gastric contents.  Over-inflation will cause necrosis 
and ulceration of the trachea, with possible development of the tracheosophageal 
fistula.
4.6.2 Arterial Blood Gases in the ICU
Arterial blood gases (ABG) are routine in the ICU, especially on intubated patients to 
measure  their  outcome (see  Table  4.3  in  Results  section).   ABGs  assist  in  the 
diagnosis of PE and associated conditions such as respiratory acidosis/alkalosis or  
metabolic  acidosis/alkalosis.   ABGs  can  also  help  identify  possible  strategies  to 
correct for these imbalances.  The oxyhaemoglobin curve in Figure 4.1 shows the 
relationship between percent of haemoglobin saturation (SaO2) and partial pressure 
of arterial oxygen (PaO2).  At this site SaO2 drops dramatically with little change in  
PaO2.  Habibian (1999) suggests that oxygenation at the cellular level depends on 
the ability of O2 to bind with and be released from haemoglobin (Hgb) in the blood. 
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Figure 4.1   Oxyhaemoglobin Dissociation Curve (Morgan 1999)
Earis  and  Pearson  (1995),  suggest  that  the  Oxyhaemoglobin  dissociation  curve 
(ODC) is  a  graphic  relationship  between haemoglobin oxygen  saturation and the 
partial  pressure  of  oxygen  in  the  blood.  The  affinity  of  haemoglobin  for  oxygen 
produces an S-shaped curve representing the way oxygen normally loads onto, and 
releases from, the haemoglobin molecules. The flat upper portion represents oxygen 
loading of haemoglobin as blood passes through the lungs. Hillman (1996) suggests 
that when the partial pressure of oxygen is high, oxygen binds with the haemoglobin 
molecule.
However,  because most  haemoglobin molecules are already saturated,  additional 
loading of oxygen onto haemoglobin will not significantly increase as partial pressure 
continues  to  increase.  The  steep  lower  portion  of  the  curve  represents  the 
relationship  at  the  tissue  level.  Haemoglobin  molecules  are  not  well  saturated 
because they have already lost some of their oxygen to tissues. Even with minor 
reductions in the partial pressure of oxygen, large amounts of oxygen are off-loaded 
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from haemoglobin molecules (Earis and Pearson, 1995). These include a blood pH of 
7.4 PaCO2 of 40 mmHG, temperature of 37oC, and normal levels of 2, 3-DPG.
Transient  hypoxia  may  occur  but  is  typically  not  associated  with  any  harmful 
symptoms to the patient. 
As described by Hess (1995), ICU patients are strictly monitored while ever out of the 
intensive  care  environment.  While  in  the  department  of  Nuclear  Medicine  the 
patients’ intravenous medications assist in keeping the patient stable while out of the 
intensive care unit, these patients are therefore more conducive to have a TEBA lung 
scan.  The  most  common  indication  for  using  ventilatory  support  is  reversible 
respiratory failure caused by either hypoxaemic or hypercapnoeic failure according to 
Hess (1995).
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4.7 Aims
The aims of the experiments in this chapter are:
 
 To determine whether TEBA can allow ICU patients to undergo a V/Q scan
 To determine whether TEBA has a role to play in the management/diagnosis 
of PE or COAD in intubated / ICU patients
 To verify/assess the quality of images of ICU patients using TEBA (see Figure 
4.3).
Consent for the Unconscious Patient:
The patient’s relative (next of kin) or the Director of Intensive Care who has read the 
Informed Consent form explaining the purpose of the aims of our research, expected 
duration  of  participation  and  a  full  description  of  the  procedure  which  included 
administering a small amount of radiation to the volunteer patient. 
Ethics: See Appendix B
Study Cohort:
There were 25 unconscious intubated ICU patients in the study, including 18 males 
and 7 females with a mean age of (60.88 years). 
Chap 4 - 19
4. 8 Materials and Methods
In this experiment 25 intubated ICU patients, (18 males and 7 females with a mean 
age of 60.88 years), were required to undertake a ventilation / perfusion (V/Q) lung 
scan using the TEBA positive  ventilation system.  The project  aimed to  verify the 
quality of images produced by this system using, the same V/Q lung scan procedure 
described in chapter 2 of this thesis, compared to conventional CAL images post 
ventilation. For this experiment ICU patients had only one TEBA lung scintigraphy 
scan as they were too ill to return to the nuclear medicine department. However, if  
they had a high probability lung scan, they returned for a second scan within 5-7 
days to check progress after being treated with anticoagulants. 
As discussed in chapter 1 of this thesis positive pressure ventilation or TEBA is used 
for intubated patients because the conventional method of ventilation is not the best 
method to use for the unconscious patient.
Two medical radiation scientists, with specific knowledge on how to use the TEBA 
apparatus, were required to perform the ventilation/perfusion lung scans on each ICU 
patient  and  a  registrar  and  nurse  from  the  intensive  care  unit  were  present 
throughout each lung scan to observe the patient.
As all patients in this experiment were unconscious they were all at risk of developing 
Hypoxia within the first few seconds of ventilation, (Fahey, 1995). Therefore, oxygen 
saturation measurements were taken on each patient throughout the V/Q scan.
The main objectives of ventilation are to support pulmonary gas exchange for these 
intubated patients, thereby improving arterial oxygenation and augmenting alveolar 
ventilation and correcting acid / base levels as PaCO2 and pH of the patient. West 
implied that improving the functional residual lung capacity will improve lung volume 
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and  reduce  the  work  of  breathing  (West,  1990)   While  minimizing  the  work  of 
breathing  and  promoting  gas  exchange,  several  changes  will  occur  as  a  patient 
changes from breathing spontaneously to breathing by mechanical means.
For  the  ventilation  perfusion  lung  scan,  the  routine  six  projections  of  anterior,  
posterior, right posterior oblique, left posterior oblique, right anterior oblique and left 
anterior oblique were acquired. Each patient was required to have their arms raised 
above their head onto a pillow to minimise attenuation by the arms when acquiring 
images. This proved quite difficult as the patients were unconscious or sometimes 
semi-conscious, so arms had to be held onto the pillow by another staff member or  
ICU nurse. From the patient perspective this position was difficult for a number of  
reasons,  the  main  being  tiredness  and  discomfort  for  the  patient  who  could  not 
communicate.; also these patients had multiple sets of intravenous lines in both arms 
as  well  as  central  lines  in  their  neck  for  arterial  pressure  measurements  and 
administration of drugs. Furthermore, each patient was required to have intubation 
tubing connected to a Positive End-Expiratory Pressure (PEEP) system to ensure 
continuous ventilation throughout the time of the V/Q scan. 
4.8.1  Inclusion and Exclusion Criteria
All intubated ICU patients were included in our study. Not included were:
 ICU patients weaned off their ventilators
 Children
 pregnant women or breast feeding mothers.
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4.9 Results
Lung scintigraphy plays a major role in interpreting patients suspected of PE. The 
lung scan is most useful when it presents as either low or high probability of PE in  
conjunction with corresponding likelihood of PE. A normal or low probability scan is 
associated with 4% prevalence of PE and a high probability of 97% when clinical  
suspicions  are  high.  However,  an  intermediate  probability  lung  scan  (IPLS) 
representing an uncertain diagnosis of PE occurs in more than one third of all lung 
scans.  There  is  also  an  inter-observer  variability  between  nuclear  medicine 
physicians must also be considered. Additional diagnostic tests are recommended for 
V/Q  scans  with  an  intermediate  probability  of  PE  as  30-40%  of  pulmonary 
angiograms have been positive for PE (Fedullo, 2003, Wong, 2001).
Each V/Q lung scan in this experiment was examined for the presence of PE by two 
nuclear medicine physicians using the following criteria. Important characteristics of 
PE on the lung scan included the finding of wedge-shaped segmental and /or pleural 
based perfusion defects. While perfusion defects of irregular shape were unlikely to 
be due to PE. Patients with multiple perfusion defects that covered more than 75% of 
a lung segment were considered to be high probability for PE; a single defect that 
covered more than 25% of the lung segment was considered to have an intermediate 
probability of PE and were thought to require more diagnostic intervention. Whereas 
patients with one perfusion defect that affected less than 25% of a lung segment was 
considered to have a low probability of PE (Early 1995). 
Table 4.1 shows the age and gender of the twenty-five patients who participated in 
the study. 
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Table 4.1 Overview of Age and Gender showing the number of ICU 
patients and their overall age groups
1 Male 63 years
2 Female 79 years
3 Male 82 years
4 Male 67 years
5 Female 68 years
6 Male 75 years
7 Male 78 years
8 Female 56 years
9 Male 44 years
10 Female 55 years
11 Female 73 years
12 Male 60 years
13 Male 84 years
14 Female 72 years
15 Male 69 years
16 Male 74 years
17 Male 75 years
18 Female 68 years
19 Male 72 years
20 Male 75 years
21 Male 73 years
22 Male 69 years
23 Male 62 years
24 Male 79 years
25 Male 65 years
Total 25   mean = 60.8
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4.9.1 Ventilation Perfusion Scan Results for ICU patients
A  major  outcome  for  this  experiment  was  the  significant  achievement  that  25 
intubated ICU patients successfully underwent a V/Q scan after being transported 
from the ICU to the nuclear medicine department at Lidcombe/Bankstown Hospital.
As shown in Table 4.2, seven patients (28%) were found to have a high probability of 
PE and were placed in anticoagulant therapy, while eleven patients (44%) had an 
intermediate probabitly of PE and these were also placed on anticoagulant therapy.  
The remaining seven patients (28%) were found to have a low probability of PE so 
anticoagulant therapy was not prescribed for this third group.  
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Table 4.2 ICU Patients Lung Scan Diagnosis and treatment showing that a high 
percentage of anticoagulation therapy may be unnecessary
Probability Total Number (/%) Anticoagulant Therapy     Yes or No
High 7 (28%) Yes
Intermediate 11 (44%) Yes
Low 7 (28%) No
These  results  show  that,  anticoagulant  therapy  should  only  be  commenced  on 
patients with a definitive diagnostic result, to stop unnecessary risk of bleeding and 
placing  patient  on  long  term  treatment  when  this  may  have  been  avoided. 
Significantly:
 7 low probability who would not need to commence anticoagulant therapy
 11 intermediate who would have commenced anticoagulation therapy
 7 high probability who commenced treatment and would have returned in 5-7 days for 
repeat TEBA lung scintigraphy to assess anticoagulation therapy if they were stable 
enough to return to the nuclear medicine department.
 7  of  25  would  have  been  commenced  on  anticoagulation  therapy  in  ICU  if  not 
transported to nuclear medicine for lung scan & diagnosed as low probability for PE
The following images  illustrate the difference in ventilation scan quality between a 
TEBA  lung  scan  on  an  intubated  ICU  patient  (figure  4.2)  and  a  conventional 
ventilation scan on a patient with CAL (figure 4.3). The scan of the TEBA assisted 
ICU patient (figure 4.2) shows an even distribution of Technegas throughout the lung 
fields. There is good edge definition and peripheral  penetration with  only minimal 
central  deposition  of  the  Technegas.  By comparison,  the  conventional  scan of  a 
patient with CAL (figure 4.3) shows non-uniformity, clumping of Technegas.
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Figure 4.2  ICU TEBA Lung Scan Image on an intubated patient
Figure 4.3 CAL conventional lung ventilation shows non-uniformity, 
clumping of Technegas
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Blood Gas Results for ICU Patients
The blood gas results are displayed in Table 4.3 and include pH levels and whether 
PaCO2, PaO2  and HCO3  were normal, raised or below normal. The results showed 
that only three of patients, (numbers 10, 15 and 24) had normal blood gas results at 
the time of the V/Q scan. The poor respiratory function of the majority of patients (21  
out of 25) in the experiment demonstrates the difficulty faced by the researchers in 
conducting a study on critically ill patients for the ICU. 
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Table 4.3  ICU Blood gas results
Patient pH PaCO2 PaO2 HCO3 Diagnosis
1 7.36  
hypercapnia
  Acidosis fully compensating
2 7.40  Normal  Respiratory Acidosis fully compensating
3 7.3 Slight  Normal Normal Pt. Has slight hypercapnia
4  7.21 
acidosis
Slight    Severe respiratory acidosis but 
compensating
5 7.3  Normal  Respiratory alkalosis and compensating.
6 7.5 Normal   Metabolic alkalosis slight to partial 
compensating
7 7.4    Respiratory Alkalosis fully compensated
8  7.2    Respiratory Acidosis, hypoxia and partial 
compensation
9 7.4    Hypoxia
10 7.4 Normal Normal Normal Normal Blood gases
11 7.45    Metabolic Alkalosis and partial 
compensation
12 7.5    Metabolic Alkalosis compensated
13  7.2    Severe metabolic acidosis
14 7.3    Metabolic acidosis with hypoxaemia
15 7.4 Normal Normal Normal Normal blood gases
16  7.2  Normal  Respiratory acidosis with hypoxia
17 7.4    Compensated respiratory acidosis
18  7.2    Metabolic acidosis
19  7.1    Respiratory Acidosis
20 7.3  Normal  Respiratory alkalosis, fully compensating
21 7.5    Metabolic alkalosis with partial 
compensation
22  7.2   Normal Metabolic acidosis
23 7.4    Respiratory acidosis
24 7.3 Normal Normal Normal Normal blood gases
25 7.3    Metabolic acidosis with hypoxaemia
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4.9.2 Blood Gas Variations
There are several factors that can change a blood gas level. These include:
1. Flushing the patients’ arterial lines prior to sampling avoids contamination, 
otherwise, the pH and electrolytes will be affected.
2. Extremely high white cell count rates will cause falsely low pO2 level and falsely 
elevated haematocrit.
3. Haemolysed samples will cause falsely elevated potassium levels. 
4. Intravenous fluids can affect sodium results. 
5. Blood gas analysis must be performed immediately for best results.
6. Other key sources of pre-analytical error is sample handling, including the 
choice of syringe, needle size, and anticoagulants, as well as air bubbles in the 
line, temperature and sample mixing (Ref. Hillman 1996 and Easis 1995).
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Oxygen Saturation Levels
Start                     Trough                             End 
Figure 4.4  Line Graph showing Oxygen Saturation Levels in ICU patients during 
TEBA ventilation with start, trough and end
Figures 4.4 and 4.5 show blood gas results for the 25 patients in the study.  The 
vertical  axis  in  Figure  4.4  represents  oxygen  saturation,  horizontal  number  of 
breaths. Three distinct  dips or troughs are shown where the patient has become 
hypoxic in the middle of the ventilation process. Hypoxia can occur and only lasts a  
few seconds then returns to normal. These ICU patients were on 100% continuous 
oxygen.
Two patients recorded 80 and 72% oxygen saturation midway through the ventilation 
showing the need for the medical radiation scientist to have a basic understanding of 
the  immediate  care  for  the  intubated  unconscious  patient.  These  incidents  also 
highlight the necessity for the intensivist and ICU nurse to be present throughout the 
scan.
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Figure 4.5  ICU Intubated Patients’ Oxygen Saturation
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4.10 Discussion and Conclusions
After much research and support from the Intensive Care Department and Nuclear 
Medicine  Departments  at  Bankstown–Lidcombe  Hospital  Sydney,  a  protocol  was 
developed  so  that  intubated  ICU  patients  could  be  transported  to  the  Nuclear 
Medicine Department for lung scintigraphy. There were limitations to using TEBA on 
the ICU patients as it required two people to use this system; the principal researcher  
and one other medical radiation scientist trained by the principal researcher in the 
use of TEBA with ICU patients. 
The  aim in  chapter  4  was  to  determine  whether  TEBA can  allow ICU intubated 
patients to undergo a lung scan in the nuclear medicine department. This aim was 
achieved after much planning to implement the safe transport and management of 
the unconscious patient.  In addition to the two specially trained medical  radiation 
scientists who performed the TEBA assisted V/Q scans, a medical intensivist and an 
ICU nurse also accompanied each patient throughout the study.
While each patient was mechanically ventilated, there was a risk of Barotrauma from 
high inflation pressures and/or volutrauma from high tidal volumes. While both these 
conditions cause respiratory failure as intrathoracic pressure changes (Hess, 1996) 
to date none of these conditions have been reported using TEBA. 
In  addition,  TEBA assisted  ventilation  also  has the  potential  to  induce increased 
intrathoracic pressure, decreasing venous return to the heart, in turn leading to a fall 
in cardiac output.  This can be evidenced by increased pulse rate and decreased 
blood pressure during TEBA ventilation of the intubated unconscious patient. This did 
occur in two critically ill patients (nos 11 & 17) who were involved in this experiment  
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(see Figure 4.5). The research team provided appropriate treatment instantaneously 
ensuring the oxygen levels  of  both patients returned quickly  to  within  acceptable 
limits.
In  this  experiment,  oxygen  supplementation  was  administered continuously  up  to 
10L/min to ICU patients with an oxygen saturation level between 91-99%. In the final 
report ICU patients were concordant with the other groups ventilated, however there 
is a concern that positive pressure ventilation may create a falsely positive diagnosis 
of PE as it can improve peripheral penetration of tracer in poorly ventilated areas that  
are associated with reflex vasoconstriction and hypoperfusion not due to vascular 
obstruction.  Clearly,  further  investigation  is  required  to  clarify  this  issue,  as  the 
numbers of subjects in this research were too small to make any definite conclusion. 
TEBA assisted ventilation can be a difficult  procedure and without  being properly 
trained in the use of this apparatus, no medical radiation scientist should attempt to 
disconnect  an  intensive  care  patient  from his  or  her  ventilator.  Once  a  medical 
radiation scientist is trained and has a good understanding of the intubated critical 
care  patient’s  management,  TEBA  can  provide  a  reliable  result  for  the  patient.  
Images from the V/Q scans were reported to be as good as and in some cases better 
than conventional images for these ICU patients.
TEBA has played an important part in diagnosing PE in ICU patients, who previously 
would have been commenced on anticoagulant therapy without  the aid of  a lung 
scintigraphy scan. TEBA provided the group of critically ill intubated patients in this 
experiment a ventilation image that was at least as good as and in some cases better  
than those obtained from the conventional ventilation methods. 
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In conclusion, the ICU intubated patients only had one lung ventilation/ perfusion 
scintigraphy scan using TEBA as they were critically ill and this research could not 
justify these patients returning for a second time. By using TEBA connections and 
removing  the  filter  from  the  tracheostomy  tube,  the  intubated  patients  could  be 
ventilated  with  no  significant  discomfort  or  complications.  Pneumothorax  or 
barotraumas were reduced due to the smaller volume of oxygen or air used during 
TEBA operation. However, TEBA required two medical radiation scientists who were 
both fully trained in the use of TEBA for ventilation scintigraphy.
TEBA has a definite role to play in the management and diagnosis of PE in ICU 
patients.
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Chapter 5 Experiment 4: Technegas at the Cellular Level
Image of Technegas particles inhaled in lung ventilation, taken 
on the JEOL100CX11 Electron Microscope  at Western 
General Hospital, Edinburgh, Scotland.
Studying Technegas at the cellular level is like 
“trying to find a needle in a haystack”
5.1 Introduction
Previous experiments have looked at the chemical nature of Technegas, but to date 
no-one has looked at  Technegas when  inhaled by humans.  In  order  to  give  the 
nuclear medicine community a better insight into the nature of Technegas, we will  
investigate  specimens  of  lung  washings  taken  from volunteer  patients  who  were 
booked in for a routine bronchoscopy.  We will look at Technegas at the cellular level, 
measuring the particles inhaled in lung ventilation. At the same time, we will delve 
into the physics and electron microscopy procedures used to study Technegas.
To examine Technegas at the cellular level proficiently, we need to take a step back 
and examine both the physics surrounding the use of Technegas and the particles of 
Technegas at the microscopic level, in order to give us a broader picture of this ultra-
fine aerosol particle. The work in this chapter will cover both discarded methods used 
as well as potential methods to try to measure the number of Technegas particles 
inhaled into the lung post ventilation, lung deposition and the physics behind Electron 
Microscopy (EM).  Chapter 5 is an extension of previous work undertaken by other 
researchers in this field and was intended to provide new research findings in the 
field of Nuclear Medicine.
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We wish to be able to visualise, using EM, the hexagonal particles of Technegas by 
setting up our own experiment using human lung washings from volunteer patients. 
We will  also try to study the effectiveness of carbon vapour,  which coats smaller 
quantities  of  technetium seen  on  our  EM microtomes.  Finally  using  EM,  we  will  
examine Techegas ultrafine particles, showing the thickness of carbon film.
5.2 What is Technegas
Technegas  is  an  aerosol  consisting  of  a  gaseous  continuous  phase  and  a 
discontinuous phase of individual particles. The discontinuous phase can be either 
solid, liquid or both. There are many terms used to denote different types of aerosols. 
One  term  used  by  Lloyd  (1994)  is  smoke,  which  is  solid  and  derived  from  a 
combustion process. Another term used is mist, which is a liquid process as used in 
Technegas.
The behaviour of an aerosol is dependent on size, shape and composition and the 
collective properties that include: size distribution, number density, etc.
Previous  research  work  on  the  chemical  nature  of  Technegas  proposed  that 
Technegas ultra fine aerosol particles range in size from a few nanometres to a few 
hundred microns. Lloyd (1994) suggests that the lower end of the range of aerosol  
particles represents the transition from molecules to particles, whereas particles of 
the upper end of the scale do not remain airborne for long enough to form an aerosol. 
The  largest  useful  size  for  studies  of  the  lung  is  approximately  10  µm;  inhaled 
particles greater than this will deposit in the upper airways.
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5.3 Aims
In this chapter, we are focussing on lung ventilation, deposition of the Technegas 
particle at both microscopic level, and the physics involved to attempt to measure this 
ultrafine particle.  Regarding Technegas ventilation, we will cover the following topics:
 uniformity of Technegas
Uniformity is the dispersion of Technegas throughout the lungs when a patient is 
ventilated.
 number of particles
The aim of this work was to measure the number of particles, size distributions, and 
regional  lung deposition of  the Technegas.  The Technegas size distribution was 
approximately lognormal with an activity median diameter of 158 nm and a geometric 
standard deviation of ±1.5.  The median size increased with the number of simmers 
and with the time from generation. The increase in size with the number of simmers 
is thought to be due to the increased salt content in the crucible prior to the “burn”.  It 
is also of significance to try to estimate the number of Technegas particles inhaled 
into the lungs.  The predicted lung deposition is 37% in the alveolar region and 5% in 
the bronchial region.  Significant changes in deposition are not predicted over the  
range of particle sizes measured.
 shape of Technegas particles
Senden’s  research  (1997)  suggested  the  active  particle  of  Technegas  was  a 
hexagonal  platelet  of metallic  technetium contained within a thin layer  of  graphite 
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carbon. The average size of the hexagonal platelets was seen to be approximately 
30-60 nm.
 electron  density of Technegas
Graphite is formed by flat hexagonal layers of carbon atoms. The bonding energy of 
two atoms located in the same layer exceeds the same energy for different layers. It  
is interesting to note that the bonding energy for the graphite between atoms in the  
same layer is as strong as the bonding in a diamond structure, although the solidity 
of  graphite,  determined  by  interlayer  bonding,  is  very  low.  All  the  carbon 
nanostructures  known  now  could  be  constructed  from  an  ordinary  hexagonal 
graphene layer. The production method of “Technegas”, discovered in 1984, appears 
to be very similar to the production method of the fullerenes; it has large (from ten to 
one  hundred  nanometers)  carbon  nanocrystals  with  the  metastable  technetium 
atoms inside. Consequently, this substance was the first commercial application of 
the filled carbon structures before the discovery of the fullerene in 1985.
 amount of  Technegas remaining in the lung
This refers to the residual amount remaining post ventilation using Technegas.
Studying Technegas under normal light microscopy and EM
Technegas  cannot  be  visualised  under  normal  light  microscopy  due  to  both  its 
electron density and the size of the Technegas particle.
 Technegas remaining in the sputum post bronchoscopy
It is of particular interest to study Technegas in human volunteers who were already 
consented for a routine bronchoscopy.  Prior to their bronchoscopy, the volunteers 
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will  have a Technegas lung ventilation scan and have Technegas “onboard”. Post  
bronchoscopy, these lung washings and a sputum specimen will be examined and 
prepared  for  EM.  To  date,  previous  research  looked  at  the  chemical  and 
physiological  nature  of  Technegas.   However,  our  work  is  distinctive  in  that  we 
studied Technegas using human subjects. Our study will incorporate physics to try to 
estimate  the  number  of  inhaled  Technegas  particles  into  the  lungs,  study  lung 
deposition, and look at the discarded and potential methods involved.
5.4 Summary of purpose of this research
 to determine the pathway of a commonly used radioactive gas; Technegas 
post inhalation into the lungs.
 to be able to investigate the shape and cellular structure of Technegas.
 Histopathology aims to visualize the body’s  extensive complex systems 
and their interactions as well as various disease states that occur within 
the  human  body.   By  examining  Technegas  at  the  cellular  level,  this 
research aims to ascertain the cellular structure of the Technegas particle 
and density, and will measure the number of Technegas particles. 
 Electron Microscopy (EM) is used for our research of the Technegas ultra 
fine particle as both the resolving power and resolution specified use the 
minimum resolvable distance.
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5.5 Relevant Research
In 1997 in the Journal of Nuclear Medicine, Senden and Burch et al. had written a 
paper on “The Physical  and Chemical Nature of Technegas” and the structure of 
inhaled technetium 99m. The results of this paper showed that the active particle 
Technegas  had  been  identified  as  hexagonal  platelets  of  metallic  technetium 
contained within a thin layer of graphite carbon. The average size of the Technegas 
platelet was 30 to 50 nm. This paper is significant as it gives an explanation for the 
physical structure and approximate size of Technegas.
In 1993 Lemb et al. wrote a paper for the European Journal of Nuclear Medicine on  
particle  structure,  size  and  distribution  of  Technegas.  There  were  many  papers 
written at this time, all looking at the chemical and physical nature of Technegas but 
not the localisation of these particles in human lung tissue. My research was intended 
to provide evidence for this localisation. EM gives detail at the cellular level, which is  
necessary to study the localisation of Technegas particles in lung washings taken 
post bronchoscopy.
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5.6 Funding
To enable this study to continue, Dr B. Elison donated funding for the use of the 
Electron Microscope (EM) at  St.  George Hospital,  Sydney and Western General, 
Edinburgh. EM work of any nature is an extremely costly service.
In  the  first  instance,  Electron  Microscopy (EM) preparation  of  samples  and Light 
Microscopy was achieved at Wollongong Hospital  and EM only undertaken at St. 
George Hospital, Sydney. More extensive EM work was later carried out at Western 
General Hospital, Scotland, which included both preparation and microscopy in the 
one unit. Any funds that were left over from St. George went towards funding the 
research at Western General in Scotland.
5.7 Inclusion / Exclusion Criteria
The study will include twenty (20) adults, eleven (11) male and nine (9) female with a 
mean age of ±48.5 years who were scheduled for a regular bronchoscopy, but will  
exclude children and females who are either pregnant or breastfeeding. 
Ethics: See Appendix B.
The  only  differences  between  patients  in  the  present  study  and  other  patients 
undergoing bronchoscopy will be:
 an additional ventilation lung scan 
 one additional bronchoscopy sample
 a sputum sample.
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I  have  considered  the  radiation  dose  implications  and  am  aware  that  naturally 
occurring background radiation is typically 2-3 mSv per year. The ventilation study 
involves  exposure  to  a  very  small  amount  of  radiation,  estimated  at  
0.6 mSv (IRCP 80), which is a fraction of the background dose. To date there have 
been no studies of the radiation dose to the lungs post ventilation of Technegas. In  
an effort  to quantify this dose, the use of microscopy is required to  examine the 
bronchial and sputum samples post ventilation and the bronchoscopy procedure.
Ethical considerations necessary for this research include: Informed Consent with a 
statement that includes an explanation of the purpose of the research, the expected 
duration  of  the  patient’s  participation,  and  a  description  of  the  procedure  which 
includes a small amount of radiation, an additional lung washing/lavage sample at 
bronchoscopy, and a sputum sample post bronchoscopy. 
5.8 Physics behind EM and Technegas Particles
In order to study EM, we need to look at the structure of the Electron Microscope and 
the physics it entails. In this section, we will look in more depth at the relationship of  
Technegas encompassing particle structure, measurement, deposition, and particle 
clearance under the following headings:
1. What is Electron Microscopy
2. X ray generation and emission in thin films
3. Spatial resolution and EM
4. Detection of X-rays in EM
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5. Estimation of number of particles
6. Lung Deposition
7. Measuring particles of Technegas
8. Senden & Burch’s study on formation of Technegas
5.8.1. What is EM 
Figure 5.1 An Electron Microscope
Electron  Microscopy (EM) involves  the  passage of  a  high-velocity  electron  beam 
through our specimens that are thin enough to transmit at least fifty percent of the 
incident electrons. The emergent beam of transmitted electrons is then refracted by a 
system of lenses to form a magnified, two-dimensional image of our specimens.
A tungsten filament or cathode in an evacuated tube is heated, thus producing the 
electron beam. Electrons being attracted to the anode pass through a small hole, 
causing an increase in energy known as kinetic energy. Electromagnets focus the 
electron beam onto a specimen causing a small amount of kinetic energy to be lost 
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due to the interaction with the specimen.  As the electron beam passes through the 
specimen,  electrons  encounter  the  electromagnetic  fields  of  many  extra 
electromagnets, directing the electron beam onto a fluorescent plate.  When beta 
particles (electrons) bombard a specimen, electrons are emitted and this beam is 
analogous to a diffracted light ray, whose intensity is a direct function of the electrons’ 
kinetic energy (Slayter & Slayter, 1992).
The major systems in EM are:  an illuminating system,  comprising of a source of 
radiation, a condenser lens assembly that focuses the “illuminating beam” onto the 
plane of our specimens, and after passing through the specimen, the beam enters 
the imaging system. This consists of a number of lenses, which together produce the 
final magnified image. The lenses are known as the objective lens, which produces 
the intermediate image, and the projector lens, which produces the final magnified 
image  of  the  specimen.  The  images  can  then  be  viewed  and  recorded 
photographically; this represents the images translated by EM (Chescoe & Goodhew, 
1984).
EM is used in our study to examine lung and sputum samples using high-energy 
electrons; this feature makes microanalysis of small known volumes straightforward. 
EM uses electrons instead of light to visualize small objects; therefore the resolution 
is  increased  relative  to  the  shortness  of  the  wavelength  of  the  electron  beams. 
Instead of lenses, electrons are focused by electromagnetic fields and form an image 
on a fluorescent screen (Chescoe & Goodhew, 1984, Conn,1990).
The tissue surface of the lungs once resolved is approximately two hundred microns 
(200  μm),  which  is  seen  as  a  stereo  view  due  to  the  large  depth  of  focus  
(Conn,1990). Taking two images from different angles gives better images; also tilting 
the specimen of lung or sputum may give greater detail in the depth of concavity.
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The lung,  as it  is  an  organ of  many shapes,  is  ideally  suited  for  EM and direct  
visualization of a three dimensional ultra structure is helpful for a patient’s diagnosis. 
EM depends either on determining the intensity of a secondary effect excited within 
the  specimen  or  on  the  measurement  of  some  change  in  the  primary  beam of 
electrons after it has interacted with the specimen (Koehler, 1973). A primary electron 
beam  of  energy  may  excite  Auger  electrons  or  x-rays  from  the  specimen  and 
subsequent  beams below the  specimen will  contain  electrons  which  have  lost  a 
characteristic amount of energy. Also excited from the specimen will be secondary 
electrons which  could  be used for  Scanning Electron  Microscopy (SEM) imaging 
(Rios et al., 1992).
In EM, the radiation source is a beam of electrons, which is produced by an electron 
gun.  This  consists  of  a  tungsten filament,  enclosed in  a  metal  casing  called  the 
cathode shield, and an anode plate. Both the cathode shield and the anode plate  
have central  apertures, which are centrally aligned with  the tungsten filament tip.  
Electrons are produced by passing heated current through the filament. The small 
difference in voltage between the filament and the cathode shield deflects electrons 
away from the walls of the shield and they form a cloud of electrons near the cathode 
shield aperture. Electrons are propelled down the column by the vast difference in 
voltage between the filament (-20 to-100kV) and the anode plate is a zero potential.  
This difference in voltage is called the “accelerating voltage”. The lenses are electro 
magnetic and a current passing through the coil creates a magnetic field, which has 
the ability to deflect electrons. To focus an electron beam onto a given plane, the 
current passing through the coil is changed (Slayter & Slayter, 1992). 
In EM the absorption of electrons by a specimen of usable thickness is very small,  
and the image is formed partly by electrons that have passed through the specimen, 
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and partly by electrons being scattered by the specimen. The majority of electrons 
pass through the specimen without deviation but some are deflected by electrons 
orbiting atoms in the specimen and within the atomic nucleus itself. This all forms a 
pattern, which is transformed into an image on the fluorescent viewing screen, as 
electrons bombarding the screen produce a visible fluorescence, and areas which 
have been deflected remain dark (Stradling,1990).
5.8.2 Apparatus used in EM
EM consists of three main parts which are the Vacuum system, the Electrical System 
and the microscope column. We will discuss these separately:
a) Vacuum system
This is necessary because electrons can only travel a few millimetres in air before  
they  collide  with  gas  molecules.  As  most  electron  microscope  columns  are 
approximately a metre in length, the air must be evacuated. The vacuum maintained 
in an electron microscope is approximately 1 x 10-4  mmHg and at this vacuum the 
electrons  can  travel  about  2.5  metres.  In  low vacuum conditions,  the  life  of  the 
filament  is  reduced  due  to  oxidation  of  the  tungsten  atoms;  this  oxidation  also 
decreases the efficiency with which the filament can emit electrons (Somlyo, 1986).
To obtain constantly high vacuum, rotary oil diffusion pumps are used. A series of air  
locks is introduced into the system at key areas to prevent long periods of time being 
spent  on  ventilating  and  re-evacuating  the  column.  These  air  locks  are  usually 
located around the specimen and camera areas. During operation, the oil diffusion 
pump generates a great deal of heat so is cooled by a water jacket cooling system 
(Somlyo,1986, Stradling,1990).
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b) Electrical System
This consists of a high-tension (HT) unit, a lens current supply unit, and voltage and 
lens current stabilizing units. The high - tension unit usually operates at between –
20kV and –100kV. This unit is used to accelerate the electrons. The lens current 
supply unit provides power to the electro-magnetic lenses and the current must be 
stable because any fluctuation in results will mean a loss in resolution. The voltage 
and current stabilizers maintain this degree of stability. The power for the auxiliary 
supplies vacuum pumps and switch circuits.
c). Microscope column
This consists of an evacuated metal tube in which are aligned, one under another the  
filament enclosed in the cathode shield, the anode plate, various electro-magnetic 
lenses, viewing screen and a photographic plate.
The first magnetic lens focuses a beam of electrons emerging from the filament; the 
condenser lens reduces the diameter size of the electron beam from approximately 
fifty microns to approximately one micron and this small diameter beam is projected 
onto a specimen by the second condenser lens. Below the two condensers lenses is 
the specimen holder, which can be manipulated by external controls in two directions, 
giving access to any part of the grid (Stradling,1990).
The  objective  lens  transforms  the  electrons,  which  have  been  scattered  by  the 
specimen into an image. The objective lens also determines the resolution of the 
microscope, and it is at this intermediate stage that electron optical aberrations such 
as astigmatism, diffraction and distortion are significant  since they will  be greatly 
magnified as the final image is formed. The depth of focus for the objective lens is  
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constant and varying the voltage current through the lens only serves to focus the 
specimen (Slayter & Slayter,1992).
The “projector lens” now magnifies the image. Increasing the current through this 
lens increases the magnification. Most modern transmission electron microscopes 
operate with a three- lens projector system, a diffraction lens, an intermediate lens 
and a projector lens.  The projector  lens current  is kept constant and varying  the 
current  to  the  other  two  lenses  determines  the  magnification.  Switching  the 
intermediate  lens  off  and  varying  the  current  of  the  diffraction  lens  adjusts  the 
magnification  from 3,000 to  18,000.  Turning the  current  of  the  diffraction  lens to 
maximum  and  varying  the  current  to  the  intermediate  lens  increases  the 
magnification from 20,000 to 500,000. The projector lens has a depth of focus of 
several metres, so the positions of the viewing screen and the photographic plate are 
not critical (Slayter & Slayter,1992).
The viewing screen is coated with a fluorescent material which when bombarded with 
electrons, fluoresces in the visible range. An image of the specimen is produced onto 
the screen.  Due to  the grain  size of  the fluorescent  material,  the best  resolution 
achieved  on  the  screen  is  about  35  microns.  Photographs  are  generally  taken 
because more detail  is  recorded on fine grain  photographic material  than on the 
viewing screen. Photographs are recorded by lifting the viewing screen and allowing 
the electrons to bombard the electron–sensitive photographic emulsion. Resolution 
achieved with modern transmission has been approximately 0.2 nanometres using 
crystalline material and between 1 and 2 nanometres is the upper limit for biological  
material (Slayter & Slayter,1992).
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5.8.2 X-Ray Generation and Emission in Thin Films
The spectrum of x-rays emitted from a thin specimen which is irradiated with a high 
energy  (>10KeV)  beam  of  electrons  will  consist  of  a  series  of  sharp  peaks 
superimposed  on  a  non  flat  background  of  continuous  radiation  known  as 
Bremsstrahlung (Slayter & Slayter,1992, Rios et al, 1992). For a thin film, very little  
energy is lost in the specimen and we can assume that the ionization cross–section, 
which is the probability that an electron will eject a particular inner shell electron, is 
consistent  throughout  the  specimen  thickness.  This  is  known  as  “the  thin  film 
criterion” and from this we can deduce the intensity of a characteristic peak from 
element  A  (Chescoe  &  Goodhew,  1984,  Conn,  1990).  In  order  to  calculate  the 
number of X-ray photons per incident electron, we will use the following formula:
X-ray photons per incident electron IA = pBN C  A    ωK Q 
AA
Parameters:
ω = Fluorescence yield
Q = Ionization cross-section, small area for high energy electrons
IA = Measured characteristic x-ray intensity
P = Density
B = Backscatter
N = Avogadros Number
CA = Concentration of element A by weight
AA = Atomic weight of element A
K = Correction factor
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Using low voltage,  EM may improve  the  contrast  of  our  bronchial  washings  and 
sputum specimens as increased inelastic scattering at lower energies increases the 
contrast at the same time. This method is accomplished by decelerating electrons 
before they impinge on our specimen, then accelerating the electrons again after 
scattering past the specimen (Koehler,1973).
Electrons interacting with Technegas bronchial washing specimens and sputum will  
be scattered over  an angular range depending on the mass and density of  each 
specimen.  To prevent  the electrons recombining,  an objective  aperture is  preset, 
thereby stopping the electrons.
It  has  been  observed  that  beyond  a  certain  level  of  enlargement,  the  useful 
magnification is exceeded, therefore the main purpose of microscopy is to obtain 
detail not perceived by an untrained eye.  Specifically, resolution is achieved when 
two or more points can be distinguished as separate points, also known as spatial  
resolution (Crang & Komparens,1988).
5.8.3 Spatial Resolution and EM
There have been limited experimental results to date to enable comparisons. It has 
been seen that scattering of electrons within the specimen will  give rise to beam 
spreading. What is clear, is how to define the magnitude of beam spreading, and 
what  proportion  of  electrons or  x-rays  generated are  to  be  included.  This  is  still  
unresolved; however Goldstein et al. (1977) assume that all scattering takes place at  
mid plane of the specimen (Chescoe & Goodhew,1984). To minimize the effect of 
spreading,  we  need  a  very  thin  sample  of  low  atomic  number  and  density,  and 
analysis should be at the highest practicable voltage.
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5.8.4 Detection of X-rays in EM
In EM, the operator must maximize the collection efficiency in order to improve the 
detection limits for a small  concentration of an element in a specimen of lung or  
sputum.  The  closest  distance  for  the  detector  in  EM  is  about  20  mm,  giving  a 
collection  efficiency  of  less  than  one  percent,  assuming  x-rays  are  emitted 
isotropically.  When the  electron  beam is  being  scattered  by  the  lung  or  sputum 
sections, the main effects are:
1) Backscattering of the electrons onto the lower condenser pole piece.
2) Fluorescence by x-rays generated onto the specimen at the region being 
studied.
5.8.5 Estimation of number of particles
Particle size and the number of particles do affect the site and amount of particle 
deposition in the lungs as well as the subsequent clearance times, which is why it is 
important to include this measurement in our research.
According to Senden and Burch in 1997, the behaviour of aerosols is dependent on 
particle size,  shape, composition and the collective properties which include size 
distribution, number density etc. The size of a Technegas particle ranges from a few 
nanometres to a few hundred microns. The lower end signifies the transition from 
molecules to particles, whereas the upper end does not remain airborne long enough 
to form an aerosol. According to James and Brown in 2002, 10 μm is the largest 
useful  size for studies and anything greater than this deposits itself  in the upper 
airways.
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Research  by  Amis  and  Crawford  et  al.  (1990)  suggests  particle  distribution  is  a 
statistical progression and the number of particles has to be large enough to achieve 
the minimal variance. If the particles are randomly located, the density is Poisson 
distributed and the variance is  equal  to  the number of  particles counted.  Activity 
concentration may also be measured.
This chapter reviews the nature and characterisation of Technegas and its deposition 
into  the  lungs.  We  study  the  structure  of  Technegas  with  the  aid  of  Electron 
Microscopy  and  observe  the  clearance  from  the  lungs.  This  work  has  also 
investigated  the  number  of  particles  in  Technegas,  a  technetium -99m ultra  fine 
aerosol.  Brown (2002)  reported  that  dosimetry  research of  ultrafine particles  and 
particle numbers in humans has being very poorly characterised. Determining the 
number of particles may give an idea of how much aerosol is inhaled by healthy 
subjects compared to subjects with obstructive lung disease. 
Brown  (2002)  studied  both  the  deposition  and  clearance  rate  of  aerosol  in  both 
healthy and CAL subjects and reported that relative to healthy subjects, patients with 
moderate to severe CAL received a higher dose from ultrafine particle exposure. 
Brown  (2002)  also  noted  that  lung  clearance  did  not  statistically  differ  between 
healthy and CAL subjects. 
An article by Weibert in 2006 further suggests that there is a fast and substantial  
uptake of particles in the lung.  Weibert  studied 15 healthy subjects who inhaled 
Technegas particles of 100 nm in size. Radioactivity over the lung was studied for a 
period of 70 hours. The clearance of these ultrafine particles from the lungs was also 
measured.  Lung  retention  at  46  hours  was  mean  SD  ±  99.4%  and  cumulative 
leaching of 99m technetium from the particles 2.6 ± 0.96% at  70 hours. Weibert 
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concluded  that  there  is  no  evidence  of  quantitatively  important  translocation  of 
100nm particles to the systemic circulation from the lungs.
According  to  Lloyd  (1994),  an  aerosol  is  a  two  phase  system  consisting  of  the 
gaseous or continuous phase and a discontinuous phase of individual particles. The 
characterisation of an aerosol is therefore dependant on both the individual particle 
properties and the collective properties such as size distribution, number density etc.
A Technegas aerosol particle ranges in size from a few nanometres to a few hundred 
microns.  Senden  and  Burch  (1996)  identified  the  size  of  Technegas  particles  or 
aggregates to be a log-normal distribution ranging from 30 – 60 nm in width and 
approximately 5 nm in thickness, with 80% of particles being below 100 nm.
5.8.6 Lung deposition
The  lung  deposition  (DF  =  1-  exhaled  activity  divided  by  inhaled  activity, 
respectively) affects both the tissue dose to the airways as well as the mucociliary 
clearance  rate,  the  normal  being  3  mm/ml/minute  (Lloyd  1996).  Half  life  (the 
biological half-life is the time taken for half of a radioactive material present in a body 
as a result of inhalation to be eliminated) for mucociliary clearance studies depends 
on the site of particle deposition; approximately an hour for central airways and three 
hours for peripheral deposition. Due to a number of factors such as non–specificity 
of the measurement of particle sizes for different diseases, variables in particle size 
and  inhalation  techniques,  mucociliary  clearance  studies  are  not  widely  used  in 
clinical practice. In retrospect, mucociliary clearance studies have been used for a 
variety of respiratory diseases as sarcoidosis,  pneumoconiosis etc.  and therefore 
papers on the usefulness of clearance studies have been published.
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There is a notable decrease in the speed and clearance capacity of mucous as the 
airways narrow towards the lung periphery due to the diminished cilia in this region. 
Therefore the rate at which mucociliary clearance occurs will depend on the rate of 
inhalation from the patient, the site of deposition of the particles and their size. CAL 
and patients with a respiratory disease will have a reduced clearance due to excess 
mucous production and limited cilia motility as Technegas does not diffuse through 
the alveolar capillary barrier and the only limiting factor for image acquisition is the 
half- life.
Mucociliary  clearance  is  impaired  in  stable,  acutely ill  patients  with  no  airway 
manipulation  and  correlates  with simple  markers  of  underlying  disease  severity. 
Mucociliary dysfunction may help to explain the increased susceptibility of hospital-
acquired respiratory infection in critically ill patients (Laghi, 1995). 
Dose rate of technetium: this is calculated by DR = DF multiplied by the minute 
ventilation multiplied by concentration which is a measurement of 10μg/m3; it is used 
for health epidemiological studies to aid in ambient particulate exposure increments 
of ultra fine particulates (Lloyd 1996).  Dose rates are calculated to give an estimate 
of the ultra fine particle mass that would be deposited per hour in the lungs. Browns’ 
research  paper,  Ultrafine  Particle  Distribution  and  Clearance  in  Healthy  and  
Obstructed Lungs (2002), reported that 54% higher dose rate was found in Chronic 
Airway Limitation (CAL) patients than in healthy subjects (p=0.02).
Previous research has shown that pulmonary particle clearance is similar between 
CAL and healthy subjects.  In 2002 Brown estimated 85% particle retention at 24 
hours post deposition.  Isotope leaching would not cause differences between the 
two groups of CAL and healthy patients. According to Miller and associates in 1995, 
ventilation  is  reduced  to  obstructed  regions  while  healthier  regions  receive  the 
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balance of ventilation and associated particle exposure. The pattern therefore is less 
uniform in CAL subjects than in healthy ones.  Miller and associates assumed that a 
quarter of  the parenchymal  lung in CAL patients might receive all  the deposition 
normally distributed across the full parenchymal lung. By using this approximation 
and the dose rate, the parenchyma in CAL patients would receive a 600% greater  
dose than the tissues seen in the normal healthy lung.  The increased surface dose 
in  CAL  subjects  may  elicit  an  inflammatory  response  with  systemic  effects  as 
described by Seaton, et al. (1995).
Other  research  has  proposed  that  ultra  fine  particles  in  the  circulation  may 
accumulate in other organs such as the liver. Brown (2002) found no accumulation in 
the liver or other organs.  Any activity seen in the liver may be due to scatter from the 
lung and can also include overlap of the lung parenchyma in the liver region.
To measure particles in Technegas aerosol, a large number of particles have to be 
“measured” not  calculated and placed into size-range intervals to produce a size 
distribution. A size histogram may be used where the height of each bar represents 
the number of particles, n1,  in each size (diameter) range, r1. Aerosol particle size 
distributions  are  regularly  skewed  and  cover  a  large  range  of  sizes  and  so  a 
geometrical progression of size intervals is often used. If there is a limit of a small 
size interval, a continuous size distribution function, n(r), is acquired. If a log scale is 
used, the ordinate scale is transformed to represent the number of particles in each 
log size interval (dn/dlogr). Therefore particle size distribution can be measured by 
using the average size and spread of sizes. If a size distribution is normal, then it can 
be completely described by the mean and standard deviation (Gosling, 1998).
Technegas aerosol distributions are almost certainly skewed; having a longer tail at 
the larger particle size and so using a log distribution will result in a reasonable fit 
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(see Poisson Distribution in figure 5.2). Fitting these functions to size distributions 
provides a  suitable  means  to  summarise  the  distribution.  In  normal  distributions, 
particles  lie  within  95%  within  2  standard  deviations  of  the  mean.  In  normal 
distributions,  the aerosol  approaches monodispersity  as i  approaches 0,  however 
log–normal distribution of a monodisperse aerosol is defined as:   i lg = 1.
When investigating a radio – aerosol activity size distribution, a(r) is significant. This 
is derived as the integral divided by the known size interval, giving the fraction of the 
total  activity  contained  within  the  size  range.  Size  distributions  are  defined  as 
da/dlogr (r), giving the fractional activity per unit log size interval as a function of size  
or diameter (Gosling, 1998). The activity median diameter separates the activity size 
distribution into halves; half being contained within the larger particles and the other 
half  within  the  smaller  particles.  If  the  relationship  between  Technegas  and  the 
particle  size  is  known,  the  distribution  can  be  measured  from  the  number  size 
distribution.
Sites  of  deposition  of  inhaled  Technegas  are  important  to  study  for  diagnostic 
purposes.  Technegas  particle  deposition  on  airway  surfaces  occurs  by  inertial 
impaction, gravitational sedimentation and Brownian diffusion. For effective delivery 
of Technegas to the lungs, detailed knowledge of Technegas deposition is necessary 
within the lung. Deposition measurement of Technegas is complex, and assumptions 
are made that  the proportion deposited in the alveoli  is  distinguishable from that 
deposited in the airways, as this is a slow cleared alveolar or bronchial compartment.
Technegas particles with sizes between 0.05 - 2 μm have a somewhat low bronchial  
deposition and reasonably higher alveolar deposition, making this level suitable for 
lung scintigraphy. Deposition of smaller particles (1 - 2 μm) will be due to the effect of 
impaction  and  susceptible  to  airway  diameter  and  the  velocity  of  the  patient’s 
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Technegas inhalation technique. Particles of 0.1 μm or less will be deposited by the  
process of diffusion and are therefore far less sensitive to alteration.
Gosling (2002) suggests that a patient’s changing inhalation pattern of Technegas 
and image differences seen with a wide variety of disease patterns, mathematical  
models have the advantage of being able to see differing figures for the deposition of 
particles at each stage of division of the bronchial tree.
5.8.7 Variations in deposition with particle size
A  semi-empirical  model  of  deposition  in  the  respiratory  tract  as  presented  by 
Stahlhofen et al. in 1989 is based on a wide ranging survey of experimental data and 
predictions  from  theoretical  models.  The  model  yields  analytical  expressions  for 
deposition in different functional regions. This allows extrapolation of experimental 
data to particles of any size and density and any breathing pattern. We have used 
this  model  to  predict  the  variation  in  deposition  with  particle  size,  assuming  an 
inhalation  pattern  typical  for  the  conventional  breathing  method  (a  slow  deep 
inspiration from functional residual capacity with a breath hold; inhaled volume 2.5 
litres, inhalation rate 400 cc/sec with a 5 second breath hold).
Lloyd  (1994)  explains  the  modelled  deposition  in  the  alveolar,  bronchial  and 
extrathoracic regions as a function of particle size (assuming spherical particles of 
unit density). It can be seen that particles with sizes between approximately 0.05-
2µm  have  a  relatively  low  bronchial  deposition  and  a  reasonably  high  alveolar 
deposition.  This  range  should  therefore  be  suitable  for  ventilation  imaging,  and 
outside  this  range,  unacceptable  bronchial  deposition  may  occur.  The  model  by 
Stahlhofen (1989) was derived from studies in normal subjects as it is important to 
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consider the effect of airways narrowing in disease. Deposition for particles in the 1-
2µm range will be largely due to impaction and therefore site deposition is likely to be 
sensitive to changes both in the airway diameter and in inhalation velocity. Particles 
of 0.1µm and less will  deposit mainly by diffusion and should be less sensitive to 
changes.
5.8.9 Formation of Technegas (Senden & Burch)
Since  Technegas  invention  in  1986,  there  have  been  several  papers  written  on 
investigations of this agent, studying particle size and composition of Technegas. 
The study conducted by Senden and Burch et al. in 1996 investigated the formation 
of Technegas and is based on the chemistry and structure of the particle.
Method: 0.1ml of solution that ranged in concentration from 10 -2 to 5 x 10-6 mol/ L-1 
was added to the crucible. Aerosol was collected by electrostatic precipitation on a 
copper EM grid supporting holey carbon films immediately post generation. Residue 
was also scraped off the surface of the crucible and the entire gray residue within the  
crucible removed. 
This powder was transferred as a suspension under ethanol to reduce any dispersal  
of the powder occurring. The suspension was then transferred to a quartz plate and 
moistened with five (5%) percent ethylene glycol in ethanol to act as a binder. Both 
aerosol and powder from the residue left in and outside the crucible were examined, 
using  different  techniques  such  as  diffraction  studies  as  well  as  SEM,  EM and 
energy–dispersive x-ray analysis EDXA.
Results:  Aerosol  results  from  the  investigators’  experiments  showed  hexagonal 
platelets. EM showing particles larger than a few hundred nanometers were rare and 
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most  appeared  to  be  less  than  one  hundred  nanometers  (100  nm)  as  this 
experiment used higher crucible loadings than in a clinical situation. In this case the 
distribution was around thirty to sixty nanometers (30 - 60nm) in diameter. This size 
also corresponds to a study by Lem and Oei in 1993. Electron diffraction proved the 
Technegas particle consists of a native metal. Crucible residue under EM showed 
half micron sized technetium particles distributed over the interior of the crucible with 
some concentration  around the  rim of  the  crucible.  The particles  were  spherical 
which included a technetium-rich centre surrounded by carbon. The carbon is thin 
enough for the electrons to penetrate and scatter from the metal centre.
Conclusion:  Senden  and  Burch’s  research  showed  that  the  formation  and 
stabilization  of  the  active  particle  in  Technegas  is  dependent  on:  a  chemical 
reductant,  a  volatile  substrate  and  component,  and  surface  passivation  of  the 
resultant  aerosol.  The  reduction  of  carbon  occurs  at  the  crucible,  temperatures 
above the melting point for technetium - 2250°C, cause the vapour pressure in the 
metal to increase. Once in the vapour phase, technetium will condense and collect in 
the chamber as a metallic aerosol. It is at this stage that technetium particles form 
the hexagonal platelets.
The effectiveness of carbon to passivate the available metal surfaces at high crucible 
loadings indicates that there is carbon vapour present to coat the smaller quantities  
of technetium present in clinical loads. Carbon film thickness is on average a few 
nanometers, seen on EM images; the carbon therefore appears to form a coherent 
layer around the whole metal surface. The carbon film also protects the condensed 
technetium metal from reoxidation.
Some researchers have thought that Technegas contained radio-labelled fullerenes 
or “bucky balls”, such as C60 and C70. Research by Senden and Burch (1997) has 
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shown this not to be the case, as technetium aerosol can be accounted for as a 
hexagonal platelet. The comparative volumes of a fullerene with an average platelet 
would mean that a fullerene species would have to be the active Technegas species 
and  it  would  have  to  exist  in  populations  around  a  million  times  the  number  of  
observed platelets. Secondly, according to Senden and Burch (1997), the conditions 
are far from optimal for the efficient production of fullerenes. Particle size, if spherical 
in shape, can be defined by its diameter or radius. Spherical particles are usually 
found in aerosols,  whereas solid particles have different shapes as plate shaped. 
Agglomerations or clusters of Technegas particles make different shapes, which can 
be very complex where differences in size of the particles are seen. If particles have 
a well-defined shape we can then determine surface area and volume, and if density 
is known, particle mass can then be defined.
5.9 History of Microscopy
In ancient Roman times, people used magnifying glasses to observe an image. It 
was not until 1590, that two magnifying glasses were used in succession to enable 
better visualization of an object. From the 1590s until the 1930s, a microscope was 
described as an apparatus in which light was focused by using curved glass surfaces 
or mirrors to form enlarged images (Slayter & Slayter, 1992).
De Brogli, Schrodinger, Ruska, Avagadro and Rutherford made a dynamic impact on 
science and pre-empted the introduction of  Electron Microscopy (EM) in  the  20 th 
century. EM has increased in popularity from the 1950s onwards as specimens could 
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be resolved in the order of atomic dimensions. Only in recent times has its popularity 
declined due to the cost of using EM.
Ernst Ruska designed the first electron microscope in 1933 and studied the flow of  
electrons in a sealed vacuum. Ruska proved that electrons would flow in a straight 
path if a sealed vacuum was maintained to stop electrons moving around. Electrons 
were projected onto a screen, below which the image was formed so that specimens 
could be examined. 
Later  in  1941,  American  engineers  advanced  the  microscopic  magnification  ten 
thousand (10,000) times.  EM images produced detailed structures of the specimen 
by using a short wavelength of electron beams measuring approximately 5 nm to 
increase the resolving power, as is practiced today in the 21st century (Saxton,1978).
In 1924 DeBroglis theory demonstrated material particles in the form of waves, and 
today we use DeBroglis theory for the electron beam in terms of ray paths. Later, 
Schrodinger’s Cartesian coordinates (x, y, z) were seen to measure electrons moving 
in a linear momentum but Schrodinger neglected to mention the existence of spin or 
the  angular  momentum  of  electrons  at  the  time  of  his  research  (Slayter  & 
Slayter,1992). 
Rutherford’s  “Scatter  Law”  was  calculated  by  the  fraction  of  incident  electrons 
scattered  through  a  thin  film  of  thickness,  enabling  us  to  determine  Avagadros 
number, which is the number of atoms per cubic centimetre exposed to the electron 
beam. It is clear that to produce EM, we must have high velocity electrons passing 
through a thin specimen, enough to transmit at least 50% of the incident electrons.  
The emerging electrons are refracted by a series of electromagnets, forming a two-
dimensional image of the specimen. The resolving property is an instrument property, 
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specifying  the  smallest  point  a  microscope  can  resolve.   The  related  quantity 
resolution  is  the  amount  of  detail  in  the  image  of  the  specimen and  requires  a  
satisfactory resolving power,  which  is  dependent  on contrasting a combination of 
properties of both the microscope and the specimen (Slayter & Slayter,1992).
5.10 Physiology of the Lung
To gain a better understanding of the physiology taking place in the lungs, we will  
study both upper and lower respiratory tracts and the dynamics involved.
5.10.1 Upper Respiratory Tract (URT)
As mentioned  in  earlier  chapters,  respiratory  gas  exchange  occurs  in  the  lungs, 
which are always in a state of partial inflation, achieved by the rigidity of the chest 
wall.  Negative pressure occurs between the outermost surface and inner wall of the 
thorax. Visceral fluids coat the two surfaces, the viscera and pleura, thus achieving 
movement of the lungs (Barnes & Stockley, 1994).
The main purpose of the respiratory passages is to deliver inspired air to the gas 
exchanging or respiratory area of the lung. Exchange of gases between air and blood 
commences in the lung acinus which is made up of bronchioles and alveolar ducts 
(Ramzi et al, 1994). The trachea, as discussed, penetrates each lung leading onto 
the mainstream bronchus which branch by “dichotomy”, progressively reducing their 
dimension.
Airways  work  to  a  structural  hierarchy  directly  related  to  ventilation  and  gas 
exchange.  The  acinus  is  the  complex  of  all  airways  lying  distal  to  the  terminal  
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bronchiole and served by a first order respiratory bronchiole. In gas exchange, this is 
the largest unit. Branching of airways commences with a parent branch, which in turn 
gives  rise  to  two  smaller  daughter  branches.  These  branches  are  known  as 
functional  zones,  which  are  the  number  of  branches  which  progressively  by 
generation travel down the inverted tree. In all, there are 23 levels, the trachea being 
zero,  bronchi  –  bronchioles  –  terminal  bronchioles  consist  of  16  levels.  The 
respiratory bronchioles – alveolar ducts – alveolar sacs are located at levels 17 to 23.  
The  number  of  branches  used  is  always  twice  the  number  seen  in  the  parent  
generation, a consequence of dichotomy (Barnes & Stockley, 1994).
The pseudo – stratified ciliated columnar epithelium lining the nasal passages is also 
known  as  respiratory-type  epithelium.  The  nasal  vestibule  contains  keratinizing 
stratified squamous epithelium.  Squamous epithelium dominates in the oropharynx,  
vocal cords and anterior margins of the epiglottis.
Mucous functions mainly  to  warm and humidify  air,  and acts  as an immunologic 
defence  and  a  ciliary  cleansing  mechanism  against  infective  and  inert  particles. 
Lastly, via the olfactory epithelium, mucosa provides a sense of smell.
The  conchae  or  mucoperiosteum  are  contiguous  with  underlying  bone.  The 
respiratory mucosa is modified so the lamina propria or subepithelial tissues are filled 
with fibrous and elastic tissue mixed with seromucous glands and dilatable vascular 
sinuses that contribute to the warming of air.  Mucous is made up of viscous fluid 
containing glycoproteins which line the respiratory tract to the distal bronchus.  Cilia  
moves mucous in the direction of the pharynx, where it is swallowed or expectorated. 
The serous component contains immunoglobulins, lysosomes and enzymes directed 
against  bacteria.   Defence mechanisms of  the URT are lymphoid tissue seen as 
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single  cells  of  focal  collections  containing  lymphoid  follicles  (Barnes  &  Stockley,  
1994).
The larynx is cartilage, its upper end being the epiglottis.  Within the lumen of the  
larynx,  the  vocal  cords  are  situated,  also  known  as  folds,  covered  by  stratified 
squamous  epithelium  also  seen  on  the  lingual  and  laryngeal  surfaces  of  the 
epiglottis.   All  the  surfaces  are  of  pseudostratified  ciliated  columnar  epithelium. 
Elastic cartilage forms the basis of the epiglottis and provides elastic recoil of the 
organ post-swallowing.
Hyaline cartilage of the trachea assists in keeping the airways open.  Posterior ends 
consist of smooth muscle, which complete the encirclement of the lumen (Barnes & 
Stockley, 1994). 
During forced respiration, the fibroelastic tissues located between the cartilage and 
smooth muscle allow tracheal movement in both diameter and length. 
The major feature of the tracheal  mucosa or respiratory epithelium is the ciliated 
columnar cells and mucous secreting goblet cells.  Brush cells with apical micro-villi,  
and roundish brush cells represent stem cells or cells containing submucosa with 
elastic fibres. The respiratory epithelium of the trachea does not participate in gas 
exchange but does coat the surface with a viscous film produced by the goblet cells 
and excreted by ducts emptying the submucous glands.  This fluid contains mucins,  
immunoglobulins,  lysozymes and antiproteases,  which  disable  bacterial  functions. 
All other inhaled particles are moved via ciliary action towards the pharynx.  Where 
the trachea bifurcates the primary bronchi are formed, and their structure is similar to 
the trachea (Barnes & Stockley, 1994).
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5.10.2 Lower Respiratory Tract (LRT)
The  lower  respiratory  tract  (LRT)  causes  the  gradual  reduction  in  diameter  and 
multiple branching of the bronchi and bronchioles. Both have clusters of alveoli, and 
depending on location, there may be between 8 and 25 generations of branching 
within  the  bronchial  tree.  A  healthy  pair  of  lungs  has  a  combined  volume  of 
approximately  2.5  litres  at  rest  of  which  6  litres  accounts  for  the  total  amount 
expandable with maximum inspiration.  Lung histology shows a sponge-like structure, 
of which all the blood vessels and bronchial tree amount to 10% of the total lung 
volume.   The  remainder  is  dedicated to  respiratory  function  (Barnes & Stockley, 
1994).
Lung histology commences in the bronchus and terminates at the alveolus.  The 
bronchi contain cartilage while bronchioles lack cartilage, instead comprising smooth 
muscle walls.  Blood vessel inner lining is squamous endothelium and respiratory 
bronchioles have out-pockets of alveoli.  Alveoli are clusters of sacs arranged along 
the  respiratory  bronchioles  (Barnes  &  Stockley,  1994,  Davies  &  Moores,  2003). 
Squamous cells line the alveoli commencing with epithelial lining of the bronchial tree 
following simplification and reduction in height.
The bronchus is made up of  respiratory mucosa and islands or cusps of hyaline 
cartilage, similar to the trachea.  Elastic fibres are found in the lamina propria and 
submucosa; seromucous glands empty secretions into the bronchial epithelium via 
collecting ducts.  On the epithelium these secretions mix with mucin secreted from 
the epithelium goblet cells.  The mucoid layer produced contains immunoglobulins 
and  antibacterial  substances.   Mucosa  is  kept  wet  and  traps  particulate  matter. 
Lymphoid cells occur in the lamina propria and submucosa. Oxygen molecules reach 
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the alveoli by convection or mass air-flow and molecular diffusion within the air phase 
(Barnes & Stockley, 1994, Davies & Moores, 2003).
The bronchioles are the final conducting portions of the airways and lie between the 
larger  airways  containing  submucosa,  cartilage and alveoli,  where  gas exchange 
occurs.  Bronchioles  are  usually  less  than  one  millimetre  in  diameter  and  lack 
cartilage and submucosal glands. Rather incomplete bundles of smooth muscle form 
a circle around the mucosa. The epithelial lining is simply columnar cells becoming 
cuboidal as the bronchioles decrease in size; ciliated cells remain and goblet cells 
disappear (Barnes & Stockley, 1994, Davies & Moores, 2003). 
Clara cells begin as non-ciliated elements.  Clara cells secrete proteins and thus 
reduce  the  stickiness  of  the  mucus  produced  by  the  large  diameter  airways  to 
produce lysozyme and immunoglobulins.  As bronchioles are very small, with lack of 
cartilaginous support, blockage and closure can occur individually. This could be due 
to  hypersecretion  of  mucous  observed  in  chronic  bronchitis,  hyperplasia  and 
contraction  of  smooth  muscle  seen  in  congestive  airways  limitation  (CAL)  and 
asthma, which can reduce airflow, in some instances becoming fatal.
The main unit of lung function is the acini, which includes all components capable of 
facilitating gas exchange namely respiratory bronchioles, alveolar ducts and alveoli.  
Transitional airways are respiratory bronchioles as they conduct air and participate in 
an exchange being “alveolar like”.  They are able to expand and contract as they are  
lined by cuboidal epithelium containing clara cells. Alveoli are distributed along their 
length  forming  the  alveolar  duct,  structures  which  are  tube-like  branching  and 
terminating into one or more sacs lined by alveoli,  with small  amounts of smooth 
muscle present in some walls of the ducts.
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Bronchioles  are  not  easily  occluded  as  they  possess  a  small  lumen  and  have 
spasmodic contractions of smooth muscle in the walls of the ducts. Paraffin sections 
show alveoli to be honeycomb arrangements of empty spaces bordered by the thin 
walls forming open sacs or closed polygons (Koehler, 1973). The pores of Kohn, 
which  are  small  openings of  5  -10  μm in  diameter,  provide  a potential  route for 
communication between alveoli.   Alveoli  air  pressure is equivalent to atmospheric 
pressure, so that the only way more air can fill the alveoli, is for the whole lung to  
expand in  volume, thereby decreasing pressure to  allow more air  to  be inspired. 
Within  the  adjacent  alveolar  walls  are  capillaries  of  the  pulmonary  circulation 
supported  by  collagen  and  elastic  fibres  also  containing  lymphoid  cells  and 
macrophages.  There are 500 million alveoli with a surface area estimated to be 80-
140 metres squared depending on body size (Barnes & Stockley, 1994, Davies & 
Moores, 2003).
Diffusion  of  gases  occurs  through  capillaries,  which  have  a  total  length  of  1600 
kilometres or 1000 miles and contain only 100 millilitres of blood.  It can be seen how 
thinly this volume would be spread over the total alveolar surface allowing for rapid 
gas exchange.
The histology of alveolar epithelium has various cell types:
type 1 alveolar cells which are squamous epithelium and cover most of the alveolar 
wall
type 2 alveolar cells which are cuboid and account for less than ten percent of 
the alveolar surface area and macrophages.
The pleura are serous membranes covering the surface of the lungs except the hilum 
and the  inner  thorax.   The surface of  the  lungs  supports  squamous  or  cuboidal 
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mesothelial cells, deep within which is supporting tissue with elastic fibres and blood 
vessels.  The watery fluid enables the two membranes to slide over one another but 
resists separation.  The visceral pleura contribute to the elastic recoil of the lungs. 
(Barnes & Stockley, 1994, Davies & Moores, 2003).
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5.11 Materials and Methods
In this section we will firstly review the broncoscopy procedures and outcomes. We 
also need to measure the number of Technegas particles inhaled. In doing so, we 
used several methods, including discarded and potential methods until we ultimately 
found  a  mathematical  method  of  describing  the  number  of  particles  inhaled  at 
ventilation. Thus this section reviews:
 What bronchoscopy entails
 bronchoscopy set-up
 broncoscopy procedure
 post bronchoscopy procedure
 discarded methods 
 potential methods 
 potential outcomes
5.11.1. What bronchoscopy entails
A bronchoscopy (see diagram in figure 5.2 below) is an examination where doctors 
pass a thin, flexible tube, called a bronchoscope, down your throat and into the main 
bronchi (airways) of the lungs. With the bronchoscope your doctors are able to do the 
following:
 look at the lining of the air passages leading into the lungs
 take photographs of what they see
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 take 'washings' (lavages) of the surface of any suspicious looking area so that 
the cells can be looked at under the microscope (this is called a cytological 
test)
 take  a  small  piece  of  tissue  from  any  suspicious  area  so  that  it  can  be 
examined under the microscope (this is called a biopsy). 
Lung cancers most often arise from the surface of the lining of the bronchi and so a  
bronchoscopy often confirms the diagnosis of lung cancer. Sometimes if a growth is 
deep inside the lung, then a bronchoscopy may fail to detect it.
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Bronchopscopy
Figure 5.2  Depicting the bronchoscopy procedure and location of bronchoscope
Source: Patient UK EMIS Feb.2006
The tip of the bronchoscope will  be inserted into a nostril  and then gently guided 
round the  back of  your  throat  into  your  trachea.  The bronchoscope can also  be 
passed via the mouth rather than via the nose if you have narrow nasal passages.  
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The  bronchoscope  inspects  the  lining  of  the  trachea  and  main  bronchi  and 
bronchoscopes transmit pictures through a camera attachment onto a TV monitor for 
real time viewing during the procedure to aid in diagnosis.
Today bronchoscopy is widely considered a safe and invaluable diagnostic tool and 
should  be  utilized  by  more  physicians  for  a  definitive  diagnosis  and  subsequent  
treatment  for  their  patients.  In  1967  fibre-optic  bronchoscopy  was  introduced  for  
clinical use. Prior to this time bronchoscopes were rigid and required a full surgical  
procedure including the use of a general anaesthetic.  With the introduction of the 
fibre-optic scope, bronchial pathology was visualized and sampled peripherally. 
5.11.2 Bronchoscopy set-up
Prior to the patients’ bronchoscopies, a lung ventilation study was acquired in the 
Nuclear  Medicine  Department,  Wollongong  Hospital  Sydney,  Australia.  The  lung 
study only involved exposure to a very small amount of radiation, estimated to be  
1.5 mSv. Naturally occurring background radiation is 2-3 mSv, and so the radiation 
risk to these patients was minimal and also to the staff in the Bronchoscopy Unit.
The  bronchoscopies  were  carried  out  at  Wollongong  Hospital  and  the  lung 
washings / lavages were prepared in the pathology department and made ready for 
transportation to the EM department at St. George Hospital, Sydney.
I  was  given  extensive  training  in  Cytology  and  Histopathology  over  a  period  of 
several months which included preparation techniques for lung washings and sputum 
preparation.
 All the lung study samples were bronchial washings; trans-bronchial samples would 
only be taken if required by the specialist. Trans-bronchial specimens are preferred 
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for this study as ideally, the closer a sample is taken to the terminal bronchi, the more 
alveoli  sampling  would  be  obtained  and  the  better  the  study  results  would  be. 
However, due to the specialist’s decision regarding our patient’s risk of haemorrhage, 
all our samples were taken from the left lower lobe of the lung. This would ultimately  
limit our findings.
5.11.3 Bronchoscopy procedure
For our research patients, the bronchoscope was inserted via the mouth with nasal 
prongs delivering a steady stream of two to three litres of oxygen to prevent hypoxia 
occurring during the procedure. All bronchoscopes were in the day theatres under 
sterile operating conditions.
In  a  routine  bronchoscopy,  respiratory  specialists  are  able  to  choose  from  two 
sampling techniques: Lavage and /or biopsy, depending on the provisional diagnosis 
of  the patient.  The sampling techniques used in  this present  study would be the 
routine procedure as chosen by the respiratory specialist for each patient.
Prior to the bronchoscope being inserted, Xylocaine 1% an anaesthetizing spray was 
introduced into the back of the mouth and tongue for local anaesthesia. At this point 
a cannula was inserted ready for “light” anaesthesia. A short acting benzodiazepine, 
Medazolam was used to suppress anxiety. If coughing was a problem, an opiate was 
used to  suppress the cough and minimize  anxiety.  The patients  were  positioned 
supine with the specialist proximal to the patient’s head. Laying them supine means 
the patient is less likely to experience vaso-vagal attacks, as blood will not have time 
to “pool” in the abdomen, causing a vaso–vagal reaction.
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While  the  bronchoscope is  inserted,  20 mls  of  lignocaine 2% mixed with  normal 
saline are introduced via  a side channel.  The amount  of  lignocaine administered 
depended  on  the  amount  of  patient  discomfort  while  the  bronchoscope  is  being 
inserted. As the tube is positioned in the bronchi, the worst part of the test is over.  
Examination usually takes approximately fifteen to twenty minutes. 
During  the  bronchoscopy,  the  pathway  taken  allows  direct  visualization  of  the 
trachea, bronchi and as far as possible into the lung. For all our research volunteers 
this was the left lower lobe of the lung. This is possible as the bronchoscope is a long 
flexible tube, with a light at the distal end allowing direct viewing of the respiratory 
system. All samples taken were lavage washings from the left lower lobe of the lung. 
The specialist had made the decision not to take lung biopsies from these patients 
due to the increased risk of haemorrhage.
5.11.4 Post bronchoscopy procedure
As soon as the patient was “awake” in the post-op ward, I asked them to take a deep 
cough and to “expectorate” into a sterile jar which was counted on a gamma camera 
to measure the amount of activity left in the lungs post bronchoscopy. Technegas 
had been inhaled, so there would be activity left within the lung post bronchoscopy. 
The remaining fraction of administered activity should be uniformly distributed within 
the lungs, where it is thought to remain for an extensive period of time. Lloyd et al  
(1995)  had  studied  radiation  to  the  lungs  post  ventilation,  looking  mainly  at 
biochemical cellular reactions to Technegas and pertechnetate. After measuring the 
activity left in the sputum post bronchoscopy these specimens were taken with the 
lung washings for EM preparation.
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The patient is not allowed to eat or drink for two hours until the swallowing reflex has 
returned to normal. Patients usually remain in the day-only ward until their swallowing 
reflex returns to normal, approximately three hours post bronchoscopy.
5.11.5 Discarded Methods
When trying to estimate the number of Technegas particles inhaled into the lungs, a 
number  of  possible  methods were  considered but  discarded at  the outset  of  our 
study.  We thought the ideas, however, should be included in our paper although 
considered not viable or valid to our research.  These methods included:
1 Trying  to  calculate  the  net  activity  produced  in  a  Technegas  chamber 
measuring activity pre and post burn, after decay correcting. 
2 Calculating the number of multi-carbon molecules produced. 
3 Finding out the labelling efficiency of the Technegas particle. 
4 Calculating the total activity in the lungs by drawing a region of interest or ROI  
and attenuate and decay correct to time of burn.
5 Calculating the number of radioactive Technegas particles in the lung.
As  Technegas  cannot  be  calculated  only  measured,  this  rules  out  the  above 
methods.  The  reason  for  only  measuring  relates  to: the  activity  in  an  aliquot  of 
pertechnetate – 99m, which does not reflect the total amount of technetium in the 
solution, also remembering that the particles formed from technetium particles are in 
the gas phase. 
According to Lemb and Oei (1993), you cannot measure the loss of carbon from a 
crucible, as it is too unreliable.  Measuring the output of Technegas has proven to be 
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too difficult, as one would need to invest “x” amount of dollars in equipment, and it 
still would not be easy to run this experiment.
5.11.6 Potential Methods
There  is  a  concept  that  may work  for  this  experiment  on  finding  the  number  of 
particles inhaled, bearing in mind that the distribution of particles is quite wide and 
that  the  activity  size  distribution  is  log-normal  with  median  160  nm and  Graded 
Standard Deviation (GSD) is ±  1.5. The next step would be to adjust the vertical 
scale of the distribution so that the integral equals the activity in the patient.
Assumptions may be made about the relationship between particle size and activity 
and one would have to assume a spherical particle with activity proportional to the 
mass. From this number we could derive size distribution. 
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The calculation for spherical particles would be: A (r) = k pi /6 r*r*r n (r)
Where A (r) is the activity distribution
K = the activity per unit mass
n (r) = the number distribution.
The work that follows provides a potential method for the estimation of the number of 
Technegas particles from knowledge of total activity.
Let X denote particle diameter.  Lloyd (1994) established that a reasonable model is 
provided by the log-normal distribution with probability density function given by: 
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This establishes the distribution of particle diameters.  In particular, the proportion of 
particles in the size range x to x + dx, where dx is small, is given approximately by 
f(x)dx.   If  there  are  N  particles  in  total,  we  would  thus  expect  Nf(x)dx  to  have 
diameters in range x to x+dx.  On the assumptions that particles are spherical, with 
activity proportional to mass, we have, for a particle of diameter x: 
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Each  particle  of  diameter  x  produces  activity  A(x).  Since  dx  is  small,  we  can 
reasonably say that all the particles in the size range x to x + dx will produce activity 
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A(x) approximately.  Since there are Nf(x)dx of them approximately, the total activity 
from particles in the size range x to x + dx will be A(x)xNf(x)dx.  We must then total  
across the size range, i.e. from:
 x = 0 to x = ∞, and mathematically this is achieved by integration.  The integration 
could  not  be  performed  analytically  so  a  standard  technique  from  elementary 
numerical analysis, the trapezoidal rule, was used. 
The integral  on  the  right  hand side  was  evaluated using  the  trapezoidal  rule  for 
numerical  integration  to  be  4494210  (Henderson,  2006).   Thus,  we  have  the 
relationship: 
ρk
N
Nk
××
=⇒
=
4494210
Activity Total
4494210 Activity  Total ρ
The density value is known.  Thus knowledge of an estimate of the constant k, i.e. of  
the Activity per Unit Mass, would permit an estimate of N to be calculated.
By measuring the activity of Technegas we can estimate:
1. the amount of activity inhaled into the lungs.
2. how much residual activity is left in the crucible.
Primary  particles  that  make  up  the  structure  of  Technegas  range  in  size  from  
5 – 30 nm.  Senden & Burch (1996) observed the hexagonal platelets of metallic 
technetium wrapped within a carbon capsule to be within a range of 30-60nm.  Prior  
to  ventilation,  these  technetium  99m  particles  coagulate  into  aggregates  with  a 
median diameter of 100 to 160 nm.  Depending on the time of Technegas generation  
and ventilation, the longer the time, the larger the particles; these particles can be as  
large as 225nm measured at 8.5-minute generation. Technegas particle size and the 
amount of deposition in the lung will determine the clearance rate of technetium. 
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Figure 5.3  Poisson Distribution 
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A  Poisson  distribution  is  used  to  describe  the  number  of  events  per  unit  of  a 
continuum.  In our experiment, it is common for aerosol distributions to be skewed 
(having a long tail at the larger particle sizes) and a log normal distribution is often a 
reasonable fit.
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5.11.7 Potential outcomes
The information obtained from lung washings/lavage of the main bronchioles was 
used to observe the structure, distribution, and the mechanism of clearance from the 
lung. 
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Initial investigations included:
 The migration of Technegas
 The alignment of Technegas within lung tissue
 Distinguishing between Technegas particles and lysosomes under EM as 
both cellular structures are electron dense.
 Cellular damage
The  bronchial  lung  lavage/washings  were  brought  to  the  pathology  department.  
Peracchia  and Mittler  (1972)  introduced the  idea of  fixing  tissue for  EM using  a 
gradually increasing pH value. For our research we used a Cocodylate Buffer system 
for our fixation process. Care had to be taken that Cocodylate did not react with the 
fixative as this reduces the buffering power and fixation ability. 
Washing  in  buffer  served  several  purposes,  the  main  one  being  to  remove  any 
excess primary fixative prior to post fixation. Cocodylate was also used for our freeze 
storage at 4 °C of our specimens before being transported to another hospital for 
final EM preparations.
5.12 Method for examining the specimens
The  following  items  examine  the  different  stages  of  preparation  needed  for  EM 
investigation of samples:
 Transportation of prepared specimens for EM
 Fixation procedures
 Initial preparation steps for EM
 Transitional Fluids
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 Final preparation steps for EM
 Microtomes
 Results of EM
5.12.1 Transportation of prepared specimens for EM
The  specimens  were  transported  from  Wollongong  to  the  EM unit  at  St.George 
Hospital. Unfortunately there are only one or two runs per week from Wollongong 
Hospital to St. George Hospital, Sydney. There were problems with the handling of 
the specimens in the EM unit and also with the time taken for preparation of the 
specimens  and  reporting.  St.George’s  EM  unit  had  other  researchers  using  its 
facilities and they kept our specimens for months as other projects were ahead of  
ours.  We waited a total  of  18 months for  the final  specimens that  came with  no 
accompanying  report  to  be  forwarded  to  Scotland  as  I  had  emigrated  overseas 
during this waiting period. 
On  arrival  of  the  specimens  in  Scotland,  I  was  working  at  the  Western  General  
Hospital  in  Edinburgh.  I  made  arrangements  in  the  first  instance  to  view  the 
specimens in the EM unit, having asked the microscopist if he would oversee my 
reporting of the findings from Wollongong, which was agreed. On examination of the 
sent specimens, it was found that most of the EM specimens had not been prepared 
properly and others were damaged in transit. Thus the only thing to do was to try and 
salvage what we could from the specimens and re-run the EM from scratch. This 
meant I had to study EM again and with it enough Histology and Cytology for me to  
be  able  to  prepare  the  specimens  from  scratch  and  report  on  them  under  the  
supervision of the EM specialist at Western General. The process took another year  
and many hours of my own time to achieve this goal.
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I was trained in Electron Microscopy on the JEOL 100CX11 1983 model to the stage 
where I could read and report on my samples and my supervisor would check my 
reporting. This training was invaluable for my research. Within this research I needed 
to complete smaller experiments in order to answer the questions posed. 
5.12.2. Fixation Procedures
“The knowledge of fixation dates back to 4000 BC; Hippocrates knew something of 
the  biological  effects  of  mercury  and its  salts,  as  did  the  Persians of  that  time.” 
(Bancroft 1982).
The aim of fixation is to prevent autolysis (a process by which biological cells self-
destruct) and bacteria  from occurring on the specimen.  There also should be no 
change in the specimen’s shape or volume and the specimen should be left as close 
to  its  living  status  as  possible  with  no  small  molecules  being  lost  (Koehler,1973). 
Buffers adjust the hydrogen ion concentration in fixatives as the pH value varies. 
Fixation occurs between a pH of six and eight. 
Cocodylate  buffer  wash  removed  excess  primary  fixative  prior  to  fixation. 
Glutaraldehyde  is  used  commonly  in  tissue  blocks  and  can  react  with  osmium 
tetroxide producing an electron dense precipitate of reduced osmium, which may be 
deposited onto the tissue specimen.
Our study used 1mm cubes of tissue, which are fixed at four (4°C) for between 4 - 16  
hours  in  3.1%  glutaraldehyde  in  0.1M  sodium  cocodylate  buffer.  The  fixative  is 
carefully  decanted  and  replaced  with  cold  0.1M  sodium  cocodylate  buffer.  The 
specimens are rinsed for thirty minutes.  Post fixation at four (4°C) for two hours in  
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pre-cooled one percent osmium tetroxide is decanted and the specimen is given a 
rinse in 0.1M sodium cocodylate buffer.
A dehydration method was used in our specimens to remove all free water from the 
fixed  tissue  and  replace  it  with  a  solution  that  is  miscible  with  the  embedding 
medium. Most embedding media are not miscible with water so an organic solvent,  
usually ethanol, can be used.  Dehydration has to be done as quickly as permissible,  
as all these chemicals will extract lipid from tissue. The time must be long enough to 
make  sure  all  the  water  is  removed  from  the  lung  and  sputum  specimens  as 
incompleteness  at  this  stage  will  cause  incomplete  dehydration,  resulting  in 
inadequate infiltration and polymerization of the embedding medium.
The  main  point  of  using  a  fixative  for  cytology  is  to  preserve  the  necessary 
cytomorphologic  characteristics  and  the  diagnostically  necessary  cytochemical 
elements  of  the  cell.  According  to  Keebler,  (1997)  the  appropriate  fixative  for 
cytodiagnosis involves:
 Penetrating cells rapidly
 Minimizing cell shrinkage
 Maintaining morphologic integrity
 Inactivating autolytic enzymes
 Replacing cellular water
 Allowing permeability of dyes across cell boundaries
 Permitting cell adhesion to a glass surface
 Matching for the subsequent staining method used
 Being bactericidal
 Being reproducible
 Representing a permanent cellular record.
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In former times, Papanicolaou used ether and 95% ethanol (1:1) as the fixative. The 
most common fixatives are ethanol 95%, isopropanol 80%, methanol 100% and 95% 
denatured alcohol as well as spray fixatives which have replaced ether and ethanol 
as the two primary fixatives of choice. When using fixatives, the cytologist will see 
slightly  altered  cell  appearance  and  some  various  artefacts  will  be  present. 
Cytologists are familiar with these artefacts that occur from using various fixatives.
There are two wet fixation methods according to Keebler (1997):
1. Wet fixation:  this is the instant immersion of the wet cell sample into a 
fixative solution, these cells are not exposed to air and remain in the fixing 
solution until they are numbered and stained. 
2. Wet fixation with air-drying:  immediate submersion of the cell  samples 
into a fixative, then after a specified time the samples are removed and air 
– dried. After air-drying, the samples can be placed into a container for 
transport  to  a  laboratory.  This  was  also  the  method  chosen  for  our 
research.
When the samples arrive at the laboratory,  the cell  samples are immersed into a 
Coplin Jar containing 95% ethanol.
Spray Fixation:  A spray fixative is used immediately onto the wet cell sample.  This 
is then allowed to air dry, and then placed into a container for transportation to the  
laboratory.  Immediate  fixation  is  the  goal  no  matter  what  type  of  fixative  used. 
Fixation  occurs  while  the  sample  is  wet  to  preserve  the  cellular  fixation  as  the 
specimens are easier to fix,  stain, cover slip and screen. Cellular adherence to a 
glass slide will  be highly dependant on what part of the anatomy the sample has 
Chap 5 - 52
originated from.  Cells taken from fluid adhere less (bronchial washings) to the slide 
than sputum (taken post  bronchoscopy),  which  adheres well.   Sprays  for  fixation 
purposes may be needed to achieve better results than just placing the sample in 
95% ethanol.  Mayer’s albumin may be added to fluid samples prior to centrifugation 
or onto the glass slide to assist with cellular adherence.
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Figure 5.4: Preparatory steps for EM
A B
C D
E F
G
5.12.3 Transitional fluids
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A = Impregnation
B = Semi Thin Section
C = Semi Thin Section Glass Slide
D = Semi Thin Section Xylene Vapour
E = Toluidine Blue
F = Solid Semi Thin Section Toluidine 
Blue
G = Pyramid
Where the dehydration agent and the embedding media are miscible, the penetration 
of the embedding media is facilitated by the introduction of a transitional fluid. The 
main transitional  fluids available are 1:2 epoxy propane (propylene oxide),  xylene 
and toluene.
Sectioning  the  lung  and  sputum  tissue  is  accomplished  using  a  diamond  knife, 
prepared from industrial diamonds, machined and then polished to a very high cutting 
edge. The edge is cleaned using a cotton bud and running it  parallel  not at right 
angles. Collection of debris on the diamond knife will result in a poor sample section.
Section cutting of the specimens for EM was carried out the next day. From the resin 
block 50-60 nanometre sections were cut using a diamond knife and water  bath. 
Sections that were cut were spread over the surface of a finely perforated copper grid 
approximately 3mm in diameter. The sections adhered to the grid by surface forces.
5.12.4 Preparation for EM
The method of preparing for EM entails using ultra thin sections as the electron beam 
can only penetrate matter for  a short  distance.  After embedding the specimen, a  
suitable mounting medium is required.  The specimen is cut with a diamond knife, 
and once sectioned portions are floated in water, picked up and placed on a wire grid 
for viewing. The preparation of tissue specimens for EM involves the same basic 
steps as light  microscopy;  however,  EM uses special  fixatives.   For my research 
“cocodylate” buffer and glutaraldehyde are used since the greater resolving power of 
EM  requires  finer  and  more  specific  cross  linking  of  proteins  (Keebler,  1997, 
Koehler,1973).
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Buffered  solutions  of  glutaraldehyde  are  also  used  for  EM  fixation,  enabling 
examination of  the specimen within  the electron beam; generally tiny sections of 
samples less than that used for light microscopy are infiltrated in copious amounts of 
fixative.  The tissue blocks used were no longer than 1mm cubed, and epoxy resin 
was chosen as the embedding medium for this research.
Cytology is based on cell samples prepared in various ways, and although the actual 
methods of fixation do vary in laboratories, their methods follow basic concepts. The 
goal is to reduce artificial cell changes while giving an optimal diagnostic cell sample 
(Keebler, 1997, Koehler,1973), see also figure 5.4: Preparatory steps for EM.
5.12.5 Microtomes
The microtomes used for thin sectioning are designed to strict tolerance. Machines 
are mostly  semi-automatic.  The block must  advance towards  the  knife  and each 
successive stroke gives sections of about 50 - 60 nanometres. This is achieved by a 
mechanical advance machined micrometer screw and lever system.
Glass and diamond knives are provided with a trough, which allows a fluid reservoir 
to lie behind the cutting edge so that sections when cut will float on the surface. The 
sections from the bronchial washings and sputum when viewed in refracted light, give 
the colour of the section as it is cut, which indicates its approximate thickness. Our 
sections  are  best  seen  when  they  appear  silvery  gold  (Ultramictrotome  Section 
Colour  Reference  Chart  published  by  Drukker  International,  Netherlands). 
Compression during sectioning is removed by exposing the sections to xylene vapour 
as  they  lie  in  the  water  trough  (see  EM  preparation  set-up  (figure  5.4)  and 
Microtomes (figure 5.5).
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5.12.6   Microtomes 
Figure 5.5: Microtomes
Image 1: Carbon Particles from Technegas 
in sputum
Image 2: Technegas Particle
Image 3: Technegas particles & 
Macrophage
Image 4: Lysosome
Image 5: Single Lysosome Image 6: Macrophage/Epithelial Cell
Image 7: Epithelial cells & Cilia
Image 8: Carbon particles at low 
magnification
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5.13 Results of Technegas and EM research
Our investigations produced images of the different parts of the cell under electron 
microscopy. There were some interesting cells visualised on EM that we salvaged 
from our  damaged  samples.   We decided  to  list  these  as  part  of  our  research 
material  observed under EM for Technegas at the cellular level (see list below at 
5.13.1).
The microanalysis of thin samples from the lung and sputum is limited by both the 
specimen preparation and the microscopic technique and conventional preparation 
used for our research provided useful morphological information.  However, due to 
chemical  fixation,  dehydration  and  embedding  procedures,  contamination  of  the 
specimens  may  occur  and  elements  also  bound  by  lipids,  proteins  etc.  may  be 
removed during the preparation phase.
Slight modifications to the fixing procedures can help to retain certain elements; in 
our research we used glutaraldehyde as a fixative. According to Karnovsky,  M.J. 
(1965),  glutaraldehyde  solution  of  0.1% to  1.0% concentration  may  be  used  for 
system disinfection and as a preservative for long term storage. Glutaraldehyde kills 
cells quickly by cross-linking their proteins and is usually employed alone or mixed 
with  formaldehyde as the first of two fixative processes to stabilize specimens such 
as bacteria, plant material, and human cells.  Fixation is followed by dehydration of 
the tissue in ethanol or acetone, followed by embedding in an epoxy resin or acrylic 
resin.  Safety: as a strong disinfectant, glutaraldehyde is toxic and can cause severe 
eye,  nose,  throat and  lung irritation,  along  with  headaches,  drowsiness  and 
dizziness. It is a main source of occupational asthma among health care providers.
Chap 5 - 58
To minimize elemental loss, we froze the specimens, which had to be transported 
from  one  hospital  to  another  for  final  preparation  and  reporting.  Apart  from  the 
elemental  losses during  preparation,  irradiation by the electron  beam can induce 
further redistribution of the elements within the specimen.
A tissue section for EM should not be any larger than 80 nanometres. Epoxy resin 
was used as the embedding medium as it polymerizes uniformly with the lung and 
sputum specimens. By using epoxy resin we found the specimens to be more stable 
in the electron beam and were seen to have a slow rate of sublimation or transition. 
Microtomes using Technegas EM slides. In this experiment we observed only one 
electron dense hexagonal structure of Technegas. It  was then decided to add all  
microscopic images found of interest in this summary below as these images were 
seen  in  all  20  subjects  under  the  electron  microscope.  The  total  result  was 
disappointing  as  only  one  clear  specimen  was  gained.  This  was  due  in  part  to 
damage of the original specimens both in preparation by St.George EM Unit and the 
method in  which  the specimens were  transported to  Scotland.  The results below 
were those prepared by myself and reported on in Scotland under supervision at the 
Western General, Edinburgh. Due to the limitations of our experiments, which will be 
discussed later in further detail, the following structures were observed as add-ons to 
our studies:
5.13.1 Investigational structures seen on EM
1) Technegas particle
2) Centrioles
3) Eosinophils
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4)  Epithelial Cells
5)  Endoplasmic Reticulum
6) Golgi Complex
7) Lysosomes
8) Mitochondria
9) Nucleus
10) Phagocytosis and Pinocytosis
11) Artefacts
1) Technegas Particle
An electron dense hexagonal particle was observed of metallic technetium which is 
encapsulated within a layer of graphitic carbon. No particle observed was larger than 
100 nm. There was a great deal of technetium scattering throughout the EM grid 
plates.
2) Centrioles
Stubblefield  and Brinkley’s  1967 studies of  centrioles  showed that  centrioles and 
basal bodies are two structures, which are morphologically identical. In our study, 
centrioles were seen as short cylindrical bodies lying at right angles to each other. 
Collectively these centrioles comprise the diplosome which lies partly surrounded by 
the  Golgi  Complex.  The  region  in  which  the  centrioles  lie  is  known  as  the 
centrosome,  and  the  line  joining  the  centrosome to  the  centre  of  the  nucleus is 
known as the cell axis.
3) Eosinophils
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These were readily distinguished by their large size, a bi-lobed nucleus, and large 
granules in the cytoplasm adjacent to the nucleus. The cytoplasm was observed to 
be a grayish colour under EM.
4) Epithelial Cells 
Epithelial cells with cilia were seen. The epithelium is found in the upper airway so 
this is a common cell for us to study. The cilia seen were cut so well that they where  
worth mentioning. The cells appeared to be in several layers due to their nuclei being 
situated at  different  levels  throughout.  All  cells  seemed to  be in  contact  with  the 
basement membrane, but the cells were of all different shapes and heights and none 
reached  the  “free”  surface.  The  epithelium  therefore  would  not  be  stratified  but 
pseudo-stratified.
There were some deeply placed nuclei belonging to the short basal cells; the more 
superficial are those of the columnar ciliated cells. Interspersed goblet cells were also 
seen. The short cilia were numerous and seen close together. Each cilia arises from 
a basal body which seemed to be lined up adjacent to each other and at first sight 
has the appearance of a continuous membrane. 
5) Endoplasmic Reticulum
The endoplasmic reticulum (ER) is usually difficult to see when using EM. However,  
on examining our sectioned specimens, there were quite a few. The endoplasmic 
reticulum observed consisted of a continuous system of membrane–bound cavities 
that ramify throughout the cytoplasm. The endoplasmic reticulum also has a loose 
meshed-like irregular network of branching and anastomosing tubules. Endoplasmic 
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reticulum appeared to be confined to the main mass of cell cytoplasm. The organelle 
does  often  extend  close  to  the  cell  membrane  consisting  of  a  system  of  inter-
connected cavities and passages, not a series of isolated sacs or vesicles.
There are two types of endoplasmic reticulum: the granular or rough endoplasmic 
reticulum, and the agranular or smooth endoplasmic reticulum, into which category 
our specimens fall. The rough has a cytoplasmic surface studded with loops, rows or 
spirals  of  ribosomes called  polyribisomes.  The  smooth  endoplasmic  reticulum or 
granular is not associated with ribosomes.
6) Golgi Complex
In our examination of the bronchial washings and sputum, golgi complexes consisting 
of flattened sacs, also vacuoles and vesicles were observed (see figure 5.6: Golgi 
Complex).  Golgi are composed of a smooth membrane and have a characteristic 
organization of their elements. Using EM to examine our specimens, we could see 
that Golgi  are composed of three basic elements, the most characteristic being a 
stack of flattened sacs, the ends of which are slightly dilated. Vesicles lie on the 
convex or outer face of the stack and these vesicles arise from “budding” out of the 
endoplasmic  reticulum.  Golgi  complexes  are  seen  especially  well  in  secretary 
epithelia, sputum. The functions of the golgi  are many and quite varied; golgi are 
involved  with  the  secretary  process,  production  of  nearly  every  exocrine  and 
endocrine secretion, cartilage and synovial membranes. 
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Figure 5.6 Golgi Complex seen in sputum
7) Lysosomes
Lysosomes in our specimens had contents that were medium to low electron dense 
so they could not be unequivocally distinguished by morphological features alone 
from other  vesicular  structures  in  the  cell.  It  was  only  when  increasing  the  light 
intensity  and magnification that  a  single membrane could be visualized.  In  some 
reporting sessions it  was difficult  to  distinguish if  these electron dense structures 
were in fact hexagonally shaped Technegas particles or not, as a membrane is not 
obvious.
Lysosomes in  general  are a group of  membrane bound particles containing  acid 
hydrolases,  meaning  rich  in  lytic  enzymes.  The  primary  lysosome  is  a  vesicle 
containing many acid hydrolases,  while  some may contain  mitochondria,  pigment 
masses and other dense bodies. 
“Myelin bodies” are described as lysosomal bodies by Hruban, (1972). Myelin bodies 
are produced in tissues fixed with glutaraldehyde especially when fixation lasts for 
many hours  or  days.  Myelin  figures  can be found in  the  cytoplasmic  matrix  and 
mitochondria. Myelin bodies are found in alveolar cells referred to as cytosomes or  
multi-lamellar bodies, which represent the secretary granuoles normally produced by 
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the  cells.  Myelinoid  bodies  are  also  occasionally  seen  in  cells,  which  engage  in 
erythrophagocytosis and are pleomorphic, therefore showing diversity in form.
8) Mitochondria
When studying  our  EM specimens  it  was  clear  that  the  mitochondria  had  many 
variations in size, structure and shape and remained the most distinguishable from all 
other cell  organelles in  EM. The mitochondria reported were  granular,  thread-like 
components  of  the  cytoplasm,  also  called  bioblasts.  Some  mitochondria  had 
extended diagonally across a field when seen using EM.
The  morphological  features  seen  included  a  double  membrane  bound  body 
containing matrix, a system of cristae or folds and some granuoles. The mitochondria 
remain  the  major  source  of  cellular  ATP  (adenotriphosphate),  known  as  the 
“powerhouse of the cell” (Racker, 1968). In 1902 Benda described mitochondria as 
thread–like or granular components seen in cells. These organelles in living cells are 
seen to move slowly and change their shape and size. Mitochodria also appear to be 
able to divide and recombine.
9) Nucleus
In our research of bronchial washings and sputum, light microscope studies of the 
mitotic  nucleus  and  its  chromosomes  have  shown  more  than  is  seen  with  thin 
sections used for EM. In fact EM does not elucidate satisfactorily the structure of 
chromatin,  and  the  variations  that  may  underlie  cell  differentiation,  function  and 
neoplastic transformation.
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Using EM, the nuclei  seem to show some irregularity  due to  the thinness of  the 
bronchial  washing  and  sputum  sections  which  were  seen  as  two-dimensional 
images. Thus EM shows that many nuclei, instead of being smooth and round or oval  
in shape, may be irregular depending on the type of cells for example macrophages 
that have invaginations as seen in our specimens.
Chap 5 - 65
10) Phagocytosis and Pinocytosis
Phagocytosis was named by Metchinikoff in 1883 to describe the process whereby 
cells ingest food. Metchinikoff also looks at the concept of microphages (neutrophils)  
and macrophages and their roles in defence mechanisms.
In  our  investigations  we  saw  evidence  of  macrophagic  activity  within  the  cells. 
Bronchial washings and sputum will always have macrophages present within.
Phagocytosis  and  pinocytosis  are  derived  from the  Greek  roots  for  “eating”  and 
“drinking” respectively. The distinction between particulate uptake (eating) and fluid 
uptake (drinking) relate more to the resolving power of the microscope, be it light or 
electron microscopy for the final analysis of the particulate (Koehler,1973).
Macrophages  were  seen,  including  some  macrophages,  with  carbon  particles 
scattered  throughout.  As  a  patient  coughs,  free  carbon  particles  are  dispersed 
throughout.  These  carbon particles  were  viewed  using  5k  x  magnification.   Free 
macrophages were seen and had a rounded appearance, with the cell outline being 
slightly irregular. Macrophages have various shapes when seen under EM.
The nucleus is rich in chromatin,  and also appears to show a slightly acidophilic 
cytoplasm when viewed under light microscopy. 
Alveolar macrophages travel within the cell and exist in the non–ciliated lung regions. 
The  macrophage  will  ingest  foreign  material  by  phagocytosis,  after  which  it  will 
migrate  to  the  ciliated  surface where  it  is  removed  by the  mucociliary  clearance 
mechanism. The half-life for mucociliary clearance by this method is days to months. 
Some particles that are not engulfed by the macrophage may infiltrate the lymphatic 
system or interstitial tissue, making clearance a longer process (Brown & Zenman, 
2002).
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11) Artefacts
As  our  lung  washings  and  sputum  specimens  needed  to  be  prepared  for  EM, 
artefacts may be easily introduced. An artefact is something artificially produced, and 
not indicative of the specimen we are examining. It is accepted that artefacts will be 
introduced  during  the  various  preparation  stages  for  EM,  however,  with  good 
techniques these can be minimized.  As such, artefacts can be accepted as being 
consistent as long as the microscopist can identify them as such. Artefacts that may 
occur in our research preparation for EM:
a) When preparing pellets for our research made from a suspension, centrifugation 
may  cause  isolated  cells  to  undergo  distortion  and  dislocation  of  sub-cellular 
components if the lung and sputum specimens are centrifuged prior to fixing.
b) Our bronchial lavage samples may cause stratification of the particles within the 
pellet. Systemic sampling is taken from the pellet to prevent artefacts occurring, as a 
pellet has depth and therefore sampling should be taken from top to bottom of the 
specimen.
c) There are numerous limitations which must be imposed on these thin lung and 
sputum specimens for microanalysis.
d) Contamination is usually seen when the diameter of the beam is reduced below 
100nm.
e) Micro diffraction patterns from inelastic scattering caused by the presence of a thin 
layer of carbon, which “washes out” the diffraction pattern. This is one of the most 
sensitive  ways  of  detecting  contamination  in  the  microscope  (Crang  & 
Komparens,1988).
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There are numerous sources of contamination and its effect on analytical sensitivity 
is dependent on the microscope, specimen and user combination.
Technegas was not visualized in every patient’s washing and sputum specimens, 
although carbon was scattered throughout. This may be for a number of reasons:
 Macrophages “gobbling” up the contents of the cell including Technegas.
 Technegas diffusing  across  the  alveolar  membrane and into  the  blood 
stream.
 As the specimens were  not  immediately fixed in  the operating theatre, 
exponential  decay  is  continuing  to  occur  from  the  time  of  the  lung 
ventilation study to the time of fixation process, which can be up to half an 
hour. 
 Another consideration is that although Technegas is fixed and stained, it 
may continue to decay over time.
The only quick method to see Technegas in both specimens may be to view them 
with  a  wet  preparation  technique  instantaneously,  thus  exponential  decay  is  still 
occurring but the time factor is much less. 
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5.14 Our Conclusions
We have answered some of our objectives by examining all lung washings from the 
left lower lobe of the lungs from volunteer subjects. Trans-bronchial specimens were 
not performed due to the risk of haemorrhage as indicated by the specialist. 
A  limiting  factor  of  this  study  was  that  we  were  unable  to  take  trans-bronchial  
specimens from any of our subjects and so we were compromised at the outset. If we 
had sampled more alveoli, we would have obtained a better study result. Ideally, the 
closer a sample is taken to the terminal bronchi, the more alveoli sampling would be 
obtained  and  the  better  the  results.  Some  patients  haemorrhaged  during  their 
bronchoscopy procedure, so red blood cells and some lymphocytes were also seen 
under EM. The most common particles observed were carbon scattered throughout 
each specimen as the patient inhales this from the Technegas.
Other limitations were that Technegas did not seem to migrate and remained within 
the lung. Moreover, some nuclei seemed to be dying due to a delay in immediate 
fixation. 
There  was  cellular  damage  seen  only  from the  sectioning  methods  used  by  St. 
George  Hospital,  Sydney  for  EM  preparation  and  also  damage  to  the  actual 
specimens during the transportation process from St.  George Hospital  Sydney to 
Scotland. Due to this damage, all patients’ specimens were prepared again at the 
Western General Hospital, Edinburgh, Scotland. 
Technegas was seen to be very electron dense as were the lysosomes. At times, a 
single  hexagonal  particle  of  Technegas  was  difficult  to  distinguish,  although  the 
lysosome has a double membrane surrounding it (see previous images). Artefacts 
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were also very electron dense but easily distinguished from Technegas as they had 
round shape walls.
As we did not use autoradiography due to the cost of this study and also suggestions 
that  we  may not  need  to  use  this  method  from specialists  in  microscopy  at  St. 
George, in hindsight, statistically trying to find Technegas in each sample was like 
“finding a needle in a haystack”. For future researchers interested in pursuing these 
studies, a better and less cost effective way to conduct this research may be to use a 
fluorescent tag on the technetium under microscopy.  
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Chapter 6 Experiment 5:
Sputum and Bronchial Washings at the Cellular Level
Sputum Expectorate at Wollongong Hospital, Sydney, Australia
6.1 Introduction
Predominantly  expectorate  is  made  up  of  mucous  with  cellular  and  non-cellular 
material produced by the host, and also contains substances that have been inhaled. 
Expectorant consists mainly of squamous epithelium from the oral cavity and pharynx 
containing columnar cells.  These cells exfoliate from the tracheobronchial tree and 
also  contain  goblet  cells  (Taylor,  1991).  Sputum was  examined and expected to 
contain a small amount of radioactivity still present post ventilation with Technegas 
and post bronchoscopy. Sputum was studied to see if the sputum cells had the same 
characteristics as Technegas from bronchial lavage washout specimens.
6.2 Aims
 measure activity of Technegas remaining in sputum post bronchoscopy
 investigate under EM the structure of Technegas in sputum.
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6.3. Methods and Materials
Sputum  expectorate  was  collected  immediately  post  bronchoscopy  into  a  sterile 
sealed jar in the recovery area. The sputum is expected to contain a small amount of 
radioactivity still present post ventilation with Technegas prior to the bronchoscopy.
The specimen was  obtained from a  deep cough and with  no  immediate  fixation, 
brought to the Nuclear Medicine Department for counting using the same dual head 
gamma camera used for the ventilation. Blue sheets were laid on top of the gamma 
camera collimator  and the  sputum specimen in  the  sealed jar  laid  on top of  the 
collimator to take a reading of the remaining counts. All twenty patients’ count rates 
had similar readings post bronchoscopy of between 40 and 45 MBq remaining in the 
sputum. Once counted, the specimen is brought to the laboratory for examination 
and fixing. This entailed a gross examination of expectorate as seen with the naked 
eye and results recorded as follows:
a) Using a wooden stick, a small section of expectorate is collected and smeared 
onto the cover – slip.
b) Sputum is fixed for four hours in 3.1% glutaraldehyde. The fixative is carefully 
decanted and replaced with 0.1M cacodylate buffer. The sputum is then rinsed. Post 
fixation, the sputum specimen is left at four (4°C) for two hours in pre–cooled 1% 
osmium  tetroxide  in  0.1M  sodium  cacodylate  buffer.  The  osmium  tetroxide  is 
decanted and the tissue given a rinse in 0.1M sodium cacodylate buffer.
c)  Dehydration removed all  the free water  in the sputum specimen and this  was 
replaced with a solution, which was miscible with the embedding media-ethanol. The 
ethanol is used to extract any lipid from the sputum. Incomplete removal of water 
from the sputum will result in polymerization of the embedding media.
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d)  Araldite,  which  is  a  resin,  was  used  in  combination  with  a  hardener  and  an 
accelerator to polymerize slowly in an oven at sixty (60°C) overnight.
6.3.1 Inclusion and Exclusion Criteria
Exclusion: No females who are pregnant or breast- feeding.
Inclusion: Adults who have read the Informed Consent form explaining the purpose 
of the aims of our research, expected duration of participation and a full description of  
the procedure which includes a small amount of radiation to the volunteer patient.  
Ethics approvals can be found in  Appendix 9.  The study will  include twenty (20) 
adults,  eleven  (11)  male  and  nine  (9)  female  with  a  mean  age  of  48.5  years 
scheduled for a regular bronchoscopy.
6.3.2 Preparation for cross-sectional specimens of sputum for EM
The preparation of thin specimens remains one of the most significant aspects of EM. 
The preparation of a good specimen does require a certain skill, which I am barely 
perfecting, as it takes years to achieve. It comprises the following procedures:
Section  Cutting:  EM  demands  sections  of  50  -  60  nanometers  (500  -  600 
angstroms)  from the  block,  as  the  electron  beam is  unable  to  penetrate  thicker 
sections  sufficiently  to  allow  details  of  structures  to  be  clearly  seen.  Ordinary 
microtome knives are not suitable for cutting such thin sections since it is impossible 
to polish a metal edge finely enough to obtain good sections, so therefore glass or  
diamond knives are used instead.
Chap 6 - 3
“Thick sections” of between 0.5 – 1 micron thick are mounted on a glass slide for light  
microscopy. The section is dried onto the slide on top of a hot plate then stained with  
toluidine blue in order to localize areas of interest for  subsequent EM. The block 
surface is then trimmed down to include only those structures of interest. This area is 
called the pyramid.
Next, the sections for EM are spread over the surface of a finely perforated copper 
grid approximately three (3) millimetres in diameter. The cross bars of the grid give 
sufficient  support  to  the  section  without  the  need  for  an  intervening  layer.  The 
sections adhere to the grid by surface forces.
Diamond knives are set into a block of metal and then inserted into a specially built  
holder,  which  is  used as  a  floating-out  trough.  Between  10 and 20% solution  of 
ethanol is used as the floating-out fluid as this has a lower surface tension than water  
and the cutting edge wets more readily. Ethanol can assist the specimen to expand a 
little  and  therefore  counteracts  the  compression  which  the  specimen  undergoes 
during sectioning.
It is important to fill the trough correctly when the specimen is “floated out”. Too high 
and the block face will pick up liquid as it passes the cutting edge and the section will  
be dragged over the knife edge. Too low, the sections will not float out properly and  
result in a pile-up on the cutting edge. The correct height is to fill the trough until the 
knife-edge is wet.
Block trimming: ultramicrotomes and a block are clamped into a “chuck”. Trimming 
is carried out with a razor blade under a binocular microscope. Once the tissue is 
exposed, the block face is squared off and trimmed into the shape of a trapezium. 
The slides of the block are cut so that they incline at approximately 50 degrees.
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Contrast Enhancement: if we do not prepare the bronchial  washing and sputum 
specimens any further, the contrast in the specimens will be so low that little detail  
can be distinguished. Contrast in the electron microscope relies on the differential  
absorption and scattering of electrons, which depends on the presence in the section 
of material of high atomic weight. Fixation with osmium tetroxide adds some contrast, 
but exposing the specimens to a solution of heavy metal salts as acetate further 
increases contrast. Membranes, granules and other distinctive structures take up the 
heavy metal  preferentially.  A common practice is to stain with  acetate in ethanol 
followed by lead citrate. The alcohol is used to facilitate the entry of the heavy metal 
into the substance on the thin section.
Araldite: consists of  resin (CY 212) used in combination with  a hardener (DDSA 
dodecenyl succunic anhydride), a plasticiser (dibutyl phthalate), and an accelerator 
(BDMA benzyl dimethylamine).This mixture polymerizes slowly at room temperature 
but can be accelerated by increasing the temperature. Blocks were polymerized at 
sixty  (60°C) for  two to  three days.  The amount  of  accelerator  added to  the final 
solution is critical and affects both polymerization and cutting properties. Too much 
accelerator produces a dark amber coloured block, which is much too brittle to cut; 
well-cured blocks are a pale straw colour.
The other types of epoxy resin are Epon, Spurr, Maraglas 655, Polyester Resins, 
Water Soluble Solutions, Glycol Methacrylate, Aquon and Durcapan.
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6.4 Quality Assurance for the Electron Microscope
Before  starting  the  operating  procedure  once  our  specimens  are  prepared,  it  is 
important to run a daily check on the EM as older microscopes have a tendency to 
“shift”.
My specimens were reported on the Jeol 100CX11 Electron Microscope (EM) at the 
Western General Hospital Edinburgh, Scotland. The Jeol EM was made in 1983. It is 
worth noting that the microscope is cooled by a water jacket and the temperature 
should be kept between 18 and 24°C. In Scotland, EM has to have a built-in safety 
device for temperature so if the temperature falls below 8°C, therefore if there is frost 
or snow on the ground, an EM must not be switched on.
Magnification ranges: 
Normal range x 500 – x 450,000
Lower range x1 00 – x 600
Start-up Checks:
1) Mains water on
2) Isolator switch on
3) Microscope key to start
Close Down Checks:
1) The filament emission should be turned fully anticlockwise
2) Accelerating Voltage has to be switched down to & including high tension
3) Key off
4) EM will shut down after thirteen (13) minutes
5) Mains water off
Gun Alignment:
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1) Objective aperture out
2) Specimen holder out
3) Condenser aperture always at position 2
4) Check  vacuum  panel.  EM  should  be  at  required  vacuum  and  read 
approximately forty (40) micro-amps on vacuum gauge after half an hour
5) Switch on high-tension
6) Use the priming button next to the desiccator, move up through the 
voltages until 60kV has been reached
7) Saturate the filament by turning filament tension knob clockwise. The 
beam current micro-chip reading should also be 60; adjust the gun bias if 
this reading is too high or low. Re-saturate the filament with the filament 
emission knob and set the point with the stop on the back of the filament 
emission knob
8) Using condenser knob, make a small spot with the beam. On spot size 1 
and using the gun alignment, trans centre the beam
9) Change the spot size to 3 and make the beam spot as small as possible. 
Re–centre the beam using alignment
10)  Repeat steps until the beam is centre in both spot sizes.
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Gun Alignment Tilt:
1) Spot size 1; make a small spot using the condenser
2) Turn the filament anti-clockwise until a filament is seen
3) Sharpen image with a fine condenser control
4) If filament image is not central in the spot, centralize using gun alignment.
6.5 Insertion of Holey Carbon Grid to view specimens
The grid should be placed into the specimen holder face down (dull surface face up).
Insert the specimen holder into the column and the red light appears. Thereafter:
1) Wait approximately thirty seconds (30) and the red light will go out
2) Turn the specimen rod clockwise to ninety degrees (90)
3) Hold on to the specimen tightly, because at this stage, the column vacuum 
starts to pull the specimen holder into the column
4) If the specimen holder is released too quickly, the ruby bearing at the end 
of the specimen holder could possibly be damaged and is very expensive 
to replace.
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6.5.1 Objective Aperture Insertion
After adjustment of the current centre:
1) Select a low magnification 2k, spot size 1 and make a small spot with the 
condenser
2) Insert objective aperture to preferred position (for Araldite sections, 
position 2 is used)
3) Centre the aperture with aperture controls, after proceeding with the 
objective aperture astigmatism, condenser alignment and image alignment 
then the microscope will be ready to use.
6.6 Results
6.6.1 Sputum results aid diagnosis of lung cancer
Collecting both expectorate and bronchial material aids the diagnosis of lung cancer, 
seen in many of the volunteer subjects who had a bronchoscopy.  It is interesting that  
expectorate is equal if not higher than bronchial material in the percentages of lung 
cancers diagnosed, hence the importance of both specimens being taken to further 
aid in diagnosis.
Expectorate  cytologic  specimens  may  be  divided  into:  a)  epithelial  cells,  b) 
macrophages,  c)  leukocytes,  d)  mucous,  e)  intrinsic  non  cellular  components,  f) 
extrinsic non cellular components, and g) living organisms (Wield, 1997).
Wet fixation  with  air-drying  was the method used for  sputum with  the immediate 
submersion of the cell samples into a Coplin Jar containing 95% ethanol, a fixative. 
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After a specified time, the samples are removed and air – dried, this was the chosen 
method of fixation for our research. Cellular adherence to a glass slide was good as 
the sample had originated from sputum and was viscous and sticky.  Cells taken from 
fluid  adhere  less  (bronchial  washings)  to  the  slide  than  sputum  (taken  post 
bronchoscopy), which adheres well.
6.6.2 Results of Micro-analysis
The microanalysis of thin samples from the sputum is limited more by the specimen 
preparation than the microscopic technique. Conventional preparation used for our 
research  provided  useful  morphological  information.  Due  to  chemical  fixation, 
dehydration and embedding procedures, contamination of the specimens may occur 
but if this does happen, the artefacts will be known by the person reporting on the 
specimen and allow for this.
Unfortunately, the majority of results of the sputum samples taken were destroyed in 
transit and only one sample retrieved, so one result was reported, see Figure 5.5,  
Carbon Particles from Technegas (sputum). 
Using  EM  to  examine  our  previously  damaged  specimens  was  disappointing. 
Scattered technetium was seen, and one single sample of Technegas was viewed. 
Golgi were commonly reported in sputum and are composed of three basic elements, 
the most characteristic being a stack of flattened sacs, the ends of which are slightly 
dilated. Vesicles lie on the convex or outer face of the stack and these vesicles arise 
from  “budding”  out  of  the  endoplasmic  reticulum.  Golgi  complexes  are  seen 
especially well in secretary epithelia, sputum. The functions of the golgi are many 
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and quite varied; golgi are involved with the secretary process, production of nearly 
every exocrine and endocrine secretion, cartilage and synovial membranes.
EM does not elucidate satisfactorily the structure of chromatin and the variations that  
may underlie cell differentiation, function and neoplastic transformation.
Using EM, the nuclei seem to show some irregularity, this being due to the thinness 
of the sputum sections which were seen as two-dimensional images. Therefore, EM 
shows that many nuclei instead of being smooth and round or oval may be irregular 
depending  on  the  type  of  cell  Macrophages  seen,  including  some  with  carbon 
particles  scattered  throughout.   As  a  patient  coughs,  free  carbon  particles  are 
dispersed throughout. These carbon particles were viewed using 5k x magnification.
Free macrophages were seen and had a rounded appearance, with the cell outline 
being slightly irregular.  Macrophages have various shapes when seen under EM. 
The  nucleus  is  rich  in  chromatin,  and  appears  to  show  a  slightly  acidophilic 
cytoplasm when viewed under light microscopy. 
For future researchers the technetium found within the sputum should be tagged with 
a  monoclonal  antibody  or  a  fluorescence  agent  so  that  it  can  be  seen  more 
distinctively under EM and differentiated by its hexagonal configuration and electron 
density.
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CHAPTER 7 MAJOR FINDINGS AND CONCLUSIONS
Chap 7 - 1
7.1 Novel aspect of lung scanning
This thesis involved 50 participants, 25 conventional subjects and 25 TEBA patients. 
The patients involved in these experiments were those who were inpatients in the 
Intensive Care Units,  and those with  CAL and PE.  Recent advances have been 
needed to improve the method of diagnosis and the TEBA positive pressure device 
may prove to be an invaluable tool to those working in Nuclear Medicine.
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There is  concern that  TEBA or positive pressure ventilation may create a falsely 
positive diagnosis of PE by improving the peripheral penetration of tracer in poorly 
ventilated areas that are associated with reflex vasoconstriction and hypoperfusion 
not due to vascular obstruction.  Clearly,  more research is required to clarify this 
issue,  as the number of  subjects in  these experiments was too small  to make a 
definite conclusion. This thesis investigated a novel aspect in ventilation lung 
imaging,  involving  a  series  of  experiments  on  normal  volunteers,  chronic 
airways limitation or CAL patients, and unconscious, intubated intensive (ICU) 
care  patients,  and  patients  with  Pulmonary  Embolism  (PE).The  fourth 
experiment studied Technegas at the cellular level using Electron Microscopy 
(EM). This  experiment was unique as it used bronchoscopy to obtain human lung 
washings/lavages from volunteers following the administration of Technegas for a 
ventilation lung scan. This was in considerable contrast to previous studies by Isawa 
et al. (1996), Lemb et al. (1993,1994), Senden et al. (1997) that used samples of 
Technegas obtained directly from the Technegas generator and studied both their  
chemical and physical properties. Twenty volunteers, who were already booked in for 
a routine bronchoscopy procedure, agreed to participate in the experiment that only 
required one extra sample to be taken during the procedure.  In order to evaluate 
Pulmonary Embolism (PE) in compromised patients, it was necessary to examine the 
use of positive ventilation procedures in lung scintigraphy. 
7.2 Major benefits of TEBA
The series of experiments in this thesis showed that using positive pressure known 
as  TEBA  for  lung  ventilation  was  as  good  as  or  better  than  conventional  lung 
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scinitigraphy for patients with CAL and for unconscious patients from an Intensive 
Care Unit.  The results from experiment three found that TEBA can be an effective 
tool in the management of ICU patients with a possible diagnosis of PE. TEBA has 
the  potential  to  play  an  important  role  in  diagnosing  PE  in  ICU  patients,  who 
previously may have been commenced on anticoagulant therapy without the aid of 
lung scintigraphy. TEBA was able to provide a subjectively superior ventilation image 
for these critically ill, intubated patients.
TEBA in  most  cases  showed  an  improvement  in  ventilation  count  rate  over  the 
baseline, conventional method of ventilation (see Table 3.2) for normal volunteers 
and patients with CAL or PE. When compared to conventional ventilation delivery, 
breathing time with the utilization of the TEBA was significantly shorter (see table 3.1 
and  figure  3.3).  The  mean number  of  breaths  in  both  TEBA and  CAL group  to  
achieve the required counts was approximately 3 breaths.
No  volunteers  or  patients  reported  any  significant  discomfort  or  complications 
attributable to the device. The temporary lowering of oxygen saturation associated 
with  inhaling the anoxic Technegas and Argon mixture was common for all  three 
groups within  this research (Figure 3.4).  The use of  oxygen to  drive  the positive 
pressure in patients without CO2 retention helped reduce the severity of Technegas 
induced hypoxia. This in turn may reduce the theoretical risk of tissue infarction in 
patients with severely impaired coronary or cerebral circulation in the presence of 
severe hypoxia,  although such complications have not  been reported despite  the 
large number of ventilation studies using Technegas to date.
7.3 Significant results of the experiments 
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Investigations into the use of TEBA with normal volunteers, patients with CAL and PE 
and  inpatients  from the  ICU of  a  hospital  were  conducted  in  three  experiments 
involving 124 patients and normal volunteers. A further investigation, involving the 
use of EM with human lung tissue samples, was undertaken with 20 patients who 
were due to undergo bronchoscopy. This research using human samples is a first in 
Australian Nuclear Medicine Lung research.
A limitation to performing a TEBA V/Q scan on an ICU patient, is that two trained 
nuclear medicine staff are required to complete the procedure: one to operate the 
PAS  and  the  other  to  “squeeze”  the  resuscitation  bag  in  synchronicity  with  the 
subject’s  breathing  (Leiper  1998).  If  the  operators  do  not  maintain  an  adequate 
ventilation  technique  to  deliver  the  Technegas  to  the  patient,  radioactive  tracer 
leakage and contamination of the scanning room may occur unless specially trained 
nuclear medicine personnel are available. Therefore while the ICU patient is in the 
department, an intensivist and a nurse specialist must be present. 
The requirement for specialised training of either ICU or nuclear medicine staff 
has both economic and radiation safety implications. Nuclear Medicine centres 
that plan to offer V/Q studies to ICU must address these issues as part of their  
imaging.
Technegas in human lung tissue, at the cellular level 
The final experiment in this thesis studied Technegas in human lung tissue, at the 
cellular  level.  Previous  research  using  Electron  Microscopy  (EM)  reported  the 
physical  and  chemical  nature  of  Technegas  by  directly  studying  samples  of  
Technegas. The uniqueness of experiment four related to the method of obtaining 
the Technegas samples. In this experiment the Technegas came from lung biopsy 
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samples  and  washings  of  human  volunteers  who  had  undergone  a  Technegas 
ventilation study. This was the first EM investigation of Technegas within the lung 
tissue.
The experiment aimed to identify the location and structure of Technegas in the lung 
tissue samples using electron microscopy. Analysis of the EM data showed a range 
of cellular structures,  however,  only one hexagonal  Technegas particle was seen 
under  EM.  This  hexagonal  particle  was  found  to  be  of  metallic  technetium 
encapsulated within a layer of graphitic carbon, thus demonstrating for the first time 
that it is possible to observe Technegas particles from human lung tissue samples. 
It was disappointing that no further particles were observed. However, it is likely that 
a modified form of lung sample collection, with samples taken from trans-bronchial 
specimens rather than from the left  lower lobe of the lung, would prove fruitful  in 
gaining greater understanding of the action and location of Technegas within human 
lung tissue.
7.4 Conclusions
This  is  the  first  study  to  report  the  successful  application  of  TEBA  assisted 
ventilation/perfusion  lung scintigraphy,  with  a  range of  subjects,  including  normal 
volunteers, patients with CAL and PE as well as unconscious, intubated patients from 
the Intensive Care Unit. 
Better  management  of  PE  and  CAL -  These  observations  have  led  to  new 
suggestions  about  the  use  of  TEBA  in  the  management  of  PE  and  CAL.  
New suggestions are:
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1. Introducing  oxygen  saturation  analysis  using  a  pulse  oximetry  as  a  routine 
procedure during lung ventilation.   This  provides a continual  monitoring  of  the 
patient should they become hypoxic.  
2. Prior  to  any  anticoagulation,  tests  such  as  PT,  PTT  (prothrombin  time),  or  
D-dimer tests to determine a baseline of patient status in ICU should be performed 
as a routine procedure. 
3. An  algorithm  should  be  developed  as  a  medical  standard  diagnostic  tool  to 
investigate the symptoms of each patient depending on their initial presentation.
This data confirms the potential role of TEBA in the management of ICU patients with  
lung disease and has significance for reducing the incidence of complications arising 
from unnecessary use of anti-coagulant medication.  Further, this research indicates 
that having the potential to successfully transport an intubated, unconscious patient 
to  the  nuclear  medicine  department  for  a  V/Q  scan  may  result  in  different 
management  regimes  for  ICU  patients  in  the  future  with  regard  to  commencing 
anticoagulant therapy.  For example, it is now possible to diagnose patients prior to 
commencing treatment, thus reducing the risk of haemorrhage. 
Improved Diagnostic quality of ventilation - The results demonstrated that TEBA 
assisted ventilation is as good as or better than conventional ventilation in a group of 
patients with varying levels of lung function. The data also provides evidence that  
compared to conventional ventilation lung scintigraphy, TEBA  requires less time to 
achieve an adequate count rate, giving the potential for improved diagnostic quality 
of ventilation and management of patients with life threatening lung disease.
Chap 7 - 7
A first in nuclear medicine - This EM research was the first to use human bronchial 
washings/lavage  specimens  to  study  Technegas  at  the  cellular  level.  No  other 
nuclear medicine research to date has looked at this aspect, all other researchers 
studied the chemical and physical nature of Technegas.
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Appendix A:  Preparation and Use of Technegas
Overview
Technegas is produced in a Technegas Generator, which is purpose-built for lung 
scintigraphy. Its production requires an apparatus capable of heating a graphite 
crucible to 3000°C, thereby eliminating the concern of inhalation of tungsten oxide. 
It is concluded, after several experiments, that all the technetium–99m is absorbed 
on the surface of the graphite crucible and simultaneously volatilised to become 
coated  with  graphite  above  2200°C.  The  crucible  is  heated  to  2500oC  in  an 
atmosphere  of  pure  Argon  for  15  seconds.   The  resulting  vapour  and  Argon 
mixture are inhaled by the patient via  a Patient  Administration Set (PAS).  The 
Technegas produced is a dispersion of carbon particles containing Tc-99 atoms, 
either trapped within the core, or between overlapping sheets. These clusters have 
a maximum size of 0.017 microns and the carbon mass inhaled by a patient in a 
Technegas study is measured as 5 micrograms (± 20%) (Lemb, 1993).
The  structure  of  Technegas  consists  of  hexagonal  flat  crystals  of  technetium 
metal encapsulated within a carbon capsule to be within a range of 30-60 nm in 
size.  Prior  to  ventilation,  these  technetium  99m  particles  coagulate  into 
aggregates with a median diameter of 100 to 160 nm.  Depending on the time of  
technegas generation and ventilation, the longer the time, the larger the particles. 
These particles can be as large as 225 nm measured at 8.5-minute generations 
(Burch 1996). On inhalation, it diffuses and adheres to the alveolar walls, enabling 
multiple  conventional  views.   Technegas  particle  size  and  the  amount  of 
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deposition in the lung will determine the mucociliary clearance rate of technetium 
(Lloyd 1997).  
Preparation of Technegas conducted during experiments:
The carbon crucible is removed from its package using gloves and forceps; the 
crucible well is filled with 95% or absolute ethyl alcohol (ethanol) and drawing back 
the excess ethanol with a 1ml syringe, leaving the crucible wet. Methylated alcohol  
is not used, as it may leave residues from the evaporation process, which could 
lead to pyrolysis in the gas generation stage (Tetley Medical Ltd. Users Manual  
1999). The syringe is drawn back so there is no excess alcohol left in the crucible.  
The crucible is positioned so that one end is at the left hand contact and the other  
end is aligned with the right hand contact of the Technegas machine. There must  
be good contact or a low yield of Technegas may result. Rotation of the crucible is  
required to make sure the well cavity is in the upright position. Pushing the lever 
on the side of  the Technegas Generator  opens the contacts to  enable proper 
mounting of the crucible.
Figure A1 Loading the Crucible
(Vita Medical Limited)
Figure A2 The crucible 
or “boat” and contacts
Appendix A - 2
Overfilling the crucible may cause air bubbles to become trapped in the graphite 
crucible. Any unwanted bubbles will expand and ascend to the surface, causing 
the eluant to spill and possibly splash out of the crucible. Overfilling the crucible 
may actually result in having less radioactivity being simmered and burnt.
Approximately 700 – 900 MBq of technetium 99m pertechnetate in a 1ml syringe 
(in lead glass syringe shield) is injected into the crucible. The crucible is filled to a 
meniscus, concave or flat but never convex.  On days when the generator activity  
is low, two or three simmers of the crucible is sometimes necessary to reach the 
amount  of  radioactive  concentration  necessary  for  achieving  an  adequate 
ventilation count-rate. This re-simmer is achieved by interrupting the Technegas 
generation cycle following the evaporation phase, refilling and re-evaporating the 
crucible. The drawer is closed and for safety precautions, a two handed operation 
is required to close the door of the Technegas generator, allowing the start to be 
pressed to initiate the simmer phase.
The Technegas Generator automatically checks for the presence of Argon gas or 
any gas leaks. The Technegas Generator detects gas leaks by monitoring the 
pressure in the chamber over time allowing a tolerance range of up to a 50% drop 
in  pressure.  Once  all  checks  are  completed  satisfactorily,  the  generator 
commences the simmer/purge stage, which dries the technetium pertechnetate 
onto the walls of the well  in the graphite crucible.  This is achieved by a small  
current passing through the crucible, increasing the temperature to 70°C and then 
pushing a flow of Argon gas across the top of the crucible to disturb the surface of 
the pertechnetate. Concurrently,  the chamber is purged of any air ensuring an 
inert  atmosphere  is  created.  The simmer/purge stage lasts  six  minutes.  When 
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finished, the generator rechecks for Argon gas contamination and then the burn 
generation is initiated.
During the simmering phase,  technetium eluant is  evaporated onto the carbon 
crucible composed of high purity graphite, which is heated to 2500ºC under an 
atmosphere of high purity Argon (99.99%) for 15 seconds. At this temperature, 
carbon atoms aggregate  into  small  clusters each entailing a technetium atom. 
Each particle is a single, flat crystal of technetium metal encapsulated in carbon.  
The total  particle  output  of  one Technegas dose is  in  the  range of  3.4  x  106 
particles per cc. This corresponded to less than one (1) micron of carbon inhaled 
per Technegas administration (Tetley Medical Ltd. Users Manual 1999).
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 Bankstown Hospital for thesis (approval no. 6663)
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(approval no. 6333).
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